DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	SIRPB1; DOK2; LILRA1; LILRB3; F2; IFNG; IL2RA; CD4; CD3D; CD2; ASGR2; GP1BA; CD3E; CD3G; IFITM1; CCL2; LAG3; CXCR2; FPR2; CD27; CCR1; GLP1R; IFNAR2; CXCR3; CCR5; KLRD1; ADGRE1; PTK2B; ADGRG3; ADGRG5; LILRB2; NFAM1; KLRG1; IL17RA; P2RX7; DOK1; BAG1; ADGRE3; KLRF1; CLEC1B; MARCO; ADGRE2; SIGLEC9; LY96; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV7-1; TRBV27; TRBV7-3; TRBV6-8; CD8A; TRBV17; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV10-2; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; CD86; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	95	268	35.4477611940299	0	0	0	0	0	0	0
up	TRAV19; CD300LB; TYROBP; SH2D1A; LILRA1; CRTAM; CD160; CD8A; TRBV12-3; TRAV8-4; TRAC; TRBC1; HLA-B; HLA-H; CD3D; TRBV7-9; TRAV29DV5; ITGB2; CD3E; FCGR3A; CD3G; HLA-C; CD8B; FCGR1A; IFITM1; ICAM2; HLA-E; SELL; CD19; CD1D; HLA-G; LAG3; CD33; CD22; ITGAL; CD247; ITGB7; CD40LG; HLA-F; KIR2DL1; KIR3DL1; KIR3DL2; CD300C; KLRD1; CD300E; TREML2; LAIR1; LAIR2; JAML; TREML1; OSCAR; LILRB2; LILRB1; CD300LF; SLAMF6; TREM1; SLAMF7; KLRF1; HCST; CD300A; PILRA; SIGLEC9; HHLA2;	GO:0050776~regulation of immune response	63	216	29.1666666666667	0	0	0	0	0	0	0
down	TMEM129; PSMD11; PSMD12; PSMD14; PSMA7; PSMD3; PSMD10; FBXO21; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; CTNNB1; PSMC2; CCNF; PSMC4; PSMD8; UBE2A; PSMB2; PSMD7; THOP1; PSME3; PSMC5; RBX1; UBE2L3; PSMD2; ERCC8; SKP2; PPIL2; UBE2V2; PSMD5; FBXW9; LRSAM1; NHLRC1; RNF180; FBXO22; RNF217; DDB2; FBXW5; MIB2; SPSB1; RNF183; FBXO17; PSMB7; PSMD1; RUSC1; DDA1; HDAC6; FBXL7; FBXO4; STUB1; PSMD13; BTRC; UBE2S; UBE2J2; UBE2T; UBE2C; RNF14; UBE3B;	GO:0000209~protein polyubiquitination	62	245	25.3061224489796	0	0	0	0	0	0	0
down	KLK10; TMPRSS11D; KLK8; ZMPSTE24; PRSS23; F10; LTF; CFI; CTSD; CAPN1; CTSB; CTSG; MMP7; DLD; C1S; LTA4H; PEPD; APEH; CTSE; IDE; CPA3; PCSK2; CAPN2; KEL; PSMB5; PRSS3; GGT5; MMP12; CTSK; PSMC4; KLK7; MMP16; METAP1; CTSC; BACE1; RHBDL3; UBE2N; ADAM17; ADAMTSL3; HTRA3; PMPCA; FAP; ADAM15; WFDC2; HABP2; PCOLCE; NEDD8; TYSND1; GGT6; THSD4; TMPRSS11F; ATG4D; AMZ2; FBXL6; ADAMTS14; PIGK; HTRA1; GGH; RHBDF1; SCRN2; CAPNS2; TMEM59; ADAM33; TINAGL1; MMP28; RNPEP; CHMP1A; XPNPEP1; TMPRSS4; UFSP2; RHBDL2; DPP3; CTSF; KLK11; KLK12; KLK13; DNPEP; ADAMTS8; CLCA2; RCE1; KLK5; RHBDD3; ST14; CAPN8; F12; TPSAB1; MIPEP; CPA6; TPSB2; CAPN6; NLN; PRCP; PRSS16; THOP1; TPSD1; ERMP1;	GO:0006508~proteolysis	96	436	22.0183486238532	0	0	0	0	0	0	0
down	UBA6; PSMD11; PSMD14; UBE2C; AURKA; BUB3; BUB1B; RNF40; RNF8; FBXO21; PTTG1; UCHL3; PSMC2; USP5; UBE2A; PLK1; ATXN3; USP14; UBE2I; UBE2L3; CDC20; CDC16; MAD2L1; KEAP1; NEDD8; DDB1; USP30; USP31; USP43; FBXO22; RNF217; SPSB1; AURKB; RCHY1; KCTD10; FBXO8; USP40; ANAPC11; FBXL7; CDC23; ANAPC7; ZNRF3; CBLC; STUB1; BTRC; RNF14; RNF185; NDFIP2; SPSB3; TOLLIP; RNF150; UBE3B; RMND5B; ADRM1; RBX1; UBE2S; UBA1; RNF7; PSMD3; PSMD13; COPS3;	GO:0006511~ubiquitin-dependent protein catabolic process	61	291	20.9621993127148	0	0	0	0	0	0	0
down	PLPP3; RER1; SURF4; KIF1C; KIF4A; RAB6A; KDELR1; KDELR2; NSF; PITPNB; TMED10; KIF11; COPZ1; COG7; ARF5; KIF23; TMEM115; LMAN2; BNIP1; TMED2; RINT1; ARFGAP2; KIF18A; BICD2; SCFD1; KIF2C; TMED9; KLC2; RACGAP1; COG4; PICK1; USE1; COPZ2; ATP9A; DNAJC28; GOLPH3;	GO:0006890~retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum	36	85	42.3529411764706	0	0	0	0	0	0	0
down	CDK2AP1; CHEK1; MAPK13; KLK10; OIP5; EVI5; RNF8; PAK4; GNAI3; CLTA; BRCC3; CSNK1A1; PSME3; PPP1CA; ARF6; BLCAP; GNAI1; UBE2I; CDK5; RBBP4; SMARCB1; CHAF1A; MAPK7; USP39; FIGN; STEAP3; KCTD11; CDCA2; RINT1; CDC73; DCLRE1A; NCAPG2; MRPL41; SPC24; HJURP; NUP37; PARD3; PARD3B; PCNP; CCDC124; HMCN1; CDCA3; PELO; RHNO1; CINP; TRIOBP; SUV39H2; ACTR8; HELLS; FANCI; ARL8B; HMG20B; RCC2; KLHL9; KLHL13; APEX2; KLHL21; MCTS1;	GO:0007049~cell cycle	58	248	23.3870967741935	0	0	0	0	0	0	0
down	COL6A5; PODXL; ISLR; EFS; TGFB1I1; MTSS1; NRP2; SORBS3; FARP2; FN1; SPP1; PTPRF; HAPLN1; LAMC1; CEACAM1; ENG; KITLG; CD9; CDH3; NME2; TNC; AZGP1; COL8A1; EPHA2; EPHA3; CTNNA1; CTNNB1; THBS2; ITGAE; COL15A1; CXCL12; CD151; CCL11; APLP1; EMP2; MFAP4; CDH11; LGALS4; ARF6; RAC1; CLDN10; ADAM17; TNFAIP6; DGCR2; DST; COL16A1; DPT; DDR1; LGALS3BP; SPOCK1; TROAP; FAP; MSLN; TPBG; LY6D; HES1; HABP2; DSC3; IGFBP7; AOC3; FLG2; CERCAM; HES5; GRHL2; AMTN; PPFIBP1; EGFL6; TM9SF4; NEO1; MAGI1; BOC; CNTN3; CLCA2; SSX2IP; LOXL2; ADGRG1; PCDH17; CDH16; PCDHAC1; PCDHB13; PCDHA10; PCDHB14; PARD3B; PCDH10; PCDHB10; PCDH19; PCDHB11; PCDHB15; SIGLEC8; PCDHGC3; PCDHB3; PCDHGA10; PARD3; PCDHB18P; PCDHGA6; PCDHB4; PCDHGA8; PCDHGB7; TGFBI;	GO:0007155~cell adhesion	99	454	21.8061674008811	0	0	0	0	0	0	0
down	MATN2; NCKAP5; TXNDC9; CTDSPL; HSPA12A; PI15; CALU; PRICKLE3; MFSD11; TSPAN9; MSMB; GLI4; ESD; BGN; TM4SF1; PNPLA4; XG; TMEM50B; RWDD2B; EVA1C; KRTDAP; MRPS22; REEP5; LMNB2; RAD51AP2; HMGN3; FAM189A2; EXOC3L2; PRICKLE4; TMEM35A; BOLA3; CDKAL1; DHRS7B; GGT6; INO80C; TRPT1; UNC93A; NAXD; UEVLD; RPUSD2; RBFA; TMEM256; UBR7; SLC43A3; ZNF114; GSTCD; KLHDC9; BEST2; ABHD11; GIPC2; SPRYD4; HPSE2; CASKIN2; THAP4; TMEM54; TOMM40L; KIAA1191; TMEM143; TMEM125; EXOSC8; ISOC1; FLYWCH2; SCRN2; CYYR1; HHIPL1; FAM210A; DEPDC7; CDCA3; ARPC5L; DCUN1D5; C2orf49; TMEM106C; GPR87; GSDMC; TSPYL1; FAM234A; LPAR5; MRPL46; GHITM; C11orf1; PLEKHA5; EPB41L4A; MRPL47; EMC7; IFT46; PXMP2; STRN4; CCM2L; TMEM51; EMC3; SIPA1L2; IMPACT; FETUB; MRPS28; TMX2; AMMECR1; DMRT2; MPC1; PXMP4;	GO:0008150~biological_process	99	603	16.4179104477612	0	0	0	0	0	0	0
down	CLDN5; DLL1; ITGB1BP1; BIRC5; VEGFD; GREM1; CLDN7; EGFR; HRAS; KRT6A; FN1; CXCL10; SLC25A5; FGF1; CAPN1; ADRA2A; CDK4; PTHLH; BMP4; RARG; FOSL1; EPCAM; NTF3; KITLG; EPHA1; FGFR2; FGFR3; TNC; CDK2; SERPINB3; PRDX3; ALDH3A1; TTK; SHMT2; KDR; SSR1; ID4; SOX9; UBE2A; MVD; EMP2; ROMO1; EIF5A; ADAM17; BNC1; PTK2; PRKCZ; FOXM1; CDC20; TSPAN31; HDAC1; KLF5; HES1; CTF1; CCL14; RNF187; HES5; SAPCD2; MYOCD; DYNAP; OSR2; SLC35F6; TRPM4; BRK1; HPSE2; TFAP2B; HDAC2; TSLP; TBRG4; SFRP2; S100A13; OSMR; PRMT1; WDR77; MTA3; DERL2; WWTR1; PDF; ACER3; ASH2L; SERTAD1; CNOT7; MCTS1; CEP131; CLEC11A; ERBB2; ERBB3;	GO:0008284~positive regulation of cell population proliferation	87	490	17.7551020408163	0	0	0	0	0	0	0
down	ZBTB7C; NUPR2; SULT2B1; DLL1; ITGB1BP1; PDCD5; SLC9A3R1; IRF6; TAX1BP3; HGS; ALOX15B; FGF10; TGFB1I1; EEF1E1; SPRY2; SLIT3; TMEM127; PRKRA; GJB6; LDOC1; GAS8; HRAS; LMNA; TFAP2A; BCHE; SERPINE2; TMIGD3; HSPA1A; HSPA1B; GLI3; VDR; PTHLH; BMP2; BMP4; RARG; FOSL1; NME1; CD9; NPPC; IGFBP6; AZGP1; NOS3; S100A11; CDH5; CTNNB1; PHB; NF2; CDKN2C; FABP6; NUDT6; PMP22; DPT; DDR1; RBBP4; TMEM115; AIMP2; STK3; CDK10; DHCR24; SMAD1; STK11; IGFBP7; BAK1; CDKN3; TNS2; KANK2; CDC73; PODN; PBRM1; IFNLR1; P3H3; SIRT2; ABI1; MYOCD; DLG5; RNF139; TFAP2B; NDRG1; FRZB; DLG3; RERG; DNAJA3; SFRP2; DLC1; NDN; COPS8; CDC6; LZTS2; SOX7; ING2; DLL4; SMYD2; PEMT; CNOT7; ADAMTS8; NR2E3; ADGRG1;	GO:0008285~negative regulation of cell population proliferation	97	396	24.4949494949495	0	0	0	0	0	0	0
down	AGPAT2; FOXN1; GJB5; KRT14; PTHLH; DSP; KRT15; SPRR1B; SPRR2E; CRABP2; S100A7; NTF4; SPRR1A; SPRR2B; SPRR2A; KLK7; ALDH3A2; BNC1; PLOD1; TFDP1; KRT31; UGCG; ZNF750; GRHL2; CERS3; GRHL3; EVPL; SPRR2F; CALML5; SPRR3; POU2F3; KLK5; KRTDAP;	GO:0008544~epidermis development	33	82	40.2439024390244	0	0	0	0	0	0	0
down	TMEM129; UBA6; UBE2C; PEX10; RNF40; BCL10; UCHL3; UBA1; CCNF; USP5; UBE2A; PLK1; UBE2M; UBE2N; RBX1; UBE2L3; RAB40B; CDC20; NFX1; TRIM28; MED21; TNFAIP1; KEAP1; LRRC41; UBE2V2; NEDD8; NFE2L2; DDB1; UBE2S; DCAF10; KCTD11; CDC73; SPSB3; TRAF7; KLHL17; KCTD9; RRAGA; G2E3; CAND1; KLHL7; UBE2J2; FBXL6; COMMD1; UBR7; RNF139; PCNP; ASB5; RAB40A; PEX13; FBXW5; MUL1; SPSB1; TSPAN17; MED8; RNF170; LRR1; TRIM47; RCHY1; RAB40C; CDCA3; BARD1; UBAC1; TRAIP; RNF26; TRIM31; TRIM7; WDR61; WWTR1; BTBD1; KCTD10; MAGEF1; UBE2T; ANAPC11; WSB2; KCMF1; KLHL9; KLHL13; SAE1; RNF7; RNF14; PEF1; KLHL21; FBXL7; FBXO4; RNF150; ZNRF3; CBLC; STUB1; PDZRN3; BTRC; HIF3A; MIB2; CDC16; PJA1; ANAPC7; CDC23; RNF8;	GO:0016567~protein ubiquitination	97	444	21.8468468468468	0	0	0	0	0	0	0
down	PSMD11; PSMD12; PSMD14; PSMA7; HGS; PSMD3; SNX3; PSMD10; STAM2; IL33; ACTL6A; CDK1; UCHL3; PSMC3; CCNA2; PSMB1; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMC4; USP5; BRCC3; PSMD8; PSMB2; PSMD7; ATXN3; USP14; PSME3; PSMC5; CCNA1; CDC20; PSMD2; SKP2; KEAP1; SMAD1; NEDD8; ADRM1; PSMD5; USP39; ZC3H12A; INO80C; USP30; USP31; USP43; OTUD6B; JOSD2; DDB2; STAM; COPS5; OTUB1; PSMB7; PSMD1; BARD1; ACTR8; PSMD13; RCE1; USP40;	GO:0016579~protein deubiquitination	60	263	22.8136882129278	0	0	0	0	0	0	0
down	PSMD11; PSMD12; PSMD14; UBE2C; PSMA7; AURKA; PSMD3; BUB3; BUB1B; PSMD10; PTTG1; CDK1; CCNB1; PSMC3; PSMB1; CDK2; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMC4; PSMD8; PSMB2; PSMD7; PLK1; PSME3; PSMC5; CDC20; CDC16; PSMD2; MAD2L1; PSMD5; UBE2S; AURKB; PSMB7; PSMD1; ANAPC11; CDC23; ANAPC7; PSMD13;	GO:0031145~anaphase-promoting complex-dependent catabolic process	42	81	51.8518518518518	0	0	0	0	0	0	0
down	PSMD11; PSMD12; PSMD14; PSMA7; PSMD3; PSMD10; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; CCNF; PSMC4; PSMD8; PSMB2; PSMD7; PSME3; PSMC5; RBX1; PSMD2; PSMD5; FBXW5; PSMB7; PSMD1; WWTR1; FBXL7; FBXO4; PSMD13; BTRC; RNF7; FBXO17; FBXL6; SKP2;	GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	36	95	37.8947368421053	0	0	0	0	0	0	0
down	NDUFS8; NDUFAB1; NDUFA1; NDUFS4; NDUFB5; NDUFB3; NDUFC1; NDUFS5; NDUFS7; NDUFS2; NDUFS6; NDUFB1; NDUFS3; NDUFB6; NDUFB4; NDUFB8; NDUFB2; NDUFC2; NDUFA10; NDUFB10; NDUFB7; NDUFS1; NDUFV1; NDUFA8; NDUFA6; NDUFA5; NDUFA9; NDUFAF6; NDUFA11; TMEM126B; NUBPL; FOXRED1; ECSIT; TIMM21; ACAD9; TIMMDC1; NDUFB11; NDUFA13; BCS1L; NDUFB9;	GO:0032981~mitochondrial respiratory chain complex I assembly	40	64	62.5	0	0	0	0	0	0	0
down	AURKA; HDAC3; BIRC5; SPRY2; TRIAP1; GREM1; NOL3; PSMD10; CLDN7; BAG3; DDAH2; EGFR; TFRC; LTF; HSPB1; TFAP2A; CDK1; CEACAM5; NGFR; GSTP1; ANXA4; HSPA1A; HSPA1B; GLI3; BMP4; UNG; EPCAM; MGMT; NME2; AQP1; PRDX5; PRDX3; PRDX2; CTNNB1; KDR; SOX9; GCLC; IRAK1; PLK1; TMBIM6; DAD1; UFM1; HNRNPK; NKX3-2; GLO1; PTK2; PRKCZ; BNIP1; MAD2L1; HDAC1; FHL2; GAS6; PDE3A; ARL6IP1; DHCR24; STIL; DDB1; TAF9; NAA35; CIAPIN1; CDC73; ERC1; SUPV3L1; OSR1; SH3RF2; TFAP2B; HDAC2; APBB2; COPS5; TSLP; PSMG2; PHB2; BARD1; SMO; NAA38; HTATIP2; CARD14; ANGPTL4; WNK3; API5; ATG5; GOLPH3; BCL2L10; ATAD3A; SPHK1; PLK2; TNFSF18; PA2G4; HIGD1A; TMEM14A;	GO:0043066~negative regulation of apoptotic process	90	489	18.4049079754601	0	0	0	0	0	0	0
down	FOXE1; BHLHE40; HDAC3; BIRC5; FOXP2; RBFOX2; HR; GREM1; GMNN; ZBTB7A; TFAP2A; RB1; ENO1; GLI3; VDR; BMP2; BMP4; FABP4; BMP7; NR2F2; YWHAQ; HOXA7; CTNNB1; PHB; SOX18; ID4; SOX9; GCLC; SMARCA4; WNT4; FOXL2; PSMC5; SUMO1; UBE2I; PITX1; CDK5; E2F1; TLE1; RUNX1T1; FOXM1; FOXF2; TRIM28; HDAC1; VGLL4; GAS6; HES1; FOXD1; DEPDC1; KCTD1; ERN2; SIRT2; EID2; ZFPM2; TFAP2B; HDAC2; KAT5; SFRP2; PRMT6; PHB2; SOX7; MTA3; LGR4; CIPC; TP63; SUV39H2; CHMP1A; HEYL; NDUFA13; ZNF219; HDAC6; DKK3; HEY2; CNOT7; TIMELESS; FZD1; PA2G4; BTRC; CBY1; LOXL2; MAGED1; ZNF488; SIX5; OVOL1; SIX1; SOX13; OVOL2;	GO:0045892~negative regulation of transcription, DNA-templated	86	530	16.2264150943396	0	0	0	0	0	0	0
down	PSMD11; PSMD12; PSMD14; PSMA7; PSMD3; ERLIN1; GJB3; PSMD10; SLCO2B1; GJB6; SLC25A5; GJB1; SLC10A3; SLC25A4; PSMC3; PSMB1; AZGP1; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; GJB2; PSMC2; GJA5; PSMC4; SLC6A11; PSMD8; PSMB2; PSMD7; PEX3; PSME3; PSMC5; OCA2; PSMD2; PSMD5; SLC44A4; PDZD11; MFSD14B; LRRC8E; SLC18B1; SLC51B; LRRC8A; ABCA6; SLC35F6; SLC43A3; SLC25A43; SLC44A1; SLCO2A1; RNF185; PSMB7; PSMD1; MAGT1; ABCG4; ABCB6; GJB4; PSMD13; GJA3; ABCB8; ATP6V0E1;	GO:0055085~transmembrane transport	60	285	21.0526315789474	0	0	0	0	0	0	0
down	PSMD11; PSMD12; PSMD14; DVL1; PSMA7; PSMD3; FZD6; PSMD10; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMC4; PSMD8; PSMB2; PSMD7; AP2S1; PSME3; PSMC5; RAC1; PSMD2; PSMD5; PRICKLE2; ARHGEF19; VANGL1; DVL3; AP2M1; PSMB7; PSMD1; CELSR2; CELSR1; FZD4; PSMD13; FZD1; DAAM1;	GO:0060071~Wnt signaling pathway, planar cell polarity pathway	39	88	44.3181818181818	0	0	0	0	0	0	0
down	MRPS12; MRPS14; MRPL33; ERAL1; MRPL12; MRPS22; MRPS25; MRPS35; MRPS5; MRPS36; MRPS11; MRPS15; MRPS21; MRPS34; MRPS9; MRPL28; MRPL49; MRPL58; MRPL23; MRPL51; MRPL54; MRPL14; MRPL21; MRPL52; MRPL41; MRPL50; MRPL43; GADD45GIP1; MRPL30; MRPS27; GFM2; MRPL24; CHCHD1; MRPL38; MRRF; PTCD3; MRPL34; MRPL57; MRPL45; MRPL32; MRPL13; MRPL4; MRPL1; MRPS26; MRPL37; MRPL18; MRPL46; MRPL44; MRPL47; MRPS30; MRPL40; MRPL17; MRPS18A; AURKAIP1; MRPL22; MRPL16; MRPL39; MRPL35; MRPL15; MRPL36; MRPL27; MRPS28; MRPS17; MRPS7; MRPS2; MRPL11; MRPS16; MRPS18C; MRPS18B; MRPL42;	GO:0070126~mitochondrial translational termination	70	89	78.6516853932584	0	0	0	0	0	0	0
down	PSMD11; PSMD12; PSMD14; PSMA7; FGF10; PSMD3; DAPK3; JRK; PSMD10; EGFR; JUP; PSMC3; PSMB1; FGFR2; CDH3; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMC4; YAP1; PSMD8; PSMB2; PSMD7; DLX5; PSME3; PSMC5; CAV1; PSMD2; PSMD5; WLS; RSPO2; NRARP; DAAM2; TRPM4; SFRP2; VPS35; PSMB7; PSMD1; LGR4; PLEKHA4; GSKIP; PSMD13; CSNK1G3;	GO:0090263~positive regulation of canonical Wnt signaling pathway	46	144	31.9444444444444	0	0	0	0	0	0	0
down	PSMD11; PSMD12; PSMD14; UBE2C; PSMA7; PSMD3; BUB3; BUB1B; PSMD10; CDK1; CCNB1; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMB6; PSMB5; PSMC2; PSMC4; PSMD8; PSMB2; PSMD7; PLK1; PSME3; PSMC5; CDC20; CDC16; PSMD2; MAD2L1; PSMD5; DDB1; PSMB7; PSMD1; ANAPC11; CDC23; ANAPC7; PSMD13; BTRC;	GO:1901990~regulation of mitotic cell cycle phase transition	39	80	48.75	0	0	0	0	0	0	0
down	CDC45; RRM2; CCNA1; E2F1; ORC1; TFDP1; E2F4; CDC6; CDT1;	GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle	9	23	39.1304347826087	0.00010089401763013	0.00209991567534875	0.641887740162935	0.674072931786949	0.400874097992739	0.641786846145305	0.019706266932958
down	LETM1; VDAC1; PHB; PMPCA; MICU2; MCUR1; PHB2; SLC25A23; STOML2;	GO:0006851~mitochondrial calcium ion transmembrane transport	9	23	39.1304347826087	0.00010089401763013	0.00209991567534875	0.641887740162935	0.674072931786949	0.400874097992739	0.641786846145305	0.019706266932958
down	GOT2; GOT1; MDH2; NIT2; MDH1; MDH1B;	GO:0006107~oxaloacetate metabolic process	6	8	75	0.00010941895404492	0.00220854390324518	0.695248034001462	0.731028031974153	0.415291597302354	0.694919777139328	0.0207256682739311
down	DENR; EIF2D; GFM2; MRRF; MCTS1; PELO;	GO:0032790~ribosome disassembly	6	8	75	0.00010941895404492	0.00220854390324518	0.695248034001462	0.731028031974153	0.415291597302354	0.694919777139328	0.0207256682739311
down	TIMM10; NDUFA13; TIMM22; TIMM9; TIMM13; ROMO1;	GO:0045039~protein insertion into mitochondrial inner membrane	6	8	75	0.00010941895404492	0.00220854390324518	0.695248034001462	0.731028031974153	0.415291597302354	0.694919777139328	0.0207256682739311
down	FAP; PTGIS; ZC3H12A; SIRT2; DLC1; BOK;	GO:1900119~positive regulation of execution phase of apoptosis	6	8	75	0.00010941895404492	0.00220854390324518	0.695248034001462	0.731028031974153	0.415291597302354	0.694919777139328	0.0207256682739311
down	ZNF860; BHLHE40; DAPK3; SOX15; PFDN1; TULP3; SAP30; ZNF205; ZBTB7A; CHEK2; ABL1; RB1; ESRRA; BMP2; ZNF35; HOXB1; ZKSCAN1; ENG; POLR2A; CRABP2; PPP2R1A; PHB; ZNF133; RCAN1; CKS1B; PPP2CA; UBE2L3; E2F1; BNC1; EFEMP1; NFIA; SIX1; ZNHIT3; ZNF544; ZBED9; ERC1; ZNF454; ZNF114; ZNF596; RNF141; ARNTL2; TFAP2B; APBB2; ZNF521; ZSCAN31; MYCBP; CDCA7; SRRT; WWTR1; ING2; POFUT1; SOX17; TLE6; ZNF395; ZNF556; CELSR2; ZNF334; PAK6; GLRX2; ZNF219; ASH2L; RNF14; GTF2IRD1; ZNF391; ZNF112; ZNF229; SOX13; TCF19; MAGED1; TAF6L; NFX1; BCL11A; MLF2; SPIN4; GLI4; AJUBA; PRMT5; NUP35; SOX7; ACTR8; SPIN1; SOX18; MLF1; ZNF296; HR;	GO:0006355~regulation of transcription, DNA-templated	85	824	10.3155339805825	0.00011810557485347	0.00235541297192861	0.749616083595022	0.789063345596084	0.426542529251848	0.749616083595022	0.0221039336517492
down	DLL1; FGF1; PKM; FUT1; TJP1; SMAD1; BMPER; JMJD8;	GO:1903672~positive regulation of sprouting angiogenesis	8	18	44.4444444444444	0.00012227654961516	0.00242412352515996	0.775844707308212	0.816929627978907	0.431940759143757	0.775844707308212	0.0227487350211487
down	PLK1; CDC20; MAD2L1; TRIP13; PSMG2; AURKB; TTK; BUB1B; BUB3;	GO:0007094~mitotic spindle assembly checkpoint	9	24	37.5	0.00013112694641459	0.00255123143164313	0.831475967214945	0.876059128995908	0.443396015599287	0.831475967214945	0.023941555458584
down	ATXN3; LONP2; OMA1; HDAC6; STUB1; LONP1; CLPP;	GO:0006515~protein quality control for misfolded or incompletely synthesized proteins	7	13	53.8461538461538	0.00013136111547451	0.00255123143164313	0.832829472108427	0.877623612485237	0.443722046431632	0.832566749877478	0.023941555458584
down	CTNNB1; ID4; DLX1; HES1; HES5; DAAM2; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	7	13	53.8461538461538	0.00013136111547451	0.00255123143164313	0.832829472108427	0.877623612485237	0.443722046431632	0.832566749877478	0.023941555458584
down	CYTH3; ARF6; HES1; HES5; FBF1; PARD3; FRMD4B;	GO:0090162~establishment of epithelial cell polarity	7	13	53.8461538461538	0.00013136111547451	0.00255123143164313	0.832829472108427	0.877623612485237	0.443722046431632	0.832566749877478	0.023941555458584
up	TRAV19; PIK3CD; GRAP2; CD4; TRBV12-3; TRAV8-4; TRAC; TRBC1; HLA-DRB1; CD3D; TRBV7-9; TRAV29DV5; LCK; CD3E; CD3G; CD247; GATA3; PSMB9; PSMB10; TXK; WAS; ZAP70; TRAT1; SKAP1; PSMA8; INPP5D; CARD11; THEMIS2; PRAM1; HHLA2; CTLA4;	GO:0050852~T cell receptor signaling pathway	31	174	17.816091954023	0.00014284123710828	0.0202206055250484	0.502086948435612	0.50551513812621	0.49723034637393	0.502086948435612	0.17690919655381
down	WASL; MYO5C; MYO1D; MYO6; MYO19; MYO1B; MYO1E; MYO1C;	GO:0030050~vesicle transport along actin filament	8	19	42.1052631578947	0.00016434652190067	0.0030611257273211	1	1	0.483577199488314	0.999999999999289	0.0287265633597007
down	ITGB1BP1; ADCY6; NPR1; NOS3; AGTR1; P2RY2; GCLC; GCLM;	GO:0097746~regulation of blood vessel diameter	8	19	42.1052631578947	0.00016434652190067	0.0030611257273211	1	1	0.483577199488314	0.999999999999289	0.0287265633597007
down	GRM8; TULP1; DHRS3; LRAT; EML2; COL2A1; OAT; TACSTD2; CDH3; CNGA1; TIMP3; GLRB; GPR143; LUM; LAMB2; IRX5; EFEMP1; TGFBI; RDH10; MYO3A; BBS10; RABGGTA; HMCN1; OPA3; DLL4; CABP1; VAX2; NOB1; NR2E3; GJA3;	GO:0007601~visual perception	30	207	14.4927536231884	0.00016862787402705	0.00312945229548533	1	1	0.487854241758112	0.999999999999289	0.0293677612928671
down	KLK8; TNFRSF21; CTSC; JAM2; MTMR2; TMEM98;	GO:0031642~negative regulation of myelination	6	9	66.6666666666667	0.0001727902084988	0.00317145984335311	1	1	0.492076280230513	0.999999999999289	0.0297619732896627
down	RARG; FBN2; MFAP2; FOXL2; EFEMP1; VAX2;	GO:0048048~embryonic eye morphogenesis	6	9	66.6666666666667	0.0001727902084988	0.00317145984335311	1	1	0.492076280230513	0.999999999999289	0.0297619732896627
down	TIMM8A; BAG3; TIMM10; TIMM9; TIMM8B; TIMM13;	GO:0072321~chaperone-mediated protein transport	6	9	66.6666666666667	0.0001727902084988	0.00317145984335311	1	1	0.492076280230513	0.999999999999289	0.0297619732896627
down	SLC25A5; HSPA1A; GCLC; SLC35F6; BOK; TMEM14A;	GO:1901029~negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	6	9	66.6666666666667	0.0001727902084988	0.00317145984335311	1	1	0.492076280230513	0.999999999999289	0.0297619732896627
up	IL2RA; IL2RB; IL2RG; STAT5A; STAT5B; JAK3; PTK2B;	GO:0038110~interleukin-2-mediated signaling pathway	7	11	63.6363636363636	0.00019765910752234	0.0259079845007987	0.694376444725984	0.699515581521565	0.67125032914587	0.694376444725984	0.226667827364873
down	C1R; C3; IGLV1-47; IGLV1-51; IGLV2-23; IGLV6-57; IGHV3-23; IGKC; IGHG2; IGHG4; C1QA; C1QB; C1QC; CFI; C1S; C7; IGLV3-21; C1QBP; SUSD4; PHB2;	GO:0030449~regulation of complement activation	20	113	17.6991150442478	0.00020661538940947	0.00373080382876938	1	1	0.521290627480093	0.999999999999289	0.0350110325796872
down	GSN; GSTP1; CD9; EIF2B2; EIF2B1; HES5; LPAR1; HDAC11; ZNF488;	GO:0014003~oligodendrocyte development	9	26	34.6153846153846	0.00021450042667015	0.00383639806737059	1	1	0.527456549181899	0.999999999999289	0.0360019620140857
down	GREM1; PTHLH; BMP4; RARG; CTNNB1; SOX9; NKX3-2; EFEMP1;	GO:0032331~negative regulation of chondrocyte differentiation	8	20	40	0.00021762913979972	0.00386696883777117	1	1	0.529898557289989	0.999999999999289	0.0362888477061789
down	PSMD10; GSTP1; EFNA1; NF2; CAV1; DAG1; CASC2; LEMD2;	GO:0043409~negative regulation of MAPK cascade	8	20	40	0.00021762913979972	0.00386696883777117	1	1	0.529898557289989	0.999999999999289	0.0362888477061789
down	COL2A1; NGFR; GSTP1; COX7B; GABRA4; EIF2B2; ALDH3A2; RCAN1; PTS; STK3; UGT8; GRHL3; NDN; SH3GL1; B3GNT5; ROBO2; CELSR1; NCKAP1; HAPLN1; VAX2; SMO; SOX9;	GO:0007417~central nervous system development	22	133	16.5413533834586	0.0002396320658814	0.00418325159534331	1	1	0.543452098713167	0.999999999999289	0.0392569442446143
down	NUDT21; KRT10; RRM2; CPSF6; HSD17B8; FARSB; FARSA;	GO:0051290~protein heterotetramerization	7	15	46.6666666666667	0.00025895038599088	0.0044534469066394	1	1	0.554930677178469	0.999999999999289	0.0417925417407138
down	COPS6; COPS5; COPS8; COPS4; COPS7A; COPS3;	GO:0000338~protein deneddylation	6	10	60	0.00026196746509643	0.0044534469066394	1	1	0.556737461250355	0.999999999999289	0.0417925417407138
down	BANF1; LMNA; PPP2R1A; PPP2CA; REEP3; REEP4;	GO:0007084~mitotic nuclear envelope reassembly	6	10	60	0.00026196746509643	0.0044534469066394	1	1	0.556737461250355	0.999999999999289	0.0417925417407138
down	ARF6; RAB35; MICALL1; VPS35; TOLLIP; TMEM30A;	GO:0036010~protein localization to endosome	6	10	60	0.00026196746509643	0.0044534469066394	1	1	0.556737461250355	0.999999999999289	0.0417925417407138
down	LMNA; CDK1; CCNB1; FHL2; ATG5; HEY2;	GO:0055015~ventricular cardiac muscle cell development	6	10	60	0.00026196746509643	0.0044534469066394	1	1	0.556737461250355	0.999999999999289	0.0417925417407138
down	PDLIM4; PDLIM3; PDLIM5; PRICKLE4; PDLIM7; PDLIM1;	GO:0061061~muscle structure development	6	10	60	0.00026196746509643	0.0044534469066394	1	1	0.556737461250355	0.999999999999289	0.0417925417407138
down	EIF3D; DENR; PTBP1; EIF2D; EIF3B; MCTS1;	GO:0075522~IRES-dependent viral translational initiation	6	10	60	0.00026196746509643	0.0044534469066394	1	1	0.556737461250355	0.999999999999289	0.0417925417407138
down	DLL1; GREM1; LRP4; GLI3; CTNNB1; DLX1; TP63; HOXD9; HOXB9;	GO:0009954~proximal/distal pattern formation	9	27	33.3333333333333	0.00027036221990695	0.00454984884432829	1	1	0.561804423801271	0.999999999999289	0.0426972077419503
down	RAD51B; RAD51C; CDK1; CDK4; CCNB1; CCND1; RAB11A; MTA3; RCC2;	GO:0010971~positive regulation of G2/M transition of mitotic cell cycle	9	27	33.3333333333333	0.00027036221990695	0.00454984884432829	1	1	0.561804423801271	0.999999999999289	0.0426972077419503
down	PDE2A; NDUFS4; RAPGEF3; ADCYAP1R1; SOX9; DEFB1; MAPK7; PDE3A; PCLO;	GO:0019933~cAMP-mediated signaling	9	27	33.3333333333333	0.00027036221990695	0.00454984884432829	1	1	0.561804423801271	0.999999999999289	0.0426972077419503
down	YAP1; YWHAE; TJP1; STK3; TEAD4; AMOTL1; TEAD3; WWTR1; MOB1A;	GO:0035329~hippo signaling	9	27	33.3333333333333	0.00027036221990695	0.00454984884432829	1	1	0.561804423801271	0.999999999999289	0.0426972077419503
down	DVL1; FZD6; DVL3; FZD4; FRZB; FZD1; FZD10; SFRP2;	GO:0035567~non-canonical Wnt signaling pathway	8	21	38.0952380952381	0.00028427963892063	0.00475707458277928	1	1	0.57005217299256	0.999999999999289	0.0446418790281516
up	HLA-E; HLA-G; HLA-F; HLA-C; HLA-B; HLA-H; FCGRT;	GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib	7	12	58.3333333333333	0.00029277652415493	0.0345378706328106	1	1	0.852272461815019	0.99999999854637	0.302170325055849
up	HLA-B; HLA-C; HLA-G; HLA-H; FCGRT; HLA-F; HLA-E;	GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	7	12	58.3333333333333	0.00029277652415493	0.0345378706328106	1	1	0.852272461815019	0.99999999854637	0.302170325055849
down	GAS1; RINT1; RNF139; SCFD1; YIPF5;	GO:0060628~regulation of ER to Golgi vesicle-mediated transport	5	6	83.3333333333333	0.00030608941959364	0.00504934175877816	1	1	0.583100344325898	0.999999999999289	0.0473846058212258
down	HSPA1A; HSPA1B; RBBP7; HSBP1; HSBP1L1;	GO:0070370~cellular heat acclimation	5	6	83.3333333333333	0.00030608941959364	0.00504934175877816	1	1	0.583100344325898	0.999999999999289	0.0473846058212258
down	CCL21; NRG2; ITGB1BP1; FGF10; SPRY2; RAMP3; EGFR; F10; ERBB2; FGF1; TXN; ENG; KITLG; FGFR2; ERBB3; FGFR3; RAC1; PTK2; C1QBP; STK3; GAS6; ITSN1; FAM110C; MEIS3; CCL19;	GO:0051897~positive regulation of protein kinase B signaling	25	165	15.1515151515152	0.00031258662160782	0.0051438207363593	1	1	0.587004091184666	0.999999999999289	0.0482712261620439
down	EPHB6; STK16; ABL1; EGFR; ERBB2; EPHA1; FGFR2; ERBB3; FGFR3; EPHA2; EPHA3; WEE1; TTK; TIE1; KDR; MAP2K2; EPHB3; PTK2; EFEMP1; MELK; ABI1;	GO:0018108~peptidyl-tyrosine phosphorylation	21	127	16.5354330708661	0.00032925730409716	0.00535223369506849	1	1	0.595094142716863	0.999999999999289	0.0502270386952918
up	CCL5; CXCR2; CCR1; CCR7; CCR2; CCR5; CCR6; CXCR4;	GO:0002407~dendritic cell chemotaxis	8	17	47.0588235294118	0.00032973766721955	0.037643277557742	1	1	0.905456754499222	0.99999999854637	0.329339394912916
down	HSPA1A; HSPA1B; RNH1; RIDA; METTL3; LSM2; LSM5; YTHDF2; CNOT10;	GO:0006402~mRNA catabolic process	9	28	32.1428571428571	0.00033774393794416	0.00542420011876199	1	1	0.599157745912954	0.999999999999289	0.0509023941736869
down	HSPB1; EIF2B2; NCBP2; EIF3B; DDX1; EIF3K; GLE1; PAIP1; EIF2B1;	GO:0006446~regulation of translational initiation	9	28	32.1428571428571	0.00033774393794416	0.00542420011876199	1	1	0.599157745912954	0.999999999999289	0.0509023941736869
down	CYP1A1; RB1; CCNB1; FGFR2; OXTR; CLDN18; FOXF1; MYOCD; LGR4;	GO:0048565~digestive tract development	9	28	32.1428571428571	0.00033774393794416	0.00542420011876199	1	1	0.599157745912954	0.999999999999289	0.0509023941736869
down	AURKA; TTK; KIF11; AURKB; SPAG5; AUNIP; KNSTRN;	GO:0007051~spindle organization	7	16	43.75	0.00035239200770431	0.00558943226725273	1	1	0.606114253251424	0.999999999999289	0.052452984448472
down	ALOX15B; ALOX12B; GPX4; PON2; PON3; LTC4S; PLA2G3;	GO:0019372~lipoxygenase pathway	7	16	43.75	0.00035239200770431	0.00558943226725273	1	1	0.606114253251424	0.999999999999289	0.052452984448472
down	DNM1L; GGCT; SFN; BAK1; TIMM50; MFF; BOK; BAD;	GO:0001836~release of cytochrome c from mitochondria	8	22	36.3636363636364	0.00036670434278651	0.00575106036187023	1	1	0.613014626417509	0.999999999999289	0.053969753151991
down	SLC9A3R1; RARG; EZR; KEL; RDX; RAC1; IQGAP3; VAV3;	GO:0008361~regulation of cell size	8	22	36.3636363636364	0.00036670434278651	0.00575106036187023	1	1	0.613014626417509	0.999999999999289	0.053969753151991
down	FGF10; BMP4; BMP7; PPP1CA; RASIP1; MKS1; TIMELESS; CLIC4;	GO:0048754~branching morphogenesis of an epithelial tube	8	22	36.3636363636364	0.00036670434278651	0.00575106036187023	1	1	0.613014626417509	0.999999999999289	0.053969753151991
down	MGST3; GSTZ1; GSTP1; MGST1; ESD; AKR1A1; MGST2; GSTO2;	GO:1901687~glutathione derivative biosynthetic process	8	22	36.3636363636364	0.00036670434278651	0.00575106036187023	1	1	0.613014626417509	0.999999999999289	0.053969753151991
down	SURF4; OBSL1; ARL1; CSNK1A1; RAB2A; TMED2; HIKESHI; LYSMD3; PLEKHM2; ATL2; GORASP1; TMED9; GOLPH3; COG4; PI4K2B; COG7; DNAJC28; LMAN2; UBXN2A; TMED10;	GO:0007030~Golgi organization	20	119	16.8067226890756	0.00037486570713096	0.0058652875628618	1	1	0.616915779257761	0.999999999999289	0.0550416970115322
down	LAMA5; TGFB1I1; FGFR2; GRSF1; KDF1; JAG2;	GO:0016331~morphogenesis of embryonic epithelium	6	11	54.5454545454545	0.0003836565167572	0.0059748465931349	1	1	0.621139900629911	0.999999999999289	0.0560698332937756
down	FGF10; PLXNA2; COL2A1; FGFR2; SOX9; ZNF219;	GO:0060174~limb bud formation	6	11	54.5454545454545	0.0003836565167572	0.0059748465931349	1	1	0.621139900629911	0.999999999999289	0.0560698332937756
down	PLD2; OBSL1; PAK4; KRT6A; KRT16; DES; KRT15; SOX9; CCL11; FGD1; DST; KRT31; UGT8; NECTIN2; CCL13; PAK6; MARK1; CDC42BPB; PCLO; AJUBA; MAST2; PACSIN3;	GO:0007010~cytoskeleton organization	22	139	15.8273381294964	0.00041131848183373	0.0063759136360352	1	1	0.633127612463214	0.999999999999289	0.0598335721420477
down	GIPC1; TGFB1I1; GOT1; ITGA8; ADAM17; STK11; NPNT; MYOCD; ING2;	GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway	9	29	31.0344827586207	0.00041839834462131	0.00647064662133108	1	1	0.635965483824403	0.999999999999289	0.0607225761708815
up	CR1; C3AR1; FPR3; FPR1; FPR2; C5AR1; C5AR2;	GO:0002430~complement receptor mediated signaling pathway	7	13	53.8461538461538	0.00042141295247155	0.0438641305528481	1	1	0.99999999854637	0.99999999854637	0.383765366671294
down	PRMT5; DAPK3; OBSL1; RCC1; CAV2; NEK2; FBXW5; PKMYT1;	GO:0007088~regulation of mitotic nuclear division	8	23	34.7826086956522	0.00046756668370906	0.00709957503150059	1	1	0.655069562514783	0.999999999999289	0.066624637514589
down	GCAT; PEPD; GGT5; GSS; PTS; KYAT3; BPHL;	GO:0006520~cellular amino acid metabolic process	7	17	41.1764705882353	0.00047099439935061	0.00710319093016124	1	1	0.656526715728143	0.999999999999289	0.0666585702410531
down	PIGN; PIGA; PIGF; PIGH; PIGZ; PIGM; PIGV;	GO:0016254~preassembly of GPI anchor in ER membrane	7	17	41.1764705882353	0.00047099439935061	0.00710319093016124	1	1	0.656526715728143	0.999999999999289	0.0666585702410531
down	CHCHD10; KCNK10; KCNK6; KCNK3; KCNK1; KCNK7; KCNK5;	GO:0030322~stabilization of membrane potential	7	17	41.1764705882353	0.00047099439935061	0.00710319093016124	1	1	0.656526715728143	0.999999999999289	0.0666585702410531
up	HLA-B; HLA-H; HLA-C; HLA-E; HLA-G; HLA-F;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	6	9	66.6666666666667	0.00048221621486344	0.0460945328173129	1	1	0.99999999854637	0.99999999854637	0.403279058885381
up	TLR4; AIM2; CD36; GBP5; NLRC4; TLR6;	GO:0050702~interleukin-1 beta secretion	6	9	66.6666666666667	0.00048221621486344	0.0460945328173129	1	1	0.99999999854637	0.99999999854637	0.403279058885381
down	KALRN; NSF; RAB38; RAB14; ARF6; RAB11A; VAMP3; YIPF5; YIPF2; OSBPL1A; CHMP1A; VPS4A; HSPA1B; ARF5; HSPA1A; AP2S1; ARL1; AP3S1; KIF1C; TVP23B; ARL4D; AP1B1;	GO:0016192~vesicle-mediated transport	22	141	15.6028368794326	0.00048863528082376	0.00733611755322156	1	1	0.663382267480141	0.999999999999289	0.0688444266845776
down	ITGB1BP1; BMP4; EPHA2; BMPER; NRARP;	GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis	5	7	71.4285714285714	0.0004979320759535	0.00739263155432296	1	1	0.666779765480953	0.999999999999289	0.0693747717856821
down	MVD; DOLPP1; SRD5A3; DOLK; DPAGT1;	GO:0006489~dolichyl diphosphate biosynthetic process	5	7	71.4285714285714	0.0004979320759535	0.00739263155432296	1	1	0.666779765480953	0.999999999999289	0.0693747717856821
down	E2F8; CHMP4C; AURKB; ZFYVE19; VPS4A;	GO:0032466~negative regulation of cytokinesis	5	7	71.4285714285714	0.0004979320759535	0.00739263155432296	1	1	0.666779765480953	0.999999999999289	0.0693747717856821
down	GTF3C1; GTF3C2; GTF3C6; GTF3C5; POLR2L;	GO:0042797~tRNA transcription by RNA polymerase III	5	7	71.4285714285714	0.0004979320759535	0.00739263155432296	1	1	0.666779765480953	0.999999999999289	0.0693747717856821
down	NEK2; SPAG5; RACGAP1; ECT2; KNSTRN;	GO:0051988~regulation of attachment of spindle microtubules to kinetochore	5	7	71.4285714285714	0.0004979320759535	0.00739263155432296	1	1	0.666779765480953	0.999999999999289	0.0693747717856821
down	ZMPSTE24; CHEK2; HRAS; ELK1; YAP1; RPL26; RAD51; GTF2H5; TMEM109;	GO:0071480~cellular response to gamma radiation	9	30	30	0.00051424396968025	0.00756754176527258	1	1	0.672116868372087	0.999999999999289	0.071016184032248
down	RAMP2; PAK4; ABL1; KDR; MAPK7; GAS6; NFE2L2; NDNF; ANGPTL4;	GO:2000352~negative regulation of endothelial cell apoptotic process	9	30	30	0.00051424396968025	0.00756754176527258	1	1	0.672116868372087	0.999999999999289	0.071016184032248
down	RFC4; GINS1; GINS3; GINS2; POLD2; MCM4;	GO:0006271~DNA strand elongation involved in DNA replication	6	12	50	0.00054538586636576	0.00792113689823844	1	1	0.680684301434385	0.999999999999289	0.0743344315972427
down	RB1; DLGAP5; CDC23; ANAPC7; CDC16; ANAPC11;	GO:0045842~positive regulation of mitotic metaphase/anaphase transition	6	12	50	0.00054538586636576	0.00792113689823844	1	1	0.680684301434385	0.999999999999289	0.0743344315972427
down	SPINT2; TACSTD2; FBLN1; CTNNA1; CRK; AP1AR;	GO:2000146~negative regulation of cell motility	6	12	50	0.00054538586636576	0.00792113689823844	1	1	0.680684301434385	0.999999999999289	0.0743344315972427
down	RAMP2; RRAS; CEACAM1; CD34; KDR; RIN2;	GO:2001214~positive regulation of vasculogenesis	6	12	50	0.00054538586636576	0.00792113689823844	1	1	0.680684301434385	0.999999999999289	0.0743344315972427
down	MEIS2; FGF10; CTNNB1; NKX3-2; NKX6-1; FOXF1; MSLN; HES1;	GO:0031016~pancreas development	8	24	33.3333333333333	0.00058979090585409	0.0083660149511915	1	1	0.692485680746357	0.999999999999289	0.0785093066967637
down	POLD1; RFC4; RFC2; FEN1; RFC5; POLD2; POLE2; POLE3;	GO:0032201~telomere maintenance via semi-conservative replication	8	24	33.3333333333333	0.00058979090585409	0.0083660149511915	1	1	0.692485680746357	0.999999999999289	0.0785093066967637
down	HYAL3; CYP1A1; AOC1; GJB2; SLC1A3; HYAL2; ENDOG; AOC3;	GO:0046677~response to antibiotic	8	24	33.3333333333333	0.00058979090585409	0.0083660149511915	1	1	0.692485680746357	0.999999999999289	0.0785093066967637
down	DLL1; CANX; AP2S1; FCHO2; AP2M1; INPP5F; CLTB; CLTA;	GO:0072583~clathrin-dependent endocytosis	8	24	33.3333333333333	0.00058979090585409	0.0083660149511915	1	1	0.692485680746357	0.999999999999289	0.0785093066967637
down	DVL1; SOX9; HOXA1; SIX1; MYO3A; GRHL3; FRZB; EYA1;	GO:0090103~cochlea morphogenesis	8	24	33.3333333333333	0.00058979090585409	0.0083660149511915	1	1	0.692485680746357	0.999999999999289	0.0785093066967637
up	CD4; CD3E; CD80; CD86; STAT5B; IRF4; CARD11;	GO:0045086~positive regulation of interleukin-2 biosynthetic process	7	14	50	0.00059145607693555	0.0536708475967934	1	1	0.99999999854637	0.99999999854637	0.46956390672618
down	NME6; NME1; NME2; DTYMK; CMPK1; SUCLG1; NME7;	GO:0006165~nucleoside diphosphate phosphorylation	7	18	38.8888888888889	0.000619350669119	0.00857146962103534	1	1	0.700027036614788	0.999999999999289	0.0804373577199997
down	MTX2; MTX1; IMMT; CHCHD6; APOO; SAMM50; TMEM11;	GO:0007007~inner mitochondrial membrane organization	7	18	38.8888888888889	0.000619350669119	0.00857146962103534	1	1	0.700027036614788	0.999999999999289	0.0804373577199997
down	C1QA; ALAD; CCND1; CPOX; SLC11A2; HFE; CYBRD1;	GO:0010039~response to iron ion	7	18	38.8888888888889	0.000619350669119	0.00857146962103534	1	1	0.700027036614788	0.999999999999289	0.0804373577199997
down	PDE2A; RAPGEF3; EZR; RDX; SOX18; MARVELD2; ROBO4;	GO:0061028~establishment of endothelial barrier	7	18	38.8888888888889	0.000619350669119	0.00857146962103534	1	1	0.700027036614788	0.999999999999289	0.0804373577199997
down	VPS26A; RAB11B; MICALL1; VPS35; VPS29; ANKRD50; SNX31;	GO:1990126~retrograde transport, endosome to plasma membrane	7	18	38.8888888888889	0.000619350669119	0.00857146962103534	1	1	0.700027036614788	0.999999999999289	0.0804373577199997
down	NDC80; FGF10; SPRY2; CENPA; PLK1; GPSM2; MAD2L1; SAPCD2; ACTR10;	GO:0000132~establishment of mitotic spindle orientation	9	31	29.0322580645161	0.00062736845452571	0.00857146962103534	1	1	0.701834356638586	0.999999999999289	0.0804373577199997
down	MCM2; POLE2; CDC6; POLE3; ORC1; CDC45; MCM10; ORC5; ORC6;	GO:0006270~DNA replication initiation	9	31	29.0322580645161	0.00062736845452571	0.00857146962103534	1	1	0.701834356638586	0.999999999999289	0.0804373577199997
down	BUB1B; ZWINT; HRAS; RB1; MAD2L1; TICRR; PRCC; PLK2; WEE1;	GO:0007093~mitotic cell cycle checkpoint	9	31	29.0322580645161	0.00062736845452571	0.00857146962103534	1	1	0.701834356638586	0.999999999999289	0.0804373577199997
down	GIPC1; ABL1; S100A2; NOS3; PRSS3; PTK2; FAP; LOXL2; TGFB1I1;	GO:0043542~endothelial cell migration	9	31	29.0322580645161	0.00062736845452571	0.00857146962103534	1	1	0.701834356638586	0.999999999999289	0.0804373577199997
down	PSMD10; EGFR; CCNB1; CCND1; ADAM17; PSRC1; CDC6; CKS1B; CKS2;	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	9	31	29.0322580645161	0.00062736845452571	0.00857146962103534	1	1	0.701834356638586	0.999999999999289	0.0804373577199997
down	FGF10; RNF8; EGFR; BRCC3; UBE2N; TRIM28; EYA1; TMEM161A; ERCC8;	GO:0045739~positive regulation of DNA repair	9	31	29.0322580645161	0.00062736845452571	0.00857146962103534	1	1	0.701834356638586	0.999999999999289	0.0804373577199997
down	MEIS2; ABL1; CCNB1; FOXA1; EIF4EBP1; TTL; SMOC2; SPHK1; POLDIP2;	GO:0045931~positive regulation of mitotic cell cycle	9	31	29.0322580645161	0.00062736845452571	0.00857146962103534	1	1	0.701834356638586	0.999999999999289	0.0804373577199997
down	SPTLC2; SMPD2; ALOX12B; FA2H; CERS3; SPTSSA; ELOVL1; CERS4; SGMS2;	GO:0046513~ceramide biosynthetic process	9	31	29.0322580645161	0.00062736845452571	0.00857146962103534	1	1	0.701834356638586	0.999999999999289	0.0804373577199997
down	CAPN2; PTK2; TJP1; SYDE1; MARK2; F11R; CLIC4; CAPN6; STMN1;	GO:0051493~regulation of cytoskeleton organization	9	31	29.0322580645161	0.00062736845452571	0.00857146962103534	1	1	0.701834356638586	0.999999999999289	0.0804373577199997
down	MYO1C; ITGB1BP1; HRAS; ERBB2; CACNB3; CDK5; SLC51B; CEMIP; MFF;	GO:0090314~positive regulation of protein targeting to membrane	9	31	29.0322580645161	0.00062736845452571	0.00857146962103534	1	1	0.701834356638586	0.999999999999289	0.0804373577199997
down	KCNK1; AQP1; SLC1A3; ATP1A2; ATP1B3; KCNMA1; KCNJ8; CCDC51; ABCB8; HCN3; KCNIP3; KCNS3; KCNK5; KCNK6; KCNA7; SLC9A3; KCNK10; KCNK7; KCNF1; KCNK3;	GO:0071805~potassium ion transmembrane transport	20	125	16	0.00065173155485187	0.00888616024074567	1	1	0.707128737014285	0.999999999999289	0.0833905131376714
up	TLR4; IL18RAP; EOMES; SPN; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	6	10	60	0.00072282034513526	0.060906219081755	1	1	0.99999999854637	0.99999999854637	0.53286585654105
down	CTSV; CTSB; SPP1; VDR; GJB2; STC1; PTGIS; TPPP3;	GO:0046697~decidualization	8	25	32	0.00073656337287131	0.00984195978830648	1	1	0.724036811598307	0.999999999999289	0.0923600356950501
down	ITGB1BP1; ABL1; SDC4; KDR; WNT4; RAC1; COL16A1; EPB41L5;	GO:0051894~positive regulation of focal adhesion assembly	8	25	32	0.00073656337287131	0.00984195978830648	1	1	0.724036811598307	0.999999999999289	0.0923600356950501
down	JCHAIN; IGHA1; IGHA2; CD34; MYO1E; SULF1;	GO:0003094~glomerular filtration	6	13	46.1538461538462	0.00075546707513263	0.009865950258368	1	1	0.727423286553456	0.999999999999289	0.0925851697861134
down	DNPEP; THOP1; MIPEP; CPXM1; CPE; NLN;	GO:0006518~peptide metabolic process	6	13	46.1538461538462	0.00075546707513263	0.009865950258368	1	1	0.727423286553456	0.999999999999289	0.0925851697861134
down	CTNNB1; NF2; BMPR1A; GRHL3; EPB41L5; VAX2;	GO:0007398~ectoderm development	6	13	46.1538461538462	0.00075546707513263	0.009865950258368	1	1	0.727423286553456	0.999999999999289	0.0925851697861134
down	FN1; FBLN1; CAV1; PCOLCE; NDUFA13; PCOLCE2;	GO:0010952~positive regulation of peptidase activity	6	13	46.1538461538462	0.00075546707513263	0.009865950258368	1	1	0.727423286553456	0.999999999999289	0.0925851697861134
down	UBE2M; RBX1; NAE1; NEDD8; RNF7; DCUN1D5;	GO:0045116~protein neddylation	6	13	46.1538461538462	0.00075546707513263	0.009865950258368	1	1	0.727423286553456	0.999999999999289	0.0925851697861134
down	FGF10; CTNNB1; WNT4; FOXF1; MYOCD; HEY2;	GO:0051145~smooth muscle cell differentiation	6	13	46.1538461538462	0.00075546707513263	0.009865950258368	1	1	0.727423286553456	0.999999999999289	0.0925851697861134
down	EGFR; TFAP2A; HDAC1; OSR2; GRHL3; HDAC2;	GO:0061029~eyelid development in camera-type eye	6	13	46.1538461538462	0.00075546707513263	0.009865950258368	1	1	0.727423286553456	0.999999999999289	0.0925851697861134
down	GRHL3; SFRP2; CELSR1; FZD1; DVL3; DVL1;	GO:0090179~planar cell polarity pathway involved in neural tube closure	6	13	46.1538461538462	0.00075546707513263	0.009865950258368	1	1	0.727423286553456	0.999999999999289	0.0925851697861134
down	PIGZ; ALG3; PIGM; ALG2; ALG9; PIGV;	GO:0097502~mannosylation	6	13	46.1538461538462	0.00075546707513263	0.009865950258368	1	1	0.727423286553456	0.999999999999289	0.0925851697861134
down	TJP1; MYH14; LURAP1; CDC42BPB; F11R; EPB41L5; FRMD6; EPB41L4A; CDC42BPG;	GO:0031032~actomyosin structure organization	9	32	28.125	0.00076003077593744	0.009865950258368	1	1	0.728121448142412	0.999999999999289	0.0925851697861134
down	ERBB2; RNH1; EFNA1; EPHA2; CTNNB1; EMP2; MAPK7; HTATIP2; TNFRSF12A;	GO:0045765~regulation of angiogenesis	9	32	28.125	0.00076003077593744	0.009865950258368	1	1	0.728121448142412	0.999999999999289	0.0925851697861134
down	HUS1; RAD51; SWI5; RAD51AP1; RHNO1; TNKS1BP1; ECT2; INTS7; FBXO4;	GO:0071479~cellular response to ionizing radiation	9	32	28.125	0.00076003077593744	0.009865950258368	1	1	0.728121448142412	0.999999999999289	0.0925851697861134
down	PLXNB2; PLXNA2; FARP2; RAC1; PLXNB3; SEMA4B; SEMA3G; SEMA6D; SEMA3F;	GO:0071526~semaphorin-plexin signaling pathway	9	32	28.125	0.00076003077593744	0.009865950258368	1	1	0.728121448142412	0.999999999999289	0.0925851697861134
down	FGF10; PLRG1; EGFR; CYP1A1; RDX; ADAM17; TFDP1; CCND1; CDC45;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	9	32	28.125	0.00076003077593744	0.009865950258368	1	1	0.728121448142412	0.999999999999289	0.0925851697861134
down	ERI3; EXOSC3; EXOSC10; ERI1; EXOSC8;	GO:0000467~exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	5	8	62.5	0.00076789314988046	0.009865950258368	1	1	0.72953950397679	0.999999999999289	0.0925851697861134
down	SULT1C2; INMT; CYP1A1; AOC3; AOC1;	GO:0009308~amine metabolic process	5	8	62.5	0.00076789314988046	0.009865950258368	1	1	0.72953950397679	0.999999999999289	0.0925851697861134
down	CEACAM1; EMP2; PTK2; BMPER; RHOJ;	GO:0010594~regulation of endothelial cell migration	5	8	62.5	0.00076789314988046	0.009865950258368	1	1	0.72953950397679	0.999999999999289	0.0925851697861134
down	GJB6; GJB1; GJB2; CTNNA1; GJA5;	GO:0016264~gap junction assembly	5	8	62.5	0.00076789314988046	0.009865950258368	1	1	0.72953950397679	0.999999999999289	0.0925851697861134
down	DVL1; RER1; LRP4; FNTA; DNAJA3;	GO:0071340~skeletal muscle acetylcholine-gated channel clustering	5	8	62.5	0.00076789314988046	0.009865950258368	1	1	0.72953950397679	0.999999999999289	0.0925851697861134
down	WASL; CYFIP1; BRK1; WASF1; NCKAP1;	GO:2000601~positive regulation of Arp2/3 complex-mediated actin nucleation	5	8	62.5	0.00076789314988046	0.009865950258368	1	1	0.72953950397679	0.999999999999289	0.0925851697861134
up	CYBB; CYBA; NCF1; NCF2; PREX1; NCF1B; NCF1C; NCF4;	GO:0006801~superoxide metabolic process	8	20	40	0.00077403874168302	0.0621856782820452	1	1	0.99999999854637	0.99999999854637	0.544059789327402
down	EXOC5; MYO1B; ARL3; SCFD1; VAMP8; RABIF; SORCS1;	GO:0006892~post-Golgi vesicle-mediated transport	7	19	36.8421052631579	0.00080248323947596	0.0101734165520662	1	1	0.735877130599455	0.999999999999289	0.095470529863964
down	DLX3; OSR2; DLX5; DLX1; OSR1; DLG3; LRRC1;	GO:0009790~embryo development	7	19	36.8421052631579	0.00080248323947596	0.0101734165520662	1	1	0.735877130599455	0.999999999999289	0.095470529863964
down	SPARC; CDK4; CPOX; PPP5C; BACE1; PPP1CA; PPP2CA;	GO:0010288~response to lead ion	7	19	36.8421052631579	0.00080248323947596	0.0101734165520662	1	1	0.735877130599455	0.999999999999289	0.095470529863964
down	HACD1; ACSL3; HSD17B12; HACD2; ELOVL1; ELOVL4; TECR;	GO:0035338~long-chain fatty-acyl-CoA biosynthetic process	7	19	36.8421052631579	0.00080248323947596	0.0101734165520662	1	1	0.735877130599455	0.999999999999289	0.095470529863964
down	SLC9A3R1; NHLRC1; TRPT1; SMG8; ELP4; ECT2; FAF1;	GO:0045859~regulation of protein kinase activity	7	19	36.8421052631579	0.00080248323947596	0.0101734165520662	1	1	0.735877130599455	0.999999999999289	0.095470529863964
down	SLC25A5; SLC25A4; VDAC3; SLC29A2;	GO:0015853~adenine transport	4	4	100	0.00083996077052328	0.010548454714034	1	1	0.742525321142584	0.999999999999289	0.0989900055346027
down	PRODH; GOT2; ALDH4A1; HOGA1;	GO:0019470~4-hydroxyproline catabolic process	4	4	100	0.00083996077052328	0.010548454714034	1	1	0.742525321142584	0.999999999999289	0.0989900055346027
down	CHMP4C; AURKB; ZFYVE19; VPS4A;	GO:0044878~mitotic cytokinesis checkpoint	4	4	100	0.00083996077052328	0.010548454714034	1	1	0.742525321142584	0.999999999999289	0.0989900055346027
down	ACAT1; OXCT1; BDH1; OXCT2;	GO:0046952~ketone body catabolic process	4	4	100	0.00083996077052328	0.010548454714034	1	1	0.742525321142584	0.999999999999289	0.0989900055346027
down	CCL21; PRKRA; CNIH1; CXCL14; C1R; C3; JCHAIN; IGLV1-47; IGLV1-51; IGLV2-23; IGLV6-57; IGHV3-23; IGKC; IGHA1; IGHA2; C1QC; CD1A; CTSG; CD1E; IL1R2; BMPR1A; LTBR; TNFSF9; CXCL12; CTSC; CCL18; DEFB1; IGLV3-21; MS4A2; C1QBP; SCAP; TNFAIP1; IRAK1BP1; PXDN; CCL19; APLN; IGLV5-45; ULBP2; CXCL10; RAET1G; AZGP1; CD1B; RAET1E; CXCL11; CXCL6; IGKV6-21; IGLV3-10; CTSK;	GO:0006955~immune response	48	433	11.0854503464203	0.00085027498188072	0.0106579496321672	1	1	0.743496392246524	0.999999999999289	0.10001754016843
up	TLR4; TLR2; IFNG; CD36; HLA-G; CD40LG; CCR7; IRF8; SCIMP;	GO:0032735~positive regulation of interleukin-12 production	9	26	34.6153846153846	0.00085462484486864	0.0648165909943929	1	1	0.99999999854637	0.99999999854637	0.567077529996349
down	PLPP3; SNX3; PPP2R1A; PPP2CA; TMEM237; GSKIP; DACT3; DACT2;	GO:0030111~regulation of Wnt signaling pathway	8	26	30.7692307692308	0.00091133144102384	0.0112125849801744	1	1	0.749262282635375	0.999999999999289	0.105222412129047
down	TACSTD2; STMN1; TJP1; PHLDB2; DLC1; CORO2B; F11R; ARHGAP28;	GO:0051497~negative regulation of stress fiber assembly	8	26	30.7692307692308	0.00091133144102384	0.0112125849801744	1	1	0.749262282635375	0.999999999999289	0.105222412129047
down	TP73; YWHAQ; SFN; YWHAE; E2F1; TFDP1; BAD; TP63;	GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	8	26	30.7692307692308	0.00091133144102384	0.0112125849801744	1	1	0.749262282635375	0.999999999999289	0.105222412129047
down	YKT6; STXBP1; VAMP3; RABEPK; SCFD1; VPS45; EXOC6B; RAB3D; RAB13;	GO:0006904~vesicle docking involved in exocytosis	9	33	27.2727272727273	0.00091466229818815	0.0112125849801744	1	1	0.749620165487097	0.999999999999289	0.105222412129047
down	NCK1; ARFIP2; RAC1; CYFIP1; AJUBA; GOLPH3; ARHGEF4; VAV3; ABLIM2;	GO:0030032~lamellipodium assembly	9	33	27.2727272727273	0.00091466229818815	0.0112125849801744	1	1	0.749620165487097	0.999999999999289	0.105222412129047
down	BMP4; SDC1; FGFR2; AQP1; OSR2; OSR1; AQP3; PITX2; SSUH2;	GO:0042476~odontogenesis	9	33	27.2727272727273	0.00091466229818815	0.0112125849801744	1	1	0.749620165487097	0.999999999999289	0.105222412129047
down	STK25; NGFR; STK11; ROBO2; TRAK1; PLXNA2; PLXNB3; PLXNA1; PLXNB2;	GO:0050772~positive regulation of axonogenesis	9	33	27.2727272727273	0.00091466229818815	0.0112125849801744	1	1	0.749620165487097	0.999999999999289	0.105222412129047
up	TLR4; TYROBP; IFNG; CYBB; SPN; TNFRSF8; CCR2; TLR1;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	8	21	38.0952380952381	0.00099936990840932	0.0688553556073746	1	1	0.99999999854637	0.99999999854637	0.602412505591786
up	SH2D1A; IL18RAP; CRTAM; CD160; HLA-E; LAG3; STAT5B; SLAMF6;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	8	21	38.0952380952381	0.00099936990840932	0.0688553556073746	1	1	0.99999999854637	0.99999999854637	0.602412505591786
down	MMP12; TTLL12; METTL3; MUL1; CNOT7; YTHDF2;	GO:0060339~negative regulation of type I interferon-mediated signaling pathway	6	14	42.8571428571429	0.0010229410577991	0.0122604248937791	1	1	0.759939857429543	0.999999999999289	0.115055670332176
down	MEIS2; ANXA3; EPHA2; LUM; TBC1D7; HDAC6;	GO:0070848~response to growth factor	6	14	42.8571428571429	0.0010229410577991	0.0122604248937791	1	1	0.759939857429543	0.999999999999289	0.115055670332176
down	DNM1L; MUL1; PRMT6; VPS35; MFF; GOLPH3; PDE2A;	GO:0010821~regulation of mitochondrion organization	7	20	35	0.00102583109049881	0.0122604248937791	1	1	0.760140838059617	0.999999999999289	0.115055670332176
down	PRKRA; NAGLU; NKX3-2; SIX1; OSR2; OSR1; EYA1;	GO:0042474~middle ear morphogenesis	7	20	35	0.00102583109049881	0.0122604248937791	1	1	0.760140838059617	0.999999999999289	0.115055670332176
down	WASL; LYPLA1; DDAH2; EGFR; NOS3; SPR; CAV1;	GO:0050999~regulation of nitric-oxide synthase activity	7	20	35	0.00102583109049881	0.0122604248937791	1	1	0.760140838059617	0.999999999999289	0.115055670332176
down	ATXN3; HDAC1; SIRT2; HDAC2; HDAC11; HDAC6; HDAC3;	GO:0070932~histone H3 deacetylation	7	20	35	0.00102583109049881	0.0122604248937791	1	1	0.760140838059617	0.999999999999289	0.115055670332176
down	AURKA; CTNNB1; PRKCZ; DDR1; PAK6; IMPACT; PLXNA1;	GO:1990138~neuron projection extension	7	20	35	0.00102583109049881	0.0122604248937791	1	1	0.760140838059617	0.999999999999289	0.115055670332176
down	CCL21; CLDN7; EPCAM; CCL19; DUOX1; PHPT1; CFAP20;	GO:2000147~positive regulation of cell motility	7	20	35	0.00102583109049881	0.0122604248937791	1	1	0.760140838059617	0.999999999999289	0.115055670332176
up	PGLYRP1; HLA-B; HLA-DRB1; CD1D; PGLYRP2; NLRC4;	GO:0016045~detection of bacterium	6	11	54.5454545454545	0.0010466513992905	0.0688553556073746	1	1	0.99999999854637	0.99999999854637	0.602412505591786
up	CRTAM; TNF; IFNG; FGR; IL10; CLEC6A; RGCC; IL26; CLEC4E;	GO:0050715~positive regulation of cytokine secretion	9	27	33.3333333333333	0.00106459102351342	0.0688553556073746	1	1	0.99999999854637	0.99999999854637	0.602412505591786
down	C1R; C3; IGLV1-47; IGLV1-51; IGLV2-23; IGLV6-57; IGHV3-23; IGKC; IGHG2; IGHG4; C1QA; C1QB; C1QC; CFI; C1S; C7; IGLV3-21; C1QBP; SUSD4; IGHV3-21; IGHV3-49; IGHA2; IGHA1;	GO:0006958~complement activation, classical pathway	23	161	14.2857142857143	0.00108331196936573	0.0129012607260828	1	1	0.765655500407597	0.999999999999289	0.121069474657667
down	DVL1; KALRN; COL4A1; ERBB2; TNC; LAMB2; CACNB3; PPFIBP1; PDZRN3;	GO:0007528~neuromuscular junction development	9	34	26.4705882352941	0.00109386662152477	0.0129118779123799	1	1	0.766674129849231	0.999999999999289	0.121169109661922
down	TCP1; CTNNB1; CCT6A; CCT3; CCT4; NEK2; AURKB; CCT7; FBXO4;	GO:0032212~positive regulation of telomere maintenance via telomerase	9	34	26.4705882352941	0.00109386662152477	0.0129118779123799	1	1	0.766674129849231	0.999999999999289	0.121169109661922
down	MPC2; OXCT1; VSNL1; RAC1; ANO1; TRPM4; BAD; PHPT1; SYBU;	GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus	9	34	26.4705882352941	0.00109386662152477	0.0129118779123799	1	1	0.766674129849231	0.999999999999289	0.121169109661922
down	OVOL1; GJB3; RYR1; DHCR24; DACT2; SLC27A4; TFAP2B; ABCB6; DSP;	GO:0043588~skin development	9	34	26.4705882352941	0.00109386662152477	0.0129118779123799	1	1	0.766674129849231	0.999999999999289	0.121169109661922
down	GREM1; TCP1; CTNNB1; CCT4; NEK2; PTGES3; GRHL2; PARM1; AURKB;	GO:0051973~positive regulation of telomerase activity	9	34	26.4705882352941	0.00109386662152477	0.0129118779123799	1	1	0.766674129849231	0.999999999999289	0.121169109661922
down	ITGB1BP1; SPRY2; RAMP2; HSPB1; KDR; GAS1; DLL4; SPHK1;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	8	27	29.6296296296296	0.00111779988972516	0.0131043786466742	1	1	0.768951874604047	0.999999999999289	0.122975596893446
down	CTNND1; CDH5; PLEKHA7; CDH26; CDH24; CDH3; CDH11; CDH1;	GO:0044331~cell-cell adhesion mediated by cadherin	8	27	29.6296296296296	0.00111779988972516	0.0131043786466742	1	1	0.768951874604047	0.999999999999289	0.122975596893446
down	ENG; GRHL2; HEYL; DLL4; HEY2;	GO:0003208~cardiac ventricle morphogenesis	5	9	55.5555555555556	0.00113371214754943	0.0131043786466742	1	1	0.770403880727827	0.999999999999289	0.122975596893446
down	GPAA1; ANKRD13C; KDELR1; KDELR2; RER1;	GO:0006621~protein retention in ER lumen	5	9	55.5555555555556	0.00113371214754943	0.0131043786466742	1	1	0.770403880727827	0.999999999999289	0.122975596893446
down	PCCA; PCCB; PC; PDZD11; MCCC1;	GO:0006768~biotin metabolic process	5	9	55.5555555555556	0.00113371214754943	0.0131043786466742	1	1	0.770403880727827	0.999999999999289	0.122975596893446
down	UROD; HMBS; ALAS1; ALAD; CPOX;	GO:0006782~protoporphyrinogen IX biosynthetic process	5	9	55.5555555555556	0.00113371214754943	0.0131043786466742	1	1	0.770403880727827	0.999999999999289	0.122975596893446
down	MATN2; CD9; TSPO; CSPG4; NDN;	GO:0008347~glial cell migration	5	9	55.5555555555556	0.00113371214754943	0.0131043786466742	1	1	0.770403880727827	0.999999999999289	0.122975596893446
down	CYB5A; CYB5R3; SLC2A1; GCLC; GSTO2;	GO:0019852~L-ascorbic acid metabolic process	5	9	55.5555555555556	0.00113371214754943	0.0131043786466742	1	1	0.770403880727827	0.999999999999289	0.122975596893446
down	ERLIN1; SREBF1; SCAP; SREBF2; ARHGEF10L;	GO:0032933~SREBP signaling pathway	5	9	55.5555555555556	0.00113371214754943	0.0131043786466742	1	1	0.770403880727827	0.999999999999289	0.122975596893446
down	ACAT1; HMGCS2; BDH1; AACS; BDH2;	GO:0046951~ketone body biosynthetic process	5	9	55.5555555555556	0.00113371214754943	0.0131043786466742	1	1	0.770403880727827	0.999999999999289	0.122975596893446
down	TCP1; CCT6A; CCT3; CCT4; CCT7;	GO:1904871~positive regulation of protein localization to Cajal body	5	9	55.5555555555556	0.00113371214754943	0.0131043786466742	1	1	0.770403880727827	0.999999999999289	0.122975596893446
down	BCAT2; DLD; BCKDHB; ACAT1; ALDH6A1; HIBCH; MCCC1;	GO:0009083~branched-chain amino acid catabolic process	7	21	33.3333333333333	0.00129523174080992	0.0146018387041339	1	1	0.78574955775232	0.999999999999289	0.137028231463567
down	CLDN5; CLDN4; CLDN7; CLDN12; CLDN17; CLDN18; CLDN10;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	7	21	33.3333333333333	0.00129523174080992	0.0146018387041339	1	1	0.78574955775232	0.999999999999289	0.137028231463567
down	SNRPB; SNRPF; SNRPG; SNRPD1; SNRPD2; HTATIP2; RAB18;	GO:0051170~import into nucleus	7	21	33.3333333333333	0.00129523174080992	0.0146018387041339	1	1	0.78574955775232	0.999999999999289	0.137028231463567
down	HS6ST1; PLCD1; HES1; TMED2; NSDHL; OVOL2; HEY2;	GO:0060716~labyrinthine layer blood vessel development	7	21	33.3333333333333	0.00129523174080992	0.0146018387041339	1	1	0.78574955775232	0.999999999999289	0.137028231463567
down	DVL1; CTNNB1; CSNK1A1; PPP1CA; CAV1; DVL3; FZD1;	GO:1904886~beta-catenin destruction complex disassembly	7	21	33.3333333333333	0.00129523174080992	0.0146018387041339	1	1	0.78574955775232	0.999999999999289	0.137028231463567
down	SAP30; PHB; HDAC1; SIRT2; HDAC2; HDAC11; HDAC6; MTA3; MORF4L2;	GO:0016575~histone deacetylation	9	35	25.7142857142857	0.00130041820520277	0.0146018387041339	1	1	0.786231815128594	0.999999999999289	0.137028231463567
down	AZIN1; SNX3; EGFR; HMGCR; SERPINE2; PHB; MAD2L1; CYP51A1; SIRT2;	GO:0042177~negative regulation of protein catabolic process	9	35	25.7142857142857	0.00130041820520277	0.0146018387041339	1	1	0.786231815128594	0.999999999999289	0.137028231463567
down	NGFR; BMP2; BMPR1A; SMARCA4; KLF5; SMAD1; APLN; SREBF1; SREBF2;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	9	35	25.7142857142857	0.00130041820520277	0.0146018387041339	1	1	0.786231815128594	0.999999999999289	0.137028231463567
down	FGF10; COL2A1; HSPA1A; HSPA1B; PRDX2; CTNNA1; MAPK7; UNC5B; EYA1;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	9	35	25.7142857142857	0.00130041820520277	0.0146018387041339	1	1	0.786231815128594	0.999999999999289	0.137028231463567
down	DNM1L; SLC9A3R1; PRKRA; BCAP31; CAV1; BAD; IL20RA; BOK; STYXL1;	GO:2001244~positive regulation of intrinsic apoptotic signaling pathway	9	35	25.7142857142857	0.00130041820520277	0.0146018387041339	1	1	0.786231815128594	0.999999999999289	0.137028231463567
down	BMP4; NOS3; JAG1; ROBO2; HEYL; HEY2;	GO:0003184~pulmonary valve morphogenesis	6	15	40	0.00135751230037129	0.0149189794947038	1	1	0.79153368763339	0.999999999999289	0.14000438005261
down	SSBP1; RAD51; RECQL5; MCM2; RECQL4; MCM4;	GO:0006268~DNA unwinding involved in DNA replication	6	15	40	0.00135751230037129	0.0149189794947038	1	1	0.79153368763339	0.999999999999289	0.14000438005261
down	NRP2; CTSV; NGFR; SEMA3F; NTF4; NTF3;	GO:0021675~nerve development	6	15	40	0.00135751230037129	0.0149189794947038	1	1	0.79153368763339	0.999999999999289	0.14000438005261
down	LGALS3; EPHA3; MTMR2; LRSAM1; SNX33; PACSIN3;	GO:0045806~negative regulation of endocytosis	6	15	40	0.00135751230037129	0.0149189794947038	1	1	0.79153368763339	0.999999999999289	0.14000438005261
down	TCF21; ZBTB7A; PHB; SMARCA4; HDAC1; HEYL;	GO:0060766~negative regulation of androgen receptor signaling pathway	6	15	40	0.00135751230037129	0.0149189794947038	1	1	0.79153368763339	0.999999999999289	0.14000438005261
down	NRP2; BMP4; ENG; FGFR2; BMPR1A; ZFPM2; ROBO2; PARVA;	GO:0003148~outflow tract septum morphogenesis	8	28	28.5714285714286	0.00135992493822401	0.0149189794947038	1	1	0.791797539602306	0.999999999999289	0.14000438005261
down	FANCG; TXN; CXCL12; CCL11; BACE1; FKBPL; F11R; POLH;	GO:0009314~response to radiation	8	28	28.5714285714286	0.00135992493822401	0.0149189794947038	1	1	0.791797539602306	0.999999999999289	0.14000438005261
down	SLC25A12; SLC25A5; SLC25A4; SLC25A1; SLC25A29; SLC25A43; SLC25A23; SLC25A13;	GO:0015867~ATP transport	8	28	28.5714285714286	0.00135992493822401	0.0149189794947038	1	1	0.791797539602306	0.999999999999289	0.14000438005261
down	SNAPIN; LAMTOR1; BLOC1S2; HPS6; PLEKHM2; RAB34; ARL8B; HDAC6;	GO:0032418~lysosome localization	8	28	28.5714285714286	0.00135992493822401	0.0149189794947038	1	1	0.791797539602306	0.999999999999289	0.14000438005261
down	BMP4; RARG; CTNNB1; PITX1; RSPO2; OSR2; OSR1; TP63;	GO:0035116~embryonic hindlimb morphogenesis	8	28	28.5714285714286	0.00135992493822401	0.0149189794947038	1	1	0.791797539602306	0.999999999999289	0.14000438005261
down	TPO; PRDX3; PRDX2; PRDX1; PXDN; DUOX1; PRDX5; PRDX4;	GO:0042744~hydrogen peroxide catabolic process	8	28	28.5714285714286	0.00135992493822401	0.0149189794947038	1	1	0.791797539602306	0.999999999999289	0.14000438005261
down	POLQ; TK1; POLD1; PHB; POLD2; POLE3; CHRAC1; SPHK1;	GO:0071897~DNA biosynthetic process	8	28	28.5714285714286	0.00135992493822401	0.0149189794947038	1	1	0.791797539602306	0.999999999999289	0.14000438005261
down	TLR3; GREM1; TRIM13; ZBTB7A; BCL10; TFRC; LTF; HSPA1A; HSPA1B; PRDX3; IRAK1; RIPK4; UBE2N; CAV1; PRKCZ; ERC1; RAB7B; CARD14; NOD2; SPHK1; CRNN; TNFSF18;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	22	154	14.2857142857143	0.0013722583244582	0.0150145970747949	1	1	0.793133187767934	0.999999999999289	0.140901685396286
down	CHEK2; ERCC1; ROMO1; TP63;	GO:0001302~replicative cell aging	4	5	80	0.00143774639952254	0.0155682069614426	1	1	0.797986420733673	0.999999999999289	0.146096934106067
down	SHMT1; SHMT2; PSPH; SRR;	GO:0006563~L-serine metabolic process	4	5	80	0.00143774639952254	0.0155682069614426	1	1	0.797986420733673	0.999999999999289	0.146096934106067
down	XYLB; AKR1A1; SORD; DCXR;	GO:0019640~glucuronate catabolic process to xylulose 5-phosphate	4	5	80	0.00143774639952254	0.0155682069614426	1	1	0.797986420733673	0.999999999999289	0.146096934106067
down	AHCYL1; CA2; STC1; RAB11B;	GO:0044070~regulation of anion transport	4	5	80	0.00143774639952254	0.0155682069614426	1	1	0.797986420733673	0.999999999999289	0.146096934106067
down	CDH1; JUP; CTNNA1; CTNNB1;	GO:0071681~cellular response to indole-3-methanol	4	5	80	0.00143774639952254	0.0155682069614426	1	1	0.797986420733673	0.999999999999289	0.146096934106067
down	RRAS; FUT1; TSTA3; RIN2;	GO:1904906~positive regulation of endothelial cell-matrix adhesion via fibronectin	4	5	80	0.00143774639952254	0.0155682069614426	1	1	0.797986420733673	0.999999999999289	0.146096934106067
up	CD4; CD3E; CCL4; ZAP70; TRAT1; P2RX5; P2RX4;	GO:0050850~positive regulation of calcium-mediated signaling	7	17	41.1764705882353	0.00144287602119508	0.0851056373168233	1	1	0.99999999854637	0.99999999854637	0.744585512103903
up	CCDC88B; LCK; CCL2; CCR2; SIRPG; PYCARD; SIRPB1;	GO:0050870~positive regulation of T cell activation	7	17	41.1764705882353	0.00144287602119508	0.0851056373168233	1	1	0.99999999854637	0.99999999854637	0.744585512103903
up	IL2RA; LYN; CTLA4; HLA-G; PDCD1; INPP5D;	GO:0050777~negative regulation of immune response	6	12	50	0.00147114754519939	0.0853506747944368	1	1	0.99999999854637	0.99999999854637	0.746729334317163
down	TMEM150C; KCNK3; CASQ2; ATP6V0E1; RYR1; SCNN1A; ATP6V1A; ATP1A2; SCNN1G; CLCN2; ATP1B3; PLP2; FXYD3; ATP6V1F; ATP13A5; PDZD11; ANO1; SFXN4; TMEM109; ANO10; ATP10D; CLCA2; GABRA3; CHRNA5; GLRB; GABRE; GABRA4;	GO:0034220~ion transmembrane transport	27	208	12.9807692307692	0.00152959508026917	0.0164064415845366	1	1	0.804164138567004	0.999999999999289	0.153963190560576
down	DNM1L; CAV2; BNIP1; ATL2; CCDC47; LNPK; VAPA; SEC31A; LMAN2;	GO:0007029~endoplasmic reticulum organization	9	36	25	0.00153725975631192	0.0164064415845366	1	1	0.804604761818581	0.999999999999289	0.153963190560576
down	IDE; UCHL3; LRSAM1; PJA1; PRSS16; USE1; BACE1; CTSD; CTSE;	GO:0030163~protein catabolic process	9	36	25	0.00153725975631192	0.0164064415845366	1	1	0.804604761818581	0.999999999999289	0.153963190560576
down	ATP6AP2; BMP2; FGFR2; SMARCA4; WLS; CDC73; RSPO2; SULF1; SPIN1;	GO:0030177~positive regulation of Wnt signaling pathway	9	36	25	0.00153725975631192	0.0164064415845366	1	1	0.804604761818581	0.999999999999289	0.153963190560576
down	SPRY2; TFAP2A; PPP2R1A; PPP2CA; HES5; LTBP4; TFAP2B; ST7; PTBP1;	GO:0045595~regulation of cell differentiation	9	36	25	0.00153725975631192	0.0164064415845366	1	1	0.804604761818581	0.999999999999289	0.153963190560576
down	DNM1L; TP73; COL2A1; CDK4; PTHLH; CDH1; TSPAN8; UBXN2A; PHLDA2; C9orf116; ZC3H12A; ATRAID; NHLRC1; TSKU; TMPRSS4; CRNN; HMG20B; DHH; MAPK13; CDK2; TCF19; COQ7; MAPK7;	GO:0010468~regulation of gene expression	23	166	13.855421686747	0.00155269880469433	0.0165447858280109	1	1	0.805723341817065	0.999999999999289	0.155261456306456
down	TCF21; FOXF1; COL13A1; NOTCH4; COL16A1;	GO:0001763~morphogenesis of a branching structure	5	10	50	0.00161417311706424	0.0168789026043906	1	1	0.808307269241962	0.999999999999289	0.158396912867598
down	RRM2B; DNAJA3; TEFM; MGME1; SSBP1;	GO:0006264~mitochondrial DNA replication	5	10	50	0.00161417311706424	0.0168789026043906	1	1	0.808307269241962	0.999999999999289	0.158396912867598
down	PCSK6; TFAP2B; TWSG1; FSTL3; FSTL1;	GO:0030510~regulation of BMP signaling pathway	5	10	50	0.00161417311706424	0.0168789026043906	1	1	0.808307269241962	0.999999999999289	0.158396912867598
down	SMAD1; METTL3; SRRT; DROSHA; MRPL44;	GO:0031053~primary miRNA processing	5	10	50	0.00161417311706424	0.0168789026043906	1	1	0.808307269241962	0.999999999999289	0.158396912867598
down	"NAE1; TICRR; ORC1; CDC6; HUS1;"	GO:0033314~mitotic DNA replication checkpoint	5	10	50	0.00161417311706424	0.0168789026043906	1	1	0.808307269241962	0.999999999999289	0.158396912867598
down	CAND1; PSMC3; PSMC2; PSMC4; PSMC5;	GO:0045899~positive regulation of RNA polymerase II transcriptional preinitiation complex assembly	5	10	50	0.00161417311706424	0.0168789026043906	1	1	0.808307269241962	0.999999999999289	0.158396912867598
down	COL2A1; BMP4; BMP7; OSR2; OSR1;	GO:0060272~embryonic skeletal joint morphogenesis	5	10	50	0.00161417311706424	0.0168789026043906	1	1	0.808307269241962	0.999999999999289	0.158396912867598
down	TCP1; CCT6A; CCT3; CCT4; CCT7;	GO:1904851~positive regulation of establishment of protein localization to telomere	5	10	50	0.00161417311706424	0.0168789026043906	1	1	0.808307269241962	0.999999999999289	0.158396912867598
down	ORC5; GMNN; CCNA2; PPP2R1A; PPP2CA; ESCO2; DSCC1;	GO:0006275~regulation of DNA replication	7	22	31.8181818181818	0.00161689831863643	0.0168789026043906	1	1	0.808421277370822	0.999999999999289	0.158396912867598
down	EIF5A; CDK5; FBXO22; NUP62CL; AAAS; NXT2; NUTF2;	GO:0006913~nucleocytoplasmic transport	7	22	31.8181818181818	0.00161689831863643	0.0168789026043906	1	1	0.808421277370822	0.999999999999289	0.158396912867598
down	KRT16; KRT6C; CSNK1A1; ATXN3; DST; DSP; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	7	22	31.8181818181818	0.00161689831863643	0.0168789026043906	1	1	0.808421277370822	0.999999999999289	0.158396912867598
down	POLD1; RFC4; RFC2; RFC5; RCHY1; POLH; POLDIP2;	GO:0070987~error-free translesion synthesis	7	22	31.8181818181818	0.00161689831863643	0.0168789026043906	1	1	0.808421277370822	0.999999999999289	0.158396912867598
down	COL4A1; ENG; CTNNB1; KDR; SFRP2; NOTCH4; DLL4; NRARP;	GO:0001569~branching involved in blood vessel morphogenesis	8	29	27.5862068965517	0.00164190590379953	0.0170070904547049	1	1	0.809233213523312	0.999999999999289	0.159599867836463
down	UBE2A; PLPP4; CCDC24; HS3ST6; SMIM14; RBBP8; ASF1B; PEMT;	GO:0001835~blastocyst hatching	8	29	27.5862068965517	0.00164190590379953	0.0170070904547049	1	1	0.809233213523312	0.999999999999289	0.159599867836463
down	ERBB2; CNP; GLI3; CDKN2C; NKX6-1; CDK5; BOK; SOX9;	GO:0048709~oligodendrocyte differentiation	8	29	27.5862068965517	0.00164190590379953	0.0170070904547049	1	1	0.809233213523312	0.999999999999289	0.159599867836463
down	CTNNB1; SMARCA4; TLE1; HDAC1; CDC73; KAT5; ASH2L; PYGO1;	GO:1904837~beta-catenin-TCF complex assembly	8	29	27.5862068965517	0.00164190590379953	0.0170070904547049	1	1	0.809233213523312	0.999999999999289	0.159599867836463
down	NRG2; DAPK3; ABL1; EGFR; ERBB2; ERBB3; SSX2IP; INPP5F;	GO:2000145~regulation of cell motility	8	29	27.5862068965517	0.00164190590379953	0.0170070904547049	1	1	0.809233213523312	0.999999999999289	0.159599867836463
down	EXOSC10; MPHOSPH6; EXOSC4; WDR12; EIF6; FBXW9;	GO:0000460~maturation of 5.8S rRNA	6	16	37.5	0.00176947301825758	0.0181316706057959	1	1	0.813419479179391	0.999999999999289	0.170153280483008
down	TCF21; SOX18; STK11; NOTCH4; B9D1; AMHR2;	GO:0001944~vasculature development	6	16	37.5	0.00176947301825758	0.0181316706057959	1	1	0.813419479179391	0.999999999999289	0.170153280483008
down	STMN1; KIF18B; KIF18A; KIF2C; NCKAP5; KATNB1;	GO:0007019~microtubule depolymerization	6	16	37.5	0.00176947301825758	0.0181316706057959	1	1	0.813419479179391	0.999999999999289	0.170153280483008
down	LDHA; MDH1; NADK2; NADSYN1; GPD1L; NMNAT1;	GO:0019674~NAD metabolic process	6	16	37.5	0.00176947301825758	0.0181316706057959	1	1	0.813419479179391	0.999999999999289	0.170153280483008
down	NGFR; GPC1; WNT4; SULF1; APLN; SPRY2;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	6	16	37.5	0.00176947301825758	0.0181316706057959	1	1	0.813419479179391	0.999999999999289	0.170153280483008
down	ALOX15B; TRIM16; VDR; NME2; OVOL2; H2AFY2;	GO:0045618~positive regulation of keratinocyte differentiation	6	16	37.5	0.00176947301825758	0.0181316706057959	1	1	0.813419479179391	0.999999999999289	0.170153280483008
down	IMPA2; BPNT1; IMPA1; MTMR2; INPP1; OCRL;	GO:0046855~inositol phosphate dephosphorylation	6	16	37.5	0.00176947301825758	0.0181316706057959	1	1	0.813419479179391	0.999999999999289	0.170153280483008
up	MYO1G; ITGB7; ZAP70; GPR15; CCR6;	GO:0072678~T cell migration	5	8	62.5	0.00180066563366643	0.0980393181160846	1	1	0.99999999854637	0.99999999854637	0.857741721785476
down	E2F8; DLX3; GJB3; DCN; CCNF; PTK2; HTRA1; RTCB; PHLDA2;	GO:0001890~placenta development	9	37	24.3243243243243	0.00180749838903138	0.0184646739099674	1	1	0.814675905148376	0.999999999999289	0.173278287871921
down	SPINT1; SPINT2; PTTG1; C3; GAPDH; PI3; SERPINB3; SERPINB6; TFPI2; USP14; SPINK7; SPOCK1; WFDC2; ITIH5; FETUB; SERPINB13; SERPINB4; TIMP3; SERPINE2; SERPINB5; SERPINH1;	GO:0010951~negative regulation of endopeptidase activity	21	148	14.1891891891892	0.0018727498086154	0.0190149566434035	1	1	0.816741613190891	0.999999999999289	0.178442313533042
up	TLR4; ITGB2; LYN; ITGAM; SCIMP; PIK3AP1; LY96;	GO:0034142~toll-like receptor 4 signaling pathway	7	18	38.8888888888889	0.00187576315887217	0.0990433924924504	1	1	0.99999999854637	0.99999999854637	0.866526324748187
up	DOK2; CD4; CD8A; CD3E; LYN; CD7; CD8B; TRAT1; RASGRP4; DOK1; STAP1; SLA; NEDD9; FGR; HCK; LTK; EPHB1; BLK; CASS4; FLT3; LCK;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	21	120	17.5	0.00189645713062625	0.0990433924924504	1	1	0.99999999854637	0.99999999854637	0.866526324748187
down	CDKAL1; ADAT3; TRMT61A; URM1; QTRT1; METTL1; FTSJ1; TRUB1;	GO:0006400~tRNA modification	8	30	26.6666666666667	0.00196817458625476	0.0198331439076441	1	1	0.819953912155815	0.999999999999289	0.186120439288065
down	MFN2; APOD; NPR1; NPR3; COMT; NOS3; NDRG4; NDRG2;	GO:0048662~negative regulation of smooth muscle cell proliferation	8	30	26.6666666666667	0.00196817458625476	0.0198331439076441	1	1	0.819953912155815	0.999999999999289	0.186120439288065
down	DHRS3; LTF; TFAP2A; FGFR2; FGFR3; OSR2; SFRP2; RARG;	GO:0060349~bone morphogenesis	8	30	26.6666666666667	0.00196817458625476	0.0198331439076441	1	1	0.819953912155815	0.999999999999289	0.186120439288065
down	FOXP2; FGFR2; CTNNB1; BMPR1A; SOX9; FOXF1; SMO;	GO:0002053~positive regulation of mesenchymal cell proliferation	7	23	30.4347826086957	0.00199739213731764	0.0199769114811664	1	1	0.820928168437552	0.999999999999289	0.187469599263103
down	CDK2AP1; RFC5; POLE2; POLD1; RFC4; RFC2; POLQ;	GO:0006261~DNA-dependent DNA replication	7	23	30.4347826086957	0.00199739213731764	0.0199769114811664	1	1	0.820928168437552	0.999999999999289	0.187469599263103
down	EGFR; CEACAM1; PTPN13; CEP55; PIP4K2C; CRNN; LIME1;	GO:0014066~regulation of phosphatidylinositol 3-kinase signaling	7	23	30.4347826086957	0.00199739213731764	0.0199769114811664	1	1	0.820928168437552	0.999999999999289	0.187469599263103
down	DLL1; JAG1; FANCC; HES1; SS18; HES5; SRRT;	GO:0097150~neuronal stem cell population maintenance	7	23	30.4347826086957	0.00199739213731764	0.0199769114811664	1	1	0.820928168437552	0.999999999999289	0.187469599263103
down	HSPA1A; HSPA1B; PLK1; CHMP4C; CHMP1A; DRG1; RCC1;	GO:1901673~regulation of mitotic spindle assembly	7	23	30.4347826086957	0.00199739213731764	0.0199769114811664	1	1	0.820928168437552	0.999999999999289	0.187469599263103
up	PF4; IL10; CORO1A; CXCR5; CNR2; CXCL5; PPBP; IL16;	GO:0030595~leukocyte chemotaxis	8	24	33.3333333333333	0.00200242799734862	0.0990433924924504	1	1	0.99999999854637	0.99999999854637	0.866526324748187
up	CD74; CD19; CD27; INPP5D; TLR8; FCER1G;	GO:0016064~immunoglobulin mediated immune response	6	13	46.1538461538462	0.00201501109337565	0.0990433924924504	1	1	0.99999999854637	0.99999999854637	0.866526324748187
up	CD4; IL2RB; IL2RG; STAT5A; STAT5B; JAK3;	GO:0035723~interleukin-15-mediated signaling pathway	6	13	46.1538461538462	0.00201501109337565	0.0990433924924504	1	1	0.99999999854637	0.99999999854637	0.866526324748187
up	CRTAM; HLA-DOA; CD2; CCR2; CARD11; TBX21;	GO:0045580~regulation of T cell differentiation	6	13	46.1538461538462	0.00201501109337565	0.0990433924924504	1	1	0.99999999854637	0.99999999854637	0.866526324748187
down	RCCD1; HDAC3; DAPK3; SOX15; ZBTB7A; GPX4; SMARCA4; FOXA3; TRIM28; HDAC1; CBX2; HMGN3; HDAC11; ING2; HMG20B; PADI3; SPIN1; TAF6L; H2AFY2; FAM50B;	GO:0006325~chromatin organization	20	139	14.3884892086331	0.0020481877086227	0.0204237941512063	1	1	0.822591653582298	0.999999999999289	0.19166328631773
down	EEF1E1; AIMP2; RARS2; PPA2; FARSB; IARS2; FARSA; YARS2; TARS2;	GO:0006418~tRNA aminoacylation for protein translation	9	38	23.6842105263158	0.0021144005703464	0.0209935491498101	1	1	0.824666480357989	0.999999999999289	0.197010045818922
down	RAD51B; RAD51C; MFN2; F10; SERPINE2; RAB5A; TFPI2; CAPZA1; RAC1; HDAC1; DOCK1; GAS6; HPS6; SCUBE1; ZFPM2; AKAP1; HDAC2; DOCK6; LNPK; VPS45; EHD2; HMG20B; AK3;	GO:0007596~blood coagulation	23	171	13.4502923976608	0.00218611164862903	0.0213243606680274	1	1	0.827080388125399	0.999999999999289	0.200114484801409
down	FGF10; BMP4; BMP7; OSR2; OSR1;	GO:0001823~mesonephros development	5	11	45.4545454545455	0.0022288120497701	0.0213243606680274	1	1	0.828567421769727	0.999999999999289	0.200114484801409
down	LDOC1; NR2F2; PRDX3; TMED2; STOX2;	GO:0001893~maternal placenta development	5	11	45.4545454545455	0.0022288120497701	0.0213243606680274	1	1	0.828567421769727	0.999999999999289	0.200114484801409
down	MTHFD1; PRPS2; PRPSAP2; GART; PRPSAP1;	GO:0006164~purine nucleotide biosynthetic process	5	11	45.4545454545455	0.0022288120497701	0.0213243606680274	1	1	0.828567421769727	0.999999999999289	0.200114484801409
down	NME6; NME1; NME2; NME7; IMPDH2;	GO:0006183~GTP biosynthetic process	5	11	45.4545454545455	0.0022288120497701	0.0213243606680274	1	1	0.828567421769727	0.999999999999289	0.200114484801409
down	PSMD14; SERPINB3; ADRM1; SFRP2; PSME3;	GO:0010950~positive regulation of endopeptidase activity	5	11	45.4545454545455	0.0022288120497701	0.0213243606680274	1	1	0.828567421769727	0.999999999999289	0.200114484801409
down	CBR1; PTGS1; PTGES3; PTGIS; PTGES2;	GO:0019371~cyclooxygenase pathway	5	11	45.4545454545455	0.0022288120497701	0.0213243606680274	1	1	0.828567421769727	0.999999999999289	0.200114484801409
down	YES1; BCR; NPR1; BDKRB2; CDH5;	GO:0043114~regulation of vascular permeability	5	11	45.4545454545455	0.0022288120497701	0.0213243606680274	1	1	0.828567421769727	0.999999999999289	0.200114484801409
down	LAMA5; BMP7; FGFR2; DAG1; ESRP2;	GO:0060445~branching involved in salivary gland morphogenesis	5	11	45.4545454545455	0.0022288120497701	0.0213243606680274	1	1	0.828567421769727	0.999999999999289	0.200114484801409
down	JAG1; GALNT11; HEYL; DLL4; HEY2;	GO:0061314~Notch signaling involved in heart development	5	11	45.4545454545455	0.0022288120497701	0.0213243606680274	1	1	0.828567421769727	0.999999999999289	0.200114484801409
down	TMEM30B; SLC51B; TM9SF4; TMEM30A; SAR1A;	GO:0070863~positive regulation of protein exit from endoplasmic reticulum	5	11	45.4545454545455	0.0022288120497701	0.0213243606680274	1	1	0.828567421769727	0.999999999999289	0.200114484801409
down	JUP; DSP; CAV1; TRPM4; PKP2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	5	11	45.4545454545455	0.0022288120497701	0.0213243606680274	1	1	0.828567421769727	0.999999999999289	0.200114484801409
down	DAPK3; PPP2R1A; PPP2R1B; CTNNA1; PPP1CA;	GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	5	11	45.4545454545455	0.0022288120497701	0.0213243606680274	1	1	0.828567421769727	0.999999999999289	0.200114484801409
down	UQCRH; COX7A2; UQCRC2; UQCRC1; CHCHD10; TEFM;	GO:0006119~oxidative phosphorylation	6	17	35.2941176470588	0.00226961925726143	0.0213243606680274	1	1	0.82989178120586	0.999999999999289	0.200114484801409
down	IMPA2; PTPRD; IMPA1; INPP1; LHPP; PPA2;	GO:0006796~phosphate-containing compound metabolic process	6	17	35.2941176470588	0.00226961925726143	0.0213243606680274	1	1	0.82989178120586	0.999999999999289	0.200114484801409
down	ZMPSTE24; REEP3; NUP93; LEMD2; REEP4; VPS4A;	GO:0006998~nuclear envelope organization	6	17	35.2941176470588	0.00226961925726143	0.0213243606680274	1	1	0.82989178120586	0.999999999999289	0.200114484801409
down	SLC9A3R1; EZR; RDX; KLF5; MINK1; RAP2C;	GO:0030033~microvillus assembly	6	17	35.2941176470588	0.00226961925726143	0.0213243606680274	1	1	0.82989178120586	0.999999999999289	0.200114484801409
down	DNM1L; DCN; KDR; MUL1; VPS35; MFF;	GO:0090141~positive regulation of mitochondrial fission	6	17	35.2941176470588	0.00226961925726143	0.0213243606680274	1	1	0.82989178120586	0.999999999999289	0.200114484801409
down	CLDN18; TRIM29; LZTS2; FBXO4; TMEM98; MAGED1;	GO:1900181~negative regulation of protein localization to nucleus	6	17	35.2941176470588	0.00226961925726143	0.0213243606680274	1	1	0.82989178120586	0.999999999999289	0.200114484801409
down	DNM1L; VDAC1; SREBF1; SREBF2; CTTN; HDAC6;	GO:1903146~regulation of autophagy of mitochondrion	6	17	35.2941176470588	0.00226961925726143	0.0213243606680274	1	1	0.82989178120586	0.999999999999289	0.200114484801409
down	CD34; GJA4; KDR; GJA5;	GO:0003158~endothelium development	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	CHMP4C; AURKB; ZFYVE19; VPS4A;	GO:0009838~abscission	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	APOD; TNC; TSPO; MAP1B;	GO:0014012~peripheral nervous system axon regeneration	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	MTAP; MRI1; ADI1; ENOPH1;	GO:0019509~L-methionine salvage from methylthioadenosine	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	DCN; BGN; EGFLAM; NDNF;	GO:0019800~peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	FMC1; TMEM70; ATP23; ATPAF1;	GO:0033615~mitochondrial proton-transporting ATP synthase complex assembly	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	AP1AR; CORO1B; PICK1; ARFIP2;	GO:0034315~regulation of Arp2/3 complex-mediated actin nucleation	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	GTF3C1; GTF3C2; GTF3C6; GTF3C5;	GO:0042791~5S class rRNA transcription by RNA polymerase III	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	BCHE; UQCRC1; TMED10; SRSF9;	GO:0043279~response to alkaloid	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	PRMT5; PRMT6; PRMT1; COPRS;	GO:0043985~histone H4-R3 methylation	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	TXN; RANGAP1; CDK5; BARD1;	GO:0046826~negative regulation of protein export from nucleus	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	TMED10; TMED2; TMED9; ARFGAP2;	GO:0048205~COPI coating of Golgi vesicle	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	NDC80; CDT1; CENPH; NUF2;	GO:0051383~kinetochore organization	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	ARHGEF15; RHOJ; FZD4; CLIC4;	GO:0061299~retina vasculature morphogenesis in camera-type eye	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	ETHE1; SUOX; TSTD1; SLC25A10;	GO:0070221~sulfide oxidation, using sulfide:quinone oxidoreductase	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	GJB6; GJB2; GJB4; GJA3;	GO:1990349~gap junction-mediated intercellular transport	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	OVOL1; FBLN1; KDF1; OVOL2;	GO:2000647~negative regulation of stem cell proliferation	4	6	66.6666666666667	0.00227893930803347	0.0213243606680274	1	1	0.830117161652069	0.999999999999289	0.200114484801409
down	CA2; KRT14; ALAD; D2HGDH; SLC30A5; GGH; KHK; SLC30A4;	GO:0010043~response to zinc ion	8	31	25.8064516129032	0.00234338248736166	0.0218356184073406	1	1	0.832208385173089	0.999999999999289	0.204912287684981
down	ERCC1; FGFR2; BMPR1A; ZFPM2; TEAD4; RARG; GTPBP3; TEAD3;	GO:0048568~embryonic organ development	8	31	25.8064516129032	0.00234338248736166	0.0218356184073406	1	1	0.832208385173089	0.999999999999289	0.204912287684981
up	TLR4; TNF; CD6; IL17RA; GBP5; TLR6; GPSM3;	GO:1900017~positive regulation of cytokine production involved in inflammatory response	7	19	36.8421052631579	0.00240281284215194	0.116487049977749	1	1	0.99999999854637	0.99999999854637	1
down	EFNA1; FOXA1; PPP2CA; DACT3; SFRP2; OVOL2; STRAP;	GO:0010719~negative regulation of epithelial to mesenchymal transition	7	24	29.1666666666667	0.00244359122792748	0.0226430416002545	1	1	0.835703533294521	0.999999999999289	0.212489400020589
down	ABHD17C; ZDHHC1; ZDHHC16; ZDHHC12; ZDHHC5; ZDHHC6; ZDHHC9;	GO:0018345~protein palmitoylation	7	24	29.1666666666667	0.00244359122792748	0.0226430416002545	1	1	0.835703533294521	0.999999999999289	0.212489400020589
down	CLDN4; HRAS; ADRA2A; PTK2; MYLK; OCLN; DUOX1;	GO:0090303~positive regulation of wound healing	7	24	29.1666666666667	0.00244359122792748	0.0226430416002545	1	1	0.835703533294521	0.999999999999289	0.212489400020589
down	STX6; RAB13; RAB14; ARF6; VPS52; EHD2; VPS29; RAB35; SNX3;	GO:0032456~endocytic recycling	9	39	23.0769230769231	0.00246138587991329	0.0227448396455058	1	1	0.836228862677128	0.999999999999289	0.213444704786645
down	SLC2A1; NFE2L2; ZC3H12A; PICK1; IMPACT; HIGD1A; SH3GLB1; TBL2; KPTN;	GO:0042149~cellular response to glucose starvation	9	39	23.0769230769231	0.00246138587991329	0.0227448396455058	1	1	0.836228862677128	0.999999999999289	0.213444704786645
up	TLR4; CD74; CD36; HLA-G; LILRB1;	GO:0060907~positive regulation of macrophage cytokine production	5	9	55.5555555555556	0.0026294429378273	0.124074647426277	1	1	0.99999999854637	0.99999999854637	1
down	E2F8; RAMP2; ENG; CCBE1; PARVA; LOXL2; KDR; VEGFD;	GO:0002040~sprouting angiogenesis	8	32	25	0.0027723859954103	0.0253510864172034	1	1	0.845458498122832	0.999999999999289	0.237902541441301
down	DLL1; ZPR1; BAG3; ACTL6A; SRD5A1; MPST; VIT; ROBO2;	GO:0021510~spinal cord development	8	32	25	0.0027723859954103	0.0253510864172034	1	1	0.845458498122832	0.999999999999289	0.237902541441301
down	VAMP3; AMN; RAB34; GOLPH3; GGA1; RAB26; C16orf70; NSF;	GO:0043001~Golgi to plasma membrane protein transport	8	32	25	0.0027723859954103	0.0253510864172034	1	1	0.845458498122832	0.999999999999289	0.237902541441301
down	TFAP2A; BMP4; FGFR2; EIF4A3; MMP16; IRX5; SIX1; GRHL2;	GO:0048701~embryonic cranial skeleton morphogenesis	8	32	25	0.0027723859954103	0.0253510864172034	1	1	0.845458498122832	0.999999999999289	0.237902541441301
down	GREM1; LRP4; NR2F2; MEOX2; RSPO2; KREMEN1; LNPK; ZNRF3;	GO:0060173~limb development	8	32	25	0.0027723859954103	0.0253510864172034	1	1	0.845458498122832	0.999999999999289	0.237902541441301
down	SMPD2; B3GALNT1; GM2A; B4GALNT1; UGCG; UGT8; CPTP; SUMF2; SUMF1;	GO:0006687~glycosphingolipid metabolic process	9	40	22.5	0.00285201962070547	0.0258340482702742	1	1	0.847049827349525	0.999999999999289	0.242434806858801
down	DYNC2LI1; IFT81; WDR34; IFT43; IFT22; DYNLRB1; IFT46; CEP131; SSX2IP;	GO:0035735~intraciliary transport involved in cilium assembly	9	40	22.5	0.00285201962070547	0.0258340482702742	1	1	0.847049827349525	0.999999999999289	0.242434806858801
down	ABL1; MCC; RDX; PLK1; ITGA8; CEP55; NPNT; PHLDB2; RCC2;	GO:0045184~establishment of protein localization	9	40	22.5	0.00285201962070547	0.0258340482702742	1	1	0.847049827349525	0.999999999999289	0.242434806858801
down	BMP2; ENG; NOS3; BMPR1A; SOX9; HEYL;	GO:0003203~endocardial cushion morphogenesis	6	18	33.3333333333333	0.00286916087659683	0.0258340482702742	1	1	0.847461618652069	0.999999999999289	0.242434806858801
down	SPRY2; PPP2R5D; SPRED2; SIRT2; PARD3; DDIT4;	GO:0010801~negative regulation of peptidyl-threonine phosphorylation	6	18	33.3333333333333	0.00286916087659683	0.0258340482702742	1	1	0.847461618652069	0.999999999999289	0.242434806858801
down	BMP2; BMP4; OXTR; HES1; HES5; ZDHHC16;	GO:0021537~telencephalon development	6	18	33.3333333333333	0.00286916087659683	0.0258340482702742	1	1	0.847461618652069	0.999999999999289	0.242434806858801
down	FGF10; TCF21; GLI3; FGFR2; FOXF1; OVOL2;	GO:0048557~embryonic digestive tract morphogenesis	6	18	33.3333333333333	0.00286916087659683	0.0258340482702742	1	1	0.847461618652069	0.999999999999289	0.242434806858801
down	SNAPIN; TSPAN15; SERPINH1; STUB1; LMF2; TSPAN17;	GO:0051604~protein maturation	6	18	33.3333333333333	0.00286916087659683	0.0258340482702742	1	1	0.847461618652069	0.999999999999289	0.242434806858801
down	PSMD14; USP14; PSME3; RHBDF1; NUDT15; BTRC;	GO:0061136~regulation of proteasomal protein catabolic process	6	18	33.3333333333333	0.00286916087659683	0.0258340482702742	1	1	0.847461618652069	0.999999999999289	0.242434806858801
down	GREM1; SOX9; SIX1; SMO; LGR4; MAGED1;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	6	18	33.3333333333333	0.00286916087659683	0.0258340482702742	1	1	0.847461618652069	0.999999999999289	0.242434806858801
down	NCK1; BDKRB2; CAV1; BAK1; GPD1L; DDIT4; INPP5F;	GO:0033137~negative regulation of peptidyl-serine phosphorylation	7	25	28	0.00296265531822171	0.026490932565431	1	1	0.849600800198386	0.999999999999289	0.248599214990227
down	CDK1; CCNB1; FGFR2; BMPR1A; YAP1; ZFPM2; HEY2;	GO:0060045~positive regulation of cardiac muscle cell proliferation	7	25	28	0.00296265531822171	0.026490932565431	1	1	0.849600800198386	0.999999999999289	0.248599214990227
down	CDK4; IMPDH2; ALAD; MCM2; TUBA1B; KEAP1; RUFY4;	GO:0071353~cellular response to interleukin-4	7	25	28	0.00296265531822171	0.026490932565431	1	1	0.849600800198386	0.999999999999289	0.248599214990227
down	ADH1B; ALDH2; ADH5; ALDH1B1; ACSS2;	GO:0006069~ethanol oxidation	5	12	41.6666666666667	0.00299762685518123	0.026490932565431	1	1	0.850346519974074	0.999999999999289	0.248599214990227
down	DCN; BGN; CSPG4; DSEL; UST;	GO:0030208~dermatan sulfate biosynthetic process	5	12	41.6666666666667	0.00299762685518123	0.026490932565431	1	1	0.850346519974074	0.999999999999289	0.248599214990227
down	FGF10; TULP3; RARG; RDH10; PPP1R13L;	GO:0031076~embryonic camera-type eye development	5	12	41.6666666666667	0.00299762685518123	0.026490932565431	1	1	0.850346519974074	0.999999999999289	0.248599214990227
down	SAE1; UBA5; UBA1; UBA6; NAE1;	GO:0032446~protein modification by small protein conjugation	5	12	41.6666666666667	0.00299762685518123	0.026490932565431	1	1	0.850346519974074	0.999999999999289	0.248599214990227
down	RNF8; RECQL5; NELFB; NELFCD; NELFE;	GO:0034244~negative regulation of transcription elongation from RNA polymerase II promoter	5	12	41.6666666666667	0.00299762685518123	0.026490932565431	1	1	0.850346519974074	0.999999999999289	0.248599214990227
down	PPP2R1A; NF2; PPP2CA; CAV1; INPP5F;	GO:0042532~negative regulation of tyrosine phosphorylation of STAT protein	5	12	41.6666666666667	0.00299762685518123	0.026490932565431	1	1	0.850346519974074	0.999999999999289	0.248599214990227
down	HDAC3; MTSS1; CA2; TFPI2; NFE2L2;	GO:0071498~cellular response to fluid shear stress	5	12	41.6666666666667	0.00299762685518123	0.026490932565431	1	1	0.850346519974074	0.999999999999289	0.248599214990227
down	SEMA3F; PLXNA2; PLXNB2; PLXNA1; PLXNB3;	GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance	5	12	41.6666666666667	0.00299762685518123	0.026490932565431	1	1	0.850346519974074	0.999999999999289	0.248599214990227
down	UBE2C; PLK1; CDC20; UBE2S; GORASP1;	GO:1904668~positive regulation of ubiquitin protein ligase activity	5	12	41.6666666666667	0.00299762685518123	0.026490932565431	1	1	0.850346519974074	0.999999999999289	0.248599214990227
up	DYSF; CD74; RAC2; C5AR1; CXCR2; CCR7; NCKAP1L; C3AR1;	GO:0090023~positive regulation of neutrophil chemotaxis	8	26	30.7692307692308	0.00302355154789025	0.140794064841889	1	1	0.99999999854637	0.99999999854637	1
down	NUDT21; AHCYL1; CSTF2; GRSF1; CDC73; SSU72; CPSF2; CPSF3;	GO:0006378~mRNA polyadenylation	8	33	24.2424242424242	0.00326022968490558	0.0286331656423137	1	1	0.856086396255823	0.999999999999289	0.26870260168391
down	TRIM13; DCN; GNAI3; KDR; PAFAH1B2; RUFY4; TBK1; SCOC;	GO:0016239~positive regulation of macroautophagy	8	33	24.2424242424242	0.00326022968490558	0.0286331656423137	1	1	0.856086396255823	0.999999999999289	0.26870260168391
down	BAG3; KITLG; ERBB3; BAD; MKNK2; BAK1; BCL2L10; BOK;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	8	33	24.2424242424242	0.00326022968490558	0.0286331656423137	1	1	0.856086396255823	0.999999999999289	0.26870260168391
down	BAD; PFKM; PFKP; PFKL;	GO:0006007~glucose catabolic process	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	SDHB; SUCLA2; SDHAF3; SUCLG1;	GO:0006105~succinate metabolic process	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	SPR; PCBD1; PTS; PCBD2;	GO:0006729~tetrahydrobiopterin biosynthetic process	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	TMEM189; PEX7; FAR1; DHRS7B;	GO:0008611~ether lipid biosynthetic process	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	DNM1L; MUL1; OMA1; VAT1;	GO:0010637~negative regulation of mitochondrial fusion	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	GLI3; HES1; HES5; METTL3;	GO:0021861~forebrain radial glial cell differentiation	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	FGF10; IGSF3; FGFR2; SOX9;	GO:0032808~lacrimal gland development	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	KIF4A; KIF23; AURKB; RACGAP1;	GO:0051256~mitotic spindle midzone assembly	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	KALRN; LDOC1; CYP1A1; OXTR;	GO:0060137~maternal process involved in parturition	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	YAP1; SOX9; FOXA1; GRHL2;	GO:0060487~lung epithelial cell differentiation	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	RARG; TNC; ID4; FOXA1;	GO:0060740~prostate gland epithelium morphogenesis	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	AZGP1; SEC61G; TOMM22; TIMM22;	GO:0071806~protein transmembrane transport	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	NF2; SOX18; YAP1; SOX17;	GO:0072091~regulation of stem cell proliferation	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	RAMP2; ENG; HES1; HEY2;	GO:0097084~vascular smooth muscle cell development	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	SGTA; BCAP31; CAV1; NFE2L2;	GO:1903071~positive regulation of ER-associated ubiquitin-dependent protein catabolic process	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
down	CCL21; CXCL12; GAS6; CCL19;	GO:2000669~negative regulation of dendritic cell apoptotic process	4	7	57.1428571428571	0.00340628210138261	0.0292887654045524	1	1	0.85918647373638	0.999999999999289	0.274854955355785
up	TYROBP; TNF; CD74; PTAFR; TLR1; TLR6;	GO:0045410~positive regulation of interleukin-6 biosynthetic process	6	15	40	0.00354059198440559	0.158609557377359	1	1	0.99999999854637	0.99999999854637	1
up	TLR4; TNF; APOA2; CD74; TLR8; TLR7;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	6	15	40	0.00354059198440559	0.158609557377359	1	1	0.99999999854637	0.99999999854637	1
up	TESPA1; KCNN4; LCK; CCR7; TRAT1; CARD11;	GO:0050862~positive regulation of T cell receptor signaling pathway	6	15	40	0.00354059198440559	0.158609557377359	1	1	0.99999999854637	0.99999999854637	1
down	OIP5; GJB3; GJB5; CCL18; KREMEN1; CCL19; GJA3;	GO:0007154~cell communication	7	26	26.9230769230769	0.00356198776504346	0.0302207391230625	1	1	0.862567101215178	0.999999999999289	0.283600888864953
down	PTBP1; CDH5; PPP2R5D; PPP1R7; CDCA2; SPPL3; DLC1;	GO:0035307~positive regulation of protein dephosphorylation	7	26	26.9230769230769	0.00356198776504346	0.0302207391230625	1	1	0.862567101215178	0.999999999999289	0.283600888864953
down	PLA2G2A; PLA2G4E; LPCAT4; MBOAT2; PLA2G4D; ABHD4; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	7	26	26.9230769230769	0.00356198776504346	0.0302207391230625	1	1	0.862567101215178	0.999999999999289	0.283600888864953
down	CTNNB1; PPP1CA; DAAM2; KREMEN1; SOX7; MKS1; BTRC;	GO:0060828~regulation of canonical Wnt signaling pathway	7	26	26.9230769230769	0.00356198776504346	0.0302207391230625	1	1	0.862567101215178	0.999999999999289	0.283600888864953
down	ERCC1; CETN2; RBX1; GTF2H3; DDB1; GTF2H5; DDB2;	GO:0070911~global genome nucleotide-excision repair	7	26	26.9230769230769	0.00356198776504346	0.0302207391230625	1	1	0.862567101215178	0.999999999999289	0.283600888864953
down	DNM1L; COX10; MUL1; MFF; MTFR1L; DNM1;	GO:0000266~mitochondrial fission	6	19	31.5789473684211	0.00357962725795891	0.0302207391230625	1	1	0.862922067100451	0.999999999999289	0.283600888864953
down	CAPN2; PSMC3; PSMC4; NEK2; DAD1; MED21;	GO:0001824~blastocyst development	6	19	31.5789473684211	0.00357962725795891	0.0302207391230625	1	1	0.862922067100451	0.999999999999289	0.283600888864953
down	AQP1; CLNS1A; E2F4; LRRC8A; WNK3; TRPV4;	GO:0006884~cell volume homeostasis	6	19	31.5789473684211	0.00357962725795891	0.0302207391230625	1	1	0.862922067100451	0.999999999999289	0.283600888864953
down	MAPK13; EGFR; SORD; KCNMA1; MAP7; LRRC8A;	GO:0006970~response to osmotic stress	6	19	31.5789473684211	0.00357962725795891	0.0302207391230625	1	1	0.862922067100451	0.999999999999289	0.283600888864953
down	ZPR1; RARG; CTNNB1; HES5; SIRT2; LGI4;	GO:0031641~regulation of myelination	6	19	31.5789473684211	0.00357962725795891	0.0302207391230625	1	1	0.862922067100451	0.999999999999289	0.283600888864953
down	TOM1L1; MVB12A; HDAC6; VPS4A; VPS37C; VPS37D;	GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	6	19	31.5789473684211	0.00357962725795891	0.0302207391230625	1	1	0.862922067100451	0.999999999999289	0.283600888864953
down	PLK1; BAK1; HDAC2; BAD; AURKAIP1; BTRC;	GO:0045862~positive regulation of proteolysis	6	19	31.5789473684211	0.00357962725795891	0.0302207391230625	1	1	0.862922067100451	0.999999999999289	0.283600888864953
down	LAMA5; CDK1; RAB14; NFE2L2; RACGAP1; SOX17;	GO:0045995~regulation of embryonic development	6	19	31.5789473684211	0.00357962725795891	0.0302207391230625	1	1	0.862922067100451	0.999999999999289	0.283600888864953
up	ACOD1; TLR4; CCL2; CD36; IL10; CX3CR1; CCR5; IRF8; CARD16; LILRB2; LILRB1; NLRP7; GFI1; LITAF; STAP1; PYCARD; PF4; LY96; CD80; CD86; NR1I2; DEFA3; CXCL5; CD180; PPBP;	GO:0071222~cellular response to lipopolysaccharide	25	163	15.3374233128834	0.003668372946669	0.161791558559504	1	1	0.99999999854637	0.99999999854637	1
up	HLA-E; HLA-G; HLA-F; CLEC12B; LILRB1;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	5	10	50	0.00370305629932743	0.161791558559504	1	1	0.99999999854637	0.99999999854637	1
down	AURKA; MAPK13; CHEK2; CDK1; CDK2; CSNK1A1; PLK1; CDK5; PRKCZ; MAPK7; GAS6; MARK2; PLK2; MARK1; TBK1; CSNK1G3; MAST2; TTK; MKNK2; VRK2; PKN3;	GO:0018105~peptidyl-serine phosphorylation	21	158	13.2911392405063	0.00374942606212014	0.031549011991215	1	1	0.866657660464523	0.999999999999289	0.296065817817527
down	TGFB1I1; BMP2; BMP4; BMP7; SERPINB3; CTNNB1; HDAC2; WWTR1; LOXL2;	GO:0010718~positive regulation of epithelial to mesenchymal transition	9	42	21.4285714285714	0.00377917025769481	0.0317193925774611	1	1	0.867447882137691	0.999999999999289	0.297664722646028
down	RAMP2; RAMP3; TFRC; EZR; CD9; CAV1; CALCRL; AP2M1; DNM1;	GO:0031623~receptor internalization	9	42	21.4285714285714	0.00377917025769481	0.0317193925774611	1	1	0.867447882137691	0.999999999999289	0.297664722646028
down	PRODH; TRIM13; RAMP3; BMP4; PHB; ZC3H12A; KATNB1; FAF1;	GO:0010942~positive regulation of cell death	8	34	23.5294117647059	0.00381212789357355	0.0318758779186043	1	1	0.868253447921019	0.999999999999289	0.299133230138907
down	FOXP2; TCF21; HS6ST1; BMP4; HOXA5; FGFR2; FOXF1; MYOCD;	GO:0048286~lung alveolus development	8	34	23.5294117647059	0.00381212789357355	0.0318758779186043	1	1	0.868253447921019	0.999999999999289	0.299133230138907
down	SLIT3; NOS3; GJA5; HES1; ZFPM2; ROBO2; HEYL; HEY2;	GO:0060412~ventricular septum morphogenesis	8	34	23.5294117647059	0.00381212789357355	0.0318758779186043	1	1	0.868253447921019	0.999999999999289	0.299133230138907
down	APOD; GSTP1; S100A7; HYAL2; NUDT15;	GO:0000302~response to reactive oxygen species	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	BMP4; BMPR1A; JAG1; PPP1R13L; HEY2;	GO:0003215~cardiac right ventricle morphogenesis	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	HDAC3; HDAC1; SIRT2; SIRT5; HDAC6;	GO:0006476~protein deacetylation	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	GREM1; EPHA3; DAG1; PHLDB2; ELL3;	GO:0010717~regulation of epithelial to mesenchymal transition	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	NOS3; PRDX2; FANCC; SOD3; PRDX1;	GO:0019430~removal of superoxide radicals	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	ITGB1BP1; EFNA1; EPHA2; CRK; PTK2;	GO:0033628~regulation of cell adhesion mediated by integrin	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	HACD2; ELOVL1; ELOVL4; TECR; HACD1;	GO:0042761~very long-chain fatty acid biosynthetic process	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	PDE2A; CLDN5; RAMP2; CEACAM1; PDE3A;	GO:0043116~negative regulation of vascular permeability	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	CYP1A1; ALAD; CPOX; GCLC; SRRT;	GO:0046685~response to arsenic-containing substance	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	DTYMK; CMPK1; AK2; RAD50; AK3;	GO:0046940~nucleoside monophosphate phosphorylation	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	DHRS3; BMP7; JAG1; MKS1; HEY2;	GO:0060411~cardiac septum morphogenesis	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	SPINT2; COL4A1; CAV2; CAV1; DAG1;	GO:0071711~basement membrane organization	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	ITGB1BP1; TACSTD2; FBLN1; AP1AR; RCC2;	GO:1900025~negative regulation of substrate adhesion-dependent cell spreading	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	TAX1BP3; LEPROT; ARF6; COMMD1; SNX33;	GO:2000009~negative regulation of protein localization to cell surface	5	13	38.4615384615385	0.00394079646627965	0.0323843311085047	1	1	0.870916019047803	0.999999999999289	0.303904714251681
down	RRP36; NOB1; NHP2;	GO:0000469~cleavage involved in rRNA processing	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	SFN; KDF1; TP63;	GO:0010482~regulation of epidermal cell division	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	BAG3; HMGCR; BMP7;	GO:0010664~negative regulation of striated muscle cell apoptotic process	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	CTNNB1; OSR2; OSR1;	GO:0036023~embryonic skeletal limb joint morphogenesis	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	UCK2; UCK1; UCKL1;	GO:0044211~CTP salvage	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	GJB2; GCLC; GCLM;	GO:0044752~response to human chorionic gonadotropin	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	TNS2; PPP1R13L; NDN;	GO:0048871~multicellular organismal homeostasis	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	ACOT7; OLAH; OXSM;	GO:0051792~medium-chain fatty acid biosynthetic process	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	CCNB1; SIRT2; RCC2;	GO:0051987~positive regulation of attachment of spindle microtubules to kinetochore	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	SPDEF; AGR2; HOXA5;	GO:0060480~lung goblet cell differentiation	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	SPINT2; GRHL2; ST14;	GO:0060672~epithelial cell morphogenesis involved in placental branching	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	BMPR1A; LEMD2; SOX17;	GO:0060914~heart formation	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	HES1; SOX17; MKS1;	GO:0061009~common bile duct development	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	CTNNB1; HDAC1; HDAC2;	GO:0061198~fungiform papilla formation	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	BMP4; SOX9; SIX1;	GO:0072193~ureter smooth muscle cell differentiation	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	HES1; HES5; LGR4;	GO:0072282~metanephric nephron tubule morphogenesis	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	NCK1; METTL3; YTHDF2;	GO:1903679~positive regulation of cap-independent translational initiation	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	ADCY6; RANGAP1; CDC6;	GO:1904117~cellular response to vasopressin	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	GAS8; PPP2CA; MARK2;	GO:1904526~regulation of microtubule binding	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	ITGA8; NPNT; MYOCD;	GO:2000721~positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	ACSL3; CAPN2; RAB38;	GO:2001247~positive regulation of phosphatidylcholine biosynthetic process	3	3	100	0.00411866968615016	0.0329542900277475	1	1	0.874832938088511	0.999999999999289	0.30925338740807
down	CCL21; JUP; FUT1; EPHA1; EMP2; PRKCZ; DAG1;	GO:0001954~positive regulation of cell-matrix adhesion	7	27	25.9259259259259	0.00424919496021747	0.0337159994408705	1	1	0.877763478573923	0.999999999999289	0.316401507304768
down	SLC27A2; CH25H; SCP2; HSD17B4; OSBPL1A; HSD3B7; CYP39A1;	GO:0006699~bile acid biosynthetic process	7	27	25.9259259259259	0.00424919496021747	0.0337159994408705	1	1	0.877763478573923	0.999999999999289	0.316401507304768
down	FGF10; CTNNB1; EMP2; ARF6; GPIHBP1; GGA1; PIGK;	GO:0034394~protein localization to cell surface	7	27	25.9259259259259	0.00424919496021747	0.0337159994408705	1	1	0.877763478573923	0.999999999999289	0.316401507304768
down	DBI; PLA2G2A; PLA2G4E; LPCAT4; MBOAT2; PLA2G4D; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	7	27	25.9259259259259	0.00424919496021747	0.0337159994408705	1	1	0.877763478573923	0.999999999999289	0.316401507304768
down	BCR; CTTN; TRIP6; AJUBA; DLC1; RCC2; CORO2B;	GO:0048041~focal adhesion assembly	7	27	25.9259259259259	0.00424919496021747	0.0337159994408705	1	1	0.877763478573923	0.999999999999289	0.316401507304768
up	TNFSF14; CORO1A; STAT5B; JAK3; NCKAP1L; P2RX7; GPR174; SIT1;	GO:0043029~T cell homeostasis	8	28	28.5714285714286	0.00440951234642939	0.182544580326811	1	1	0.99999999854637	0.99999999854637	1
down	CYFIP1; PARVA; NCKAP1; RHOV; RHOJ; RAC1;	GO:0030031~cell projection assembly	6	20	30	0.0044127704635164	0.0348483681640107	1	1	0.88143214208422	0.999999999999289	0.327028010352815
down	SYNGR1; SYNGR2; TMED10; RAB11B; TMEM79; RAB26;	GO:0045055~regulated exocytosis	6	20	30	0.0044127704635164	0.0348483681640107	1	1	0.88143214208422	0.999999999999289	0.327028010352815
down	RAPGEF3; BAG3; SFN; YWHAE; GAS6; GTSE1;	GO:0046827~positive regulation of protein export from nucleus	6	20	30	0.0044127704635164	0.0348483681640107	1	1	0.88143214208422	0.999999999999289	0.327028010352815
down	KLK8; BCL10; EMP2; PMP22; RRAGA; VAPA; FAF1; SNCAIP;	GO:0008219~cell death	8	35	22.8571428571429	0.00443344475575858	0.0349703003698029	1	1	0.881979924771391	0.999999999999289	0.3281722603926
up	TLR4; CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	4	6	66.6666666666667	0.00453911361083903	0.182544580326811	1	1	0.99999999854637	0.99999999854637	1
up	TNF; APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.00453911361083903	0.182544580326811	1	1	0.99999999854637	0.99999999854637	1
up	LYN; FGR; FPR2; BTLA;	GO:0002768~immune response-regulating cell surface receptor signaling pathway	4	6	66.6666666666667	0.00453911361083903	0.182544580326811	1	1	0.99999999854637	0.99999999854637	1
up	PIK3CD; PECAM1; PRTN3; JAML;	GO:0072672~neutrophil extravasation	4	6	66.6666666666667	0.00453911361083903	0.182544580326811	1	1	0.99999999854637	0.99999999854637	1
up	KCNN4; FCMR; CD300C; VSTM1; CD300LF; CTLA4; IRF1; IRF8; IRF4;	GO:0002376~immune system process	9	35	25.7142857142857	0.00466486274543521	0.185493811866238	1	1	0.99999999854637	0.99999999854637	1
down	TRAF3IP2; TNFRSF21; BCL10; BAK1;	GO:0001783~B cell apoptotic process	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	FH; MDH2; MDH1; MDH1B;	GO:0006108~malate metabolic process	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	MVD; PDSS1; PDSS2; HMGCR;	GO:0008299~isoprenoid biosynthetic process	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	HDAC1; HDAC2; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	SLC9A3R1; HGS; APOD; NDRG4;	GO:0010642~negative regulation of platelet-derived growth factor receptor signaling pathway	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	ENG; BMPR1A; DLL4; HEY2;	GO:0035912~dorsal aorta morphogenesis	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	B3GLCT; POFUT1; RFNG; SLC35C1;	GO:0036066~protein O-linked fucosylation	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	MAOA; COMT; MAOB; PRIMA1;	GO:0042135~neurotransmitter catabolic process	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	MAOA; COMT; MAOB; MOXD1;	GO:0042420~dopamine catabolic process	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	SULT2B1; BMP4; SFN; KDF1;	GO:0045606~positive regulation of epidermal cell differentiation	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	GOT2; ALDH4A1; HOGA1; GRHPR;	GO:0046487~glyoxylate metabolic process	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	OPHN1; SLC1A3; HES1; RB1;	GO:0048667~cell morphogenesis involved in neuron differentiation	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	BMP2; BMP7; FGFR2; WWTR1;	GO:0048762~mesenchymal cell differentiation	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	AQP1; SCNN1A; SCNN1G; TRPV4;	GO:0050891~multicellular organismal water homeostasis	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	MFN2; MARK2; MUL1; HDAC6;	GO:0051646~mitochondrion localization	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	SPP1; SRD5A1; ELK1; AACS;	GO:0071394~cellular response to testosterone stimulus	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	HYAL3; MFAP4; HYAL2; STK11;	GO:0071493~cellular response to UV-B	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	DNM1L; AIFM1; CACNB3; AQP3;	GO:0090650~cellular response to oxygen-glucose deprivation	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	C1QA; C1QB; C1QC; CDK5;	GO:0098883~synapse pruning	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	BMP2; DLX5; SMAD1; SMAD5;	GO:1901522~positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	FOXE1; CTNNB1; CEP55; TP63;	GO:1904888~cranial skeletal system development	4	8	50	0.00486045711410421	0.037154134987792	1	1	0.891008194985876	0.999999999999289	0.348666048988364
down	PLXNB2; NDUFS4; HUS1; FN1; HSPB1; CDH5; PPP2CA; PTK2; RAD51;	GO:0001932~regulation of protein phosphorylation	9	44	20.4545454545455	0.00492694127102922	0.0374907683732872	1	1	0.892339864842512	0.999999999999289	0.351825122198298
down	ZMPSTE24; CLEC3B; PTHLH; BMP2; FGFR2; FGFR3; RSPO2; LGR4; ASPN;	GO:0030282~bone mineralization	9	44	20.4545454545455	0.00492694127102922	0.0374907683732872	1	1	0.892339864842512	0.999999999999289	0.351825122198298
down	HOXB1; HOXA5; HOXA7; SIX1; OSR2; EYA1; HOXD9; HOXB9; HOXA4;	GO:0048704~embryonic skeletal system morphogenesis	9	44	20.4545454545455	0.00492694127102922	0.0374907683732872	1	1	0.892339864842512	0.999999999999289	0.351825122198298
down	NDUFS4; LDHA; SPARC; FOSL1; NME1; SDC1; ALDH3A1; SREBF1; DUOX1;	GO:0051591~response to cAMP	9	44	20.4545454545455	0.00492694127102922	0.0374907683732872	1	1	0.892339864842512	0.999999999999289	0.351825122198298
down	GTF2H5; BTRC; UTP6; RRP36; TBL3; MRPS11; NOL10;	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	7	28	25	0.00503204372784438	0.0378670587522052	1	1	0.893312697190223	0.999999999999289	0.355356349065315
down	PRMT3; SNRPB; PCMT1; ETF1; EEF2KMT; PRMT1; VCPKMT;	GO:0006479~protein methylation	7	28	25	0.00503204372784438	0.0378670587522052	1	1	0.893312697190223	0.999999999999289	0.355356349065315
down	TLR3; TLR5; HSPA1A; HSPA1B; AFAP1L2; IL17D; NOD2;	GO:0032757~positive regulation of interleukin-8 production	7	28	25	0.00503204372784438	0.0378670587522052	1	1	0.893312697190223	0.999999999999289	0.355356349065315
down	DNM1L; PDCD5; BIK; BAK1; BAD; FAM162A; MFF;	GO:0090200~positive regulation of release of cytochrome c from mitochondria	7	28	25	0.00503204372784438	0.0378670587522052	1	1	0.893312697190223	0.999999999999289	0.355356349065315
up	CD74; CD3D; ZAP70; CD3E; CD3G;	GO:0045059~positive thymic T cell selection	5	11	45.4545454545455	0.00505770900576774	0.196694859026506	1	1	0.99999999854637	0.99999999854637	1
down	EXOC5; GRHL3; DLG3; TP63; CELSR1;	GO:0001736~establishment of planar polarity	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	ADH5; HOXA5; CCBE1; NDN; JAG2;	GO:0003016~respiratory system process	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	GOT2; GOT1; GCLC; GCLM; ALDH18A1;	GO:0006536~glutamate metabolic process	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	CCL21; ARFIP2; RAC1; CYFIP1; CORO1B;	GO:0031529~ruffle organization	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	NNMT; PTGIS; NAPRT; NAXD; NAXE;	GO:0034356~NAD biosynthesis via nicotinamide riboside salvage pathway	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	CD34; TSPO; CAV1; PTGIS; ZC3H12A;	GO:0045019~negative regulation of nitric oxide biosynthetic process	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	CDK1; SOD3; SORD; S100A13; LOXL2;	GO:0046688~response to copper ion	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	FOXP2; BMP4; ENG; ITGA8; SMO;	GO:0048745~smooth muscle tissue development	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	FGF10; VEGFD; NTF3; ARTN; CXCL12;	GO:0050930~induction of positive chemotaxis	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	DLL1; MNS1; PITX2; SMO; EPB41L5;	GO:0070986~left/right axis specification	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	EZR; RDX; VGLL4; VPS35; FAF1;	GO:1903364~positive regulation of cellular protein catabolic process	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	TRIM13; RNF139; RNF185; DERL2; MAN1B1;	GO:1904380~endoplasmic reticulum mannose trimming	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	MYO1C; CLDN5; TJP1; OCLN; F11R;	GO:2000810~regulation of bicellular tight junction assembly	5	14	35.7142857142857	0.00507841410596854	0.0378670587522052	1	1	0.893790660110068	0.999999999999289	0.355356349065315
down	ALDOA; TCP1; VDAC2; CCT3; CCT4; SPA17; CCT7; FETUB;	GO:0007339~binding of sperm to zona pellucida	8	36	22.2222222222222	0.00512967287809429	0.0379854115407177	1	1	0.894033934650109	0.999999999999289	0.356467008731351
down	TGFB1I1; RB1; CTNNB1; RAN; FKBP4; FHL2; KAT5; RNF14;	GO:0030521~androgen receptor signaling pathway	8	36	22.2222222222222	0.00512967287809429	0.0379854115407177	1	1	0.894033934650109	0.999999999999289	0.356467008731351
down	ATP6V0E1; TFRC; ATP6V1A; ARHGAP1; RAB11B; ATP6V1F; HFE; STEAP3;	GO:0033572~transferrin transport	8	36	22.2222222222222	0.00512967287809429	0.0379854115407177	1	1	0.894033934650109	0.999999999999289	0.356467008731351
down	SHTN1; FN1; MAP1B; RAB11A; RUFY3; CYFIP1; TNFRSF12A; CTTN;	GO:0045773~positive regulation of axon extension	8	36	22.2222222222222	0.00512967287809429	0.0379854115407177	1	1	0.894033934650109	0.999999999999289	0.356467008731351
down	DNM1L; YKT6; RABIF; VAMP3; VAPA; UBXN2A; MYOF; DNM1;	GO:0061025~membrane fusion	8	36	22.2222222222222	0.00512967287809429	0.0379854115407177	1	1	0.894033934650109	0.999999999999289	0.356467008731351
down	LDOC1; BCL10; ABL1; CXCL10; CTSG; GSTP1; BCR; CDK4; CAPN2; TSPO; CXCL6; ZC3H12A; CDC73; NOD2; PLSCR4; NFKBIL1; VDR; IL1F10; CXCL11; IRAK1; IL36G;	GO:0071222~cellular response to lipopolysaccharide	21	163	12.8834355828221	0.0051610176842154	0.0381424326861096	1	1	0.894280140208704	0.999999999999289	0.357940544379252
up	VIL1; HCLS1; WAS; AIF1; CORO7; LMOD2; PREX1; MSRB1;	GO:0030041~actin filament polymerization	8	29	27.5862068965517	0.00526333887156116	0.202466915939728	1	1	0.99999999854637	0.99999999854637	1
down	ERCC1; RBX1; GTF2H3; DDB1; GTF2H5; DDB2;	GO:0006293~nucleotide-excision repair, preincision complex stabilization	6	21	28.5714285714286	0.00538046742711373	0.039458729835946	1	1	0.896090293026303	0.999999999999289	0.370293089437263
down	FARP2; CYFIP1; BRK1; WASF1; NCKAP1; RAC1;	GO:0016601~Rac protein signal transduction	6	21	28.5714285714286	0.00538046742711373	0.039458729835946	1	1	0.896090293026303	0.999999999999289	0.370293089437263
down	CYP1A1; CYP2J2; CYP4F12; CYP2E1; CYP2S1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	6	21	28.5714285714286	0.00538046742711373	0.039458729835946	1	1	0.896090293026303	0.999999999999289	0.370293089437263
down	GPR143; RAB11A; DCTN2; RAB11B; MLPH; MREG;	GO:0032402~melanosome transport	6	21	28.5714285714286	0.00538046742711373	0.039458729835946	1	1	0.896090293026303	0.999999999999289	0.370293089437263
down	VPS37C; VPS37D; CHMP4C; MVB12A; CHMP1A; VPS4A;	GO:0039702~viral budding via host ESCRT complex	6	21	28.5714285714286	0.00538046742711373	0.039458729835946	1	1	0.896090293026303	0.999999999999289	0.370293089437263
down	HGS; CPE; RAB38; HPS6; TM9SF4; TM9SF3;	GO:0072657~protein localization to membrane	6	21	28.5714285714286	0.00538046742711373	0.039458729835946	1	1	0.896090293026303	0.999999999999289	0.370293089437263
down	CDK1; COL4A2; ALAD; UQCRC1; GCLC; GCLM; OXCT1; BNIP1; HADH;	GO:0014823~response to activity	9	45	20	0.00559374631420195	0.0409329891842095	1	1	0.897773684442109	0.999999999999289	0.384128001279836
down	EVI5; TBC1D9B; SDCCAG8; CNTROB; DYNC2LI1; TCTEX1D2; TBC1D2; ATG5; VDAC3;	GO:1902017~regulation of cilium assembly	9	45	20	0.00559374631420195	0.0409329891842095	1	1	0.897773684442109	0.999999999999289	0.384128001279836
up	GZMB; GZMA; PRF1; GZMH; GZMM; LYZ;	GO:0019835~cytolysis	6	17	35.2941176470588	0.00578929029949027	0.217960620956341	1	1	0.99999999854637	0.99999999854637	1
up	TYROBP; TNF; CD247; FCER1G; STX3; RANGRF;	GO:2000010~positive regulation of protein localization to cell surface	6	17	35.2941176470588	0.00578929029949027	0.217960620956341	1	1	0.99999999854637	0.99999999854637	1
down	RAMP3; AIFM1; EGFR; SRD5A1; CCNA2; KIF18A; KAT5; RUVBL2;	GO:0071392~cellular response to estradiol stimulus	8	37	21.6216216216216	0.00590641085035926	0.0429326226985839	1	1	0.900234918787977	0.999999999999289	0.402893188979959
down	PEX7; COL2A1; BMP4; FGFR3; MMP16; DLX5; COL13A1;	GO:0001958~endochondral ossification	7	29	24.1379310344828	0.00591841722876751	0.0429326226985839	1	1	0.900234918787977	0.999999999999289	0.402893188979959
down	CETN2; CCNH; RBX1; GTF2H3; DDB1; GTF2H5; DDB2;	GO:0006294~nucleotide-excision repair, preincision complex assembly	7	29	24.1379310344828	0.00591841722876751	0.0429326226985839	1	1	0.900234918787977	0.999999999999289	0.402893188979959
down	POLR1C; POLR2E; CCNH; POLR2H; POLR2L; GTF2H3; GTF2H5;	GO:0006362~transcription elongation from RNA polymerase I promoter	7	29	24.1379310344828	0.00591841722876751	0.0429326226985839	1	1	0.900234918787977	0.999999999999289	0.402893188979959
down	EGFR; HRAS; CDK1; RAC1; TNFAIP1; CDT1; FAF1;	GO:0045740~positive regulation of DNA replication	7	29	24.1379310344828	0.00591841722876751	0.0429326226985839	1	1	0.900234918787977	0.999999999999289	0.402893188979959
down	FKBP9; PPIC; FKBP3; FKBP14; PPIL1; FKBP7; PPIL2; FKBP4; PPIL3;	GO:0000413~protein peptidyl-prolyl isomerization	9	46	19.5652173913043	0.00632810724270572	0.0457060372848831	1	1	0.903721667444624	0.999999999999289	0.428919780806936
down	MYO1D; CNP; NR2F2; E2F1; STIL; DLC1; TWSG1; VAX2; NOTCH3;	GO:0030900~forebrain development	9	46	19.5652173913043	0.00632810724270572	0.0457060372848831	1	1	0.903721667444624	0.999999999999289	0.428919780806936
down	SLIT3; ADRA2A; GHR; IGFBP2; IGFBP7; ROBO2; RAMP2; RAMP3; OXTR;	GO:0032870~cellular response to hormone stimulus	9	46	19.5652173913043	0.00632810724270572	0.0457060372848831	1	1	0.903721667444624	0.999999999999289	0.428919780806936
down	FGF10; VEGFD; CXCL10; SAA1; SAA2; BMP4; LGALS3; NTF3; PLXNB3;	GO:0050918~positive chemotaxis	9	46	19.5652173913043	0.00632810724270572	0.0457060372848831	1	1	0.903721667444624	0.999999999999289	0.428919780806936
down	CSTF2; TRPT1; DDX1; C2orf49; RTCB;	GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation	5	15	33.3333333333333	0.00643023845531743	0.0458489040768151	1	1	0.904481935948705	0.999999999999289	0.430260487565172
down	SERPINE2; IL1R2; GAS1; TMEM59; TMEM98;	GO:0010955~negative regulation of protein processing	5	15	33.3333333333333	0.00643023845531743	0.0458489040768151	1	1	0.904481935948705	0.999999999999289	0.430260487565172
down	STMN1; SKA3; SKA2; SKA1; GAS2L1;	GO:0031110~regulation of microtubule polymerization or depolymerization	5	15	33.3333333333333	0.00643023845531743	0.0458489040768151	1	1	0.904481935948705	0.999999999999289	0.430260487565172
down	ENTPD3; ENTPD8; NUDT9; NUDT15; NUDT5;	GO:0034656~nucleobase-containing small molecule catabolic process	5	15	33.3333333333333	0.00643023845531743	0.0458489040768151	1	1	0.904481935948705	0.999999999999289	0.430260487565172
down	CTNNB1; SOX18; GJA5; SOX17; NDRG4;	GO:0035050~embryonic heart tube development	5	15	33.3333333333333	0.00643023845531743	0.0458489040768151	1	1	0.904481935948705	0.999999999999289	0.430260487565172
down	TACSTD2; SERPINB5; HES1; SIX1; HES5;	GO:0050678~regulation of epithelial cell proliferation	5	15	33.3333333333333	0.00643023845531743	0.0458489040768151	1	1	0.904481935948705	0.999999999999289	0.430260487565172
down	GSN; RDX; CAPG; TRIOBP; CAPZA1;	GO:0051016~barbed-end actin filament capping	5	15	33.3333333333333	0.00643023845531743	0.0458489040768151	1	1	0.904481935948705	0.999999999999289	0.430260487565172
down	MTHFD1; PPP2R3A; FRZB; SMO; MEOX2;	GO:0061053~somite development	5	15	33.3333333333333	0.00643023845531743	0.0458489040768151	1	1	0.904481935948705	0.999999999999289	0.430260487565172
down	RIDA; PUM1; METTL3; FTO; YTHDF2;	GO:0061157~mRNA destabilization	5	15	33.3333333333333	0.00643023845531743	0.0458489040768151	1	1	0.904481935948705	0.999999999999289	0.430260487565172
down	NCK1; PPP2R1A; PPP5C; PPP1CA; PPP2CA;	GO:0070262~peptidyl-serine dephosphorylation	5	15	33.3333333333333	0.00643023845531743	0.0458489040768151	1	1	0.904481935948705	0.999999999999289	0.430260487565172
down	HGS; SDC1; SDC4; STAM; VPS4A;	GO:1903543~positive regulation of exosomal secretion	5	15	33.3333333333333	0.00643023845531743	0.0458489040768151	1	1	0.904481935948705	0.999999999999289	0.430260487565172
down	YAP1; JAG1; HES1; HES5; NELFB;	GO:2000737~negative regulation of stem cell differentiation	5	15	33.3333333333333	0.00643023845531743	0.0458489040768151	1	1	0.904481935948705	0.999999999999289	0.430260487565172
down	CETN2; RBX1; GTF2H3; DDB1; GTF2H5; DDB2;	GO:0000717~nucleotide-excision repair, DNA duplex unwinding	6	22	27.2727272727273	0.00649462261436184	0.0460133337079019	1	1	0.904870709615565	0.999999999999289	0.431803546765083
down	FGF10; BMP7; FGFR2; SIM2; SMAD1; SMAD5;	GO:0009880~embryonic pattern specification	6	22	27.2727272727273	0.00649462261436184	0.0460133337079019	1	1	0.904870709615565	0.999999999999289	0.431803546765083
down	SCO1; TIMM21; COA4; COX16; BCS1L; COA3;	GO:0033617~mitochondrial cytochrome c oxidase assembly	6	22	27.2727272727273	0.00649462261436184	0.0460133337079019	1	1	0.904870709615565	0.999999999999289	0.431803546765083
down	MARK2; DLG5; DLG3; PARD3; LRRC1; PARD3B;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	6	22	27.2727272727273	0.00649462261436184	0.0460133337079019	1	1	0.904870709615565	0.999999999999289	0.431803546765083
down	NUPR2; FGF10; CHEK2; CDK4; CCND1; SETMAR;	GO:0071157~negative regulation of cell cycle arrest	6	22	27.2727272727273	0.00649462261436184	0.0460133337079019	1	1	0.904870709615565	0.999999999999289	0.431803546765083
down	TFAP2A; BCR; VDAC1; SIRT2; ATG5; SIRT5;	GO:2000378~negative regulation of reactive oxygen species metabolic process	6	22	27.2727272727273	0.00649462261436184	0.0460133337079019	1	1	0.904870709615565	0.999999999999289	0.431803546765083
down	RBFOX2; NOL3; ZPR1; BCAS2; SNRPB; LGALS3; PTBP1; PPP2R1A; NCBP2; SNRPF; SNRPG; SNRPD1; SNRPD2; PPP2CA; C1QBP; SF3B4; USP39; THOC7; LSM4; MAGOHB;	GO:0008380~RNA splicing	20	156	12.8205128205128	0.00653681474438272	0.0460693908372542	1	1	0.905265418758254	0.999999999999289	0.432329604438484
down	ILVBL; SLC27A2; ALDH3A2; PEX13;	GO:0001561~fatty acid alpha-oxidation	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	TCP1; ARL2; VBP1; TBCA;	GO:0007021~tubulin complex assembly	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	ADAL; NT5C3B; NUDT5; REXO2;	GO:0009117~nucleotide metabolic process	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	HOXA5; HDAC1; HDAC2; HDAC6;	GO:0010870~positive regulation of receptor biosynthetic process	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	SLC25A12; LRRC8E; LRRC8A; SLC25A13;	GO:0015810~aspartate transmembrane transport	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	PLK1; CDC6; CDC23; UBE2C;	GO:0030071~regulation of mitotic metaphase/anaphase transition	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	ALDOA; PFKL; PFKP; PFKM;	GO:0030388~fructose 1,6-bisphosphate metabolic process	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	YAP1; SOX9; STIL; COL2A1;	GO:0030903~notochord development	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	ITGB1BP1; FN1; CXCL12; COL16A1;	GO:0033622~integrin activation	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	CTNNB1; FOXF1; SOX17; EPB41L5;	GO:0048617~embryonic foregut morphogenesis	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	TULP3; GLI3; MTHFD1; HOXA1;	GO:0048702~embryonic neurocranium morphogenesis	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	EZR; MAD2L1; PARD3; PARD3B;	GO:0051660~establishment of centrosome localization	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	NOS3; SOX9; GAS6; HEY2;	GO:0070168~negative regulation of biomineral tissue development	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	PODXL; BMP4; JAG1; MYO1E;	GO:0072015~glomerular visceral epithelial cell development	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
down	RFC4; RFC2; RFC5; DSCC1;	GO:1900264~positive regulation of DNA-directed DNA polymerase activity	4	9	44.4444444444444	0.00667937443155187	0.0460693908372542	1	1	0.90648655016845	0.999999999999289	0.432329604438484
up	LPXN; CD22; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	4	7	57.1428571428571	0.00671357278811091	0.236961239523095	1	1	0.99999999854637	0.99999999854637	1
up	CD4; TRPC3; P2RX5; P2RX4; P2RX7;	GO:0010524~positive regulation of calcium ion transport into cytosol	5	12	41.6666666666667	0.00672898300845903	0.236961239523095	1	1	0.99999999854637	0.99999999854637	1
up	MEFV; IL10; JAK3; SLAMF1; TIGIT;	GO:0032695~negative regulation of interleukin-12 production	5	12	41.6666666666667	0.00672898300845903	0.236961239523095	1	1	0.99999999854637	0.99999999854637	1
down	HS3ST1; HS6ST1; SDC1; SDC4; GPC1; HS3ST6; HS3ST3A1; UGDH;	GO:0006024~glycosaminoglycan biosynthetic process	8	38	21.0526315789474	0.00676933978957872	0.0460693908372542	1	1	0.907091531803549	0.999999999999289	0.432329604438484
down	STX6; GNAI3; CAV2; VAV3; VAMP3; VAMP8; STX12; TSNARE1;	GO:0006906~vesicle fusion	8	38	21.0526315789474	0.00676933978957872	0.0460693908372542	1	1	0.907091531803549	0.999999999999289	0.432329604438484
down	ARPC2; ABL1; P4HB; CRK; RAC1; C1QBP; DOCK1; TRIOBP;	GO:1900026~positive regulation of substrate adhesion-dependent cell spreading	8	38	21.0526315789474	0.00676933978957872	0.0460693908372542	1	1	0.907091531803549	0.999999999999289	0.432329604438484
down	BMPR1A; AMHR2; SMAD5;	GO:0001880~Mullerian duct regression	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	JUP; PKP2; PKP3;	GO:0002159~desmosome assembly	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	PDHA1; DLAT; PDHB;	GO:0006086~acetyl-CoA biosynthetic process from pyruvate	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	ALAD; MAOB; LONP1;	GO:0010044~response to aluminum ion	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	SLC7A5; SLC38A9; SLC38A7;	GO:0015803~branched-chain amino acid transport	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	SCARB2; TMEM30B; TMEM30A;	GO:0015917~aminophospholipid transport	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	DPM1; DPAGT1; SRD5A3;	GO:0019348~dolichol metabolic process	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	EPHX1; PON2; PON3;	GO:0019439~aromatic compound catabolic process	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	FARP2; CDH3; SOX18;	GO:0022405~hair cycle process	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	EBP; DHCR24; DHCR7;	GO:0033489~cholesterol biosynthetic process via desmosterol	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	EBP; DHCR24; DHCR7;	GO:0033490~cholesterol biosynthetic process via lathosterol	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	FASTKD1; PDE12; TBRG4;	GO:0044528~regulation of mitochondrial mRNA stability	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	PC; CAV2; VAPA;	GO:0044791~positive regulation by host of viral release from host cell	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	HSPA4; TOMM22; SAMM50;	GO:0045040~protein insertion into mitochondrial outer membrane	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	DLL1; HES1; HES5;	GO:0045608~negative regulation of inner ear auditory receptor cell differentiation	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	ADH5; GCLC; GCLM;	GO:0051409~response to nitrosative stress	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	TSPO; YAP1; SMO;	GO:0060242~contact inhibition	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	BMP4; BMP7; BMPER;	GO:0060393~regulation of pathway-restricted SMAD protein phosphorylation	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	BMP4; BMP7; SULF1;	GO:0060686~negative regulation of prostatic bud formation	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	CTNNB1; HDAC1; HDAC2;	GO:0060789~hair follicle placode formation	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	AGR2; VAMP3; VAMP8;	GO:0070254~mucus secretion	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	FGF10; RARG; SOX9;	GO:0070384~Harderian gland development	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	CYP1A1; POR; CYP51A1;	GO:0070988~demethylation	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	RAB6A; MREG; BICD2;	GO:0072385~minus-end-directed organelle transport along microtubule	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	BMP4; SOX9; FOXD1;	GO:0090184~positive regulation of kidney development	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	BAG3; HSPA1A; IMPACT;	GO:0097201~negative regulation of transcription from RNA polymerase II promoter in response to stress	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	SNRPA; NCBP2; ZC3H3;	GO:1900363~regulation of mRNA polyadenylation	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	AGR2; TMEM33; BOK;	GO:1903899~positive regulation of PERK-mediated unfolded protein response	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	RAMP2; RAMP3; CALCRL;	GO:1990410~adrenomedullin receptor signaling pathway	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
down	RAB11B; NDRG4; INPP5F;	GO:2001135~regulation of endocytic recycling	3	4	75	0.00687639601607759	0.0460693908372542	1	1	0.907766295886334	0.999999999999289	0.432329604438484
up	CCDC88B; PF4; IL10; SLC11A1; IRF8; IRF4; TSPAN32;	GO:0042832~defense response to protozoan	7	24	29.1666666666667	0.00691433481819981	0.236961239523095	1	1	0.99999999854637	0.99999999854637	1
down	POLR1C; POLR2E; CCNH; POLR2H; POLR2L; GTF2H3; GTF2H5;	GO:0006363~termination of RNA polymerase I transcription	7	30	23.3333333333333	0.00691626987124172	0.0460693908372542	1	1	0.90820663849894	0.999999999999289	0.432329604438484
down	RAD51B; TRIP13; RAD50; KLHDC3; MSH3; RAD51C; RAD51;	GO:0007131~reciprocal meiotic recombination	7	30	23.3333333333333	0.00691626987124172	0.0460693908372542	1	1	0.90820663849894	0.999999999999289	0.432329604438484
down	BMP7; PLK1; CEMIP; WNK3; TNKS1BP1; SPHK1; TRPC6;	GO:0010800~positive regulation of peptidyl-threonine phosphorylation	7	30	23.3333333333333	0.00691626987124172	0.0460693908372542	1	1	0.90820663849894	0.999999999999289	0.432329604438484
down	DVL1; ITGB1BP1; PIGR; CDK5; PICK1; LRRC1; DLG3;	GO:0043113~receptor clustering	7	30	23.3333333333333	0.00691626987124172	0.0460693908372542	1	1	0.90820663849894	0.999999999999289	0.432329604438484
down	PSMD11; EPCAM; HOXA7; PUM1; OSR1; NELFB; ELL3;	GO:0048863~stem cell differentiation	7	30	23.3333333333333	0.00691626987124172	0.0460693908372542	1	1	0.90820663849894	0.999999999999289	0.432329604438484
down	FGF10; OXTR; KDR; MAP2K2; SOX9; CCL11; IQGAP3;	GO:0070371~ERK1 and ERK2 cascade	7	30	23.3333333333333	0.00691626987124172	0.0460693908372542	1	1	0.90820663849894	0.999999999999289	0.432329604438484
up	CLEC4D; CLEC4E; FCER1G;	GO:0002292~T cell differentiation involved in immune response	3	3	100	0.00703049735798955	0.236961239523095	1	1	0.99999999854637	0.99999999854637	1
up	HLA-G; LILRB2; LILRB1;	GO:0002767~immune response-inhibiting cell surface receptor signaling pathway	3	3	100	0.00703049735798955	0.236961239523095	1	1	0.99999999854637	0.99999999854637	1
up	LYN; LILRB2; LILRB1;	GO:0002774~Fc receptor mediated inhibitory signaling pathway	3	3	100	0.00703049735798955	0.236961239523095	1	1	0.99999999854637	0.99999999854637	1
up	CLEC4D; CLEC4E; FCER1G;	GO:0038094~Fc-gamma receptor signaling pathway	3	3	100	0.00703049735798955	0.236961239523095	1	1	0.99999999854637	0.99999999854637	1
up	CD4; CD74; CD1D;	GO:0045058~T cell selection	3	3	100	0.00703049735798955	0.236961239523095	1	1	0.99999999854637	0.99999999854637	1
up	TYROBP; ITGAM; STAP1;	GO:1904151~positive regulation of microglial cell mediated cytotoxicity	3	3	100	0.00703049735798955	0.236961239523095	1	1	0.99999999854637	0.99999999854637	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00703049735798955	0.236961239523095	1	1	0.99999999854637	0.99999999854637	1
down	RNF40; SPARC; BMP7; OXTR; CXCL12; EIF2B2; GNAI1; DAG1; EIF2B1;	GO:0043434~response to peptide hormone	9	47	19.1489361702128	0.00713431822309274	0.047380099451772	1	1	0.910041399384796	0.999999999999289	0.444629704929293
down	IMPA2; IMPA1; INPP1; PLCD1; OCRL; PPIP5K1; ITPKC; IPPK; IP6K2;	GO:0043647~inositol phosphate metabolic process	9	47	19.1489361702128	0.00713431822309274	0.047380099451772	1	1	0.910041399384796	0.999999999999289	0.444629704929293
up	DNTT; SELL; TRPC3; P2RX5; P2RX4; P2RX7;	GO:0033198~response to ATP	6	18	33.3333333333333	0.00723809505894457	0.239398302930886	1	1	0.99999999854637	0.99999999854637	1
up	CCL5; FPR2; CCR1; CCR2; AIF1; PLA2G7;	GO:0090026~positive regulation of monocyte chemotaxis	6	18	33.3333333333333	0.00723809505894457	0.239398302930886	1	1	0.99999999854637	0.99999999854637	1
up	PTK2B; TXK; LYN; LCK; HCK; FGR; BLK; SLA;	GO:0038083~peptidyl-tyrosine autophosphorylation	8	31	25.8064516129032	0.00734298110142506	0.240618612203179	1	1	0.99999999854637	0.99999999854637	1
down	PRICKLE3; ITGA8; CDK10; TCHP; RAB34; TUBD1; CBY1; NUBP2;	GO:0030030~cell projection organization	8	39	20.5128205128205	0.00772419911660571	0.0508743244203837	1	1	0.914653095665463	0.999999999999289	0.477420607327712
down	GREM1; EFNA1; ERBB3; GAS6; NCAPG2; ABI1; AFAP1L2; DLG3;	GO:0061098~positive regulation of protein tyrosine kinase activity	8	39	20.5128205128205	0.00772419911660571	0.0508743244203837	1	1	0.914653095665463	0.999999999999289	0.477420607327712
down	CHEK1; RRM2; E2F1; RAD51; RBBP4; TFDP1; RBBP7; RBBP8;	GO:0070317~negative regulation of G0 to G1 transition	8	39	20.5128205128205	0.00772419911660571	0.0508743244203837	1	1	0.914653095665463	0.999999999999289	0.477420607327712
up	DOK2; F2; CD74; ITGB3; ITGB2; LCK; CD2; LYN; DBH; CD48; ITGAM; SELL; SPN; PECAM1; ITGAL; ITGAX; PTPN6; FCER1G; SELPLG; JAML; INPP5D; CD244; TREM1; SIRPG; CD84; VPREB3; SLC7A7;	GO:0050900~leukocyte migration	27	193	13.9896373056995	0.00774798840631197	0.251560834586588	1	1	0.99999999854637	0.99999999854637	1
down	SLC27A2; ACSL3; SLC27A4; ACAD9; CYP4F12; SLC27A6;	GO:0001676~long-chain fatty acid metabolic process	6	23	26.0869565217391	0.00776707243059294	0.0508743244203837	1	1	0.915212089154028	0.999999999999289	0.477420607327712
down	ERCC1; RBX1; GTF2H3; DDB1; GTF2H5; DDB2;	GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion	6	23	26.0869565217391	0.00776707243059294	0.0508743244203837	1	1	0.915212089154028	0.999999999999289	0.477420607327712
down	PTGES3; RAD50; TNKS1BP1; NHP2; SMG5; TELO2;	GO:0007004~telomere maintenance via telomerase	6	23	26.0869565217391	0.00776707243059294	0.0508743244203837	1	1	0.915212089154028	0.999999999999289	0.477420607327712
down	SLC9A3R1; MTSS1; TLCD1; BAIAP2; FER1L6; MYOF;	GO:0007009~plasma membrane organization	6	23	26.0869565217391	0.00776707243059294	0.0508743244203837	1	1	0.915212089154028	0.999999999999289	0.477420607327712
down	CYP11A1; FDXR; CYP51A1; EBPL; CYP39A1; ARV1;	GO:0016125~sterol metabolic process	6	23	26.0869565217391	0.00776707243059294	0.0508743244203837	1	1	0.915212089154028	0.999999999999289	0.477420607327712
down	PRMT5; TP73; HDAC1; DAG1; HDAC2; ZNF488;	GO:0048714~positive regulation of oligodendrocyte differentiation	6	23	26.0869565217391	0.00776707243059294	0.0508743244203837	1	1	0.915212089154028	0.999999999999289	0.477420607327712
down	NDUFS3; VDAC2; HDAC1; NDUFA13; NOC2L; BCL2L10;	GO:2001243~negative regulation of intrinsic apoptotic signaling pathway	6	23	26.0869565217391	0.00776707243059294	0.0508743244203837	1	1	0.915212089154028	0.999999999999289	0.477420607327712
down	ENG; BMPR1A; DLL4; CCM2L; HEY2;	GO:0003222~ventricular trabecula myocardium morphogenesis	5	16	31.25	0.00801546537875908	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	MFN2; BAK1; USP30; MIGA2; MFF;	GO:0008053~mitochondrial fusion	5	16	31.25	0.00801546537875908	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	AURKA; BMP4; CTNNB1; WLS; HEY2;	GO:0009948~anterior/posterior axis specification	5	16	31.25	0.00801546537875908	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	AHCYL1; FGF12; GPD1L; PKP2; WNK3;	GO:0010765~positive regulation of sodium ion transport	5	16	31.25	0.00801546537875908	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	TMEM129; SEC61B; FAF2; DERL2; AUP1;	GO:0030970~retrograde protein transport, ER to cytosol	5	16	31.25	0.00801546537875908	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	CXCL10; SPP1; BMP7; STC1; AQP3;	GO:0033280~response to vitamin D	5	16	31.25	0.00801546537875908	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	SAA1; KRT20; RHBDF1; RHBDD3; LLGL2;	GO:0050708~regulation of protein secretion	5	16	31.25	0.00801546537875908	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	AIFM1; CCNA2; CDK2; AQP1; CRK;	GO:0071732~cellular response to nitric oxide	5	16	31.25	0.00801546537875908	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	TRIAP1; TAF9; ZNF385A; ING2; ELL3;	GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	5	16	31.25	0.00801546537875908	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	ADORA2B; IRAK1; UBE2N; CDC42EP5; MINK1; DUSP9; SH2D3A; NOD2; TNFRSF19;	GO:0007254~JNK cascade	9	48	18.75	0.00801672608691173	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	FOXP2; CDK4; NME1; TSPO; PSPH; MTAP; BAD;	GO:0033574~response to testosterone	7	31	22.5806451612903	0.00803358170979451	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	LETM1; IMMT; UQCC3; OMA1; CHCHD6; APOO; SAMM50;	GO:0042407~cristae formation	7	31	22.5806451612903	0.00803358170979451	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	HOXC6; DLX1; NKX3-2; KIAA1217; SULF1; MKS1; DMRT2;	GO:0048706~embryonic skeletal system development	7	31	22.5806451612903	0.00803358170979451	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
down	NDUFS4; NDUFS3; NDUFS1; PLA2R1; PRDX4; DDIT4; NDUFA13;	GO:0072593~reactive oxygen species metabolic process	7	31	22.5806451612903	0.00803358170979451	0.0519075042583531	1	1	0.916951760478256	0.999999999999289	0.48711629078576
up	CD27; STAT5B; NCKAP1L; BTK; INPP5D;	GO:0045579~positive regulation of B cell differentiation	5	13	38.4615384615385	0.00875122741742773	0.277267084684163	1	1	0.99999999854637	0.99999999854637	1
up	RGS13; RGS14; PLEK; CCL5; RGS2;	GO:0045744~negative regulation of G protein-coupled receptor signaling pathway	5	13	38.4615384615385	0.00875122741742773	0.277267084684163	1	1	0.99999999854637	0.99999999854637	1
down	CDC45; CDC6; CDT1; TIMELESS;	GO:0000076~DNA replication checkpoint	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	CPE; FOXF1; SFRP2; HEY2;	GO:0003214~cardiac left ventricle morphogenesis	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	NME6; NME1; NME2; NME7;	GO:0006228~UTP biosynthetic process	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	SHTN1; OPHN1; NCK1; CTTN;	GO:0006930~substrate-dependent cell migration, cell extension	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	NDC80; BUB3; SGO1; AURKB;	GO:0008608~attachment of spindle microtubules to kinetochore	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	SCGB1A1; GCLC; GSS; RHBDD3;	GO:0009410~response to xenobiotic stimulus	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	ACOT7; ACAT1; COASY; PPCS;	GO:0015937~coenzyme A biosynthetic process	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	PRKRA; TARBP2; MRPL44; DROSHA;	GO:0030422~production of siRNA involved in RNA interference	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	ALOX15B; GLI3; SOX9; FKBP4;	GO:0030850~prostate gland development	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	EMP2; PMP22; MYLK; LPAR1;	GO:0032060~bleb assembly	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	TBX6; TMED2; NRARP; EPB41L5;	GO:0032525~somite rostral/caudal axis specification	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	CLTA; AP2S1; VLDLR; AP2M1;	GO:0032802~low-density lipoprotein particle receptor catabolic process	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	GREM1; GSTP1; MAP2K2; PRDX1;	GO:0032872~regulation of stress-activated MAPK cascade	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	SHTN1; PTK2; UNC5D; UNC5B;	GO:0038007~netrin-activated signaling pathway	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	LGALS3; CTNNB1; TNFSF9; TNFSF18;	GO:0042129~regulation of T cell proliferation	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	IGFBP4; NKX6-1; BAD; BTBD10;	GO:0044342~type B pancreatic cell proliferation	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	NDC80; KIF2C; CDT1; NUF2;	GO:0051315~attachment of mitotic spindle microtubules to kinetochore	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	MTMR2; CTTN; TANC1; PICK1;	GO:0097062~dendritic spine maintenance	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	ZNF205; BAK1; CHCHD10; BOK;	GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
down	SMARCA4; SMARCB1; PWP1; IPPK;	GO:1901838~positive regulation of transcription of nucleolar large rRNA by RNA polymerase I	4	10	40	0.00889763934513743	0.0562927352886962	1	1	0.924260796250184	0.999999999999289	0.528268673360493
up	TYROBP; GNAI2; ITGB2; ITGAM; CYBA; FPR2;	GO:0032930~positive regulation of superoxide anion generation	6	19	31.5789473684211	0.00893146302740733	0.277267084684163	1	1	0.99999999854637	0.99999999854637	1
up	TNF; SELL; SPN; ITGB7; CX3CR1; SELPLG;	GO:0050901~leukocyte tethering or rolling	6	19	31.5789473684211	0.00893146302740733	0.277267084684163	1	1	0.99999999854637	0.99999999854637	1
down	DCN; STK11; ZC3H12A; TRIM65; BAD; KAT5; TMEM59; PLK2; SH3GLB1;	GO:0010508~positive regulation of autophagy	9	49	18.3673469387755	0.00897971563504552	0.0567582593734523	1	1	0.924910710409688	0.999999999999289	0.532637297294119
down	CYP1A1; CYP2E1; LTA4H; GPX4; PLP1; LTC4S;	GO:0042759~long-chain fatty acid biosynthetic process	6	24	25	0.0092094925038585	0.0581006793373736	1	1	0.926554247357504	0.999999999999289	0.545234987027908
down	DLL1; CXCL14; CXCL10; BMP4; SOX9; ANKRD2;	GO:0045662~negative regulation of myoblast differentiation	6	24	25	0.0092094925038585	0.0581006793373736	1	1	0.926554247357504	0.999999999999289	0.545234987027908
down	TBX6; BMP7; NF2; BMPR1A; WLS; TWSG1; MESP2;	GO:0001707~mesoderm formation	7	32	21.875	0.00927831278975522	0.0583145886626102	1	1	0.92735196948179	0.999999999999289	0.54724237918753
down	FGF10; BGN; NOS3; JAG1; BAK1; ATG5; DLL4;	GO:0001974~blood vessel remodeling	7	32	21.875	0.00927831278975522	0.0583145886626102	1	1	0.92735196948179	0.999999999999289	0.54724237918753
down	GART; PPP2R1A; CTSC; PPP2CA; SQLE; GLRX2; TIMP3;	GO:0010033~response to organic substance	7	32	21.875	0.00927831278975522	0.0583145886626102	1	1	0.92735196948179	0.999999999999289	0.54724237918753
down	EPHA3; RASSF7; MARK2; PHLDB2; CEP70; KIF18A; BICD2;	GO:0070507~regulation of microtubule cytoskeleton organization	7	32	21.875	0.00927831278975522	0.0583145886626102	1	1	0.92735196948179	0.999999999999289	0.54724237918753
up	LST1; ATP10A; FMNL1; F2; ITGB2; HCK; VIL1; FGR; CCL2; EPB42; CORO1A; CCL7; BAMBI; PTK2B; PLEKHO1; FGD3; SH3KBP1; PLXNC1; RHOG; RAC2; CDC42EP3; WAS; RHOF;	GO:0008360~regulation of cell shape	23	159	14.4654088050314	0.00945842024004528	0.286751896216535	1	1	0.99999999854637	0.99999999854637	1
up	CD160; HLA-E; HLA-G; HLA-F;	GO:0002729~positive regulation of natural killer cell cytokine production	4	8	50	0.00948007116624316	0.286751896216535	1	1	0.99999999854637	0.99999999854637	1
up	PRKCB; NFAM1; CMTM3; STAP1;	GO:0050861~positive regulation of B cell receptor signaling pathway	4	8	50	0.00948007116624316	0.286751896216535	1	1	0.99999999854637	0.99999999854637	1
down	EIF6; WDR12; MRPL1; FBXW9; NHP2;	GO:0000470~maturation of LSU-rRNA	5	17	29.4117647058824	0.00985252195537112	0.0611185693443217	1	1	0.931615656697798	0.999999999999289	0.573555812835044
down	FOXE1; TPO; CTSB; CTSK; DUOX1;	GO:0006590~thyroid hormone generation	5	17	29.4117647058824	0.00985252195537112	0.0611185693443217	1	1	0.931615656697798	0.999999999999289	0.573555812835044
down	TSPAN15; GALNT11; POFUT1; RFNG; LLGL2;	GO:0008593~regulation of Notch signaling pathway	5	17	29.4117647058824	0.00985252195537112	0.0611185693443217	1	1	0.931615656697798	0.999999999999289	0.573555812835044
down	SLC25A4; NDUFS1; GCLM; BIK; DNM1L;	GO:0008637~apoptotic mitochondrial changes	5	17	29.4117647058824	0.00985252195537112	0.0611185693443217	1	1	0.931615656697798	0.999999999999289	0.573555812835044
down	HDAC3; CEACAM5; HDAC1; MYOCD; ANKRD2;	GO:0010832~negative regulation of myotube differentiation	5	17	29.4117647058824	0.00985252195537112	0.0611185693443217	1	1	0.931615656697798	0.999999999999289	0.573555812835044
down	NSUN4; ZCCHC4; TRMT112; DIMT1; TFB2M;	GO:0031167~rRNA methylation	5	17	29.4117647058824	0.00985252195537112	0.0611185693443217	1	1	0.931615656697798	0.999999999999289	0.573555812835044
down	LANCL1; NAE1; AKT1S1; SIGMAR1; EGLN3;	GO:0043523~regulation of neuron apoptotic process	5	17	29.4117647058824	0.00985252195537112	0.0611185693443217	1	1	0.931615656697798	0.999999999999289	0.573555812835044
down	NDUFS4; NDUFS1; COX10; COX4I2; SLC25A13;	GO:0045333~cellular respiration	5	17	29.4117647058824	0.00985252195537112	0.0611185693443217	1	1	0.931615656697798	0.999999999999289	0.573555812835044
down	DNM1L; NOL3; ZC3H12A; STOML2; BOK;	GO:0051259~protein complex oligomerization	5	17	29.4117647058824	0.00985252195537112	0.0611185693443217	1	1	0.931615656697798	0.999999999999289	0.573555812835044
down	KIF20A; CEP55; CHMP4C; CHMP1A; VPS4A;	GO:0061952~midbody abscission	5	17	29.4117647058824	0.00985252195537112	0.0611185693443217	1	1	0.931615656697798	0.999999999999289	0.573555812835044
down	LAMA5; BIRC5; IGHG4; FN1; CXCL10; SAA1; GHR; SDC1; MAOA; CCND1; IL1R2; TXLNA; CRK; CCL11; PLP2; IL13RA2; CTF1; IL20RB; IFNLR1; IL1F10; CNOT9; BAD; NDN; OSMR; CCL19; DUOX1; IL36G; IL20RA; FZD4; IRAK1;	GO:0019221~cytokine-mediated signaling pathway	30	278	10.7913669064748	0.00989727971690235	0.0613392632547538	1	1	0.931615656697798	0.999999999999289	0.575626873668823
down	PLD2; AGPAT2; PLA2G2A; PLD1; LPCAT4; PLA2G4D; GPD1L; AGPAT5;	GO:0006654~phosphatidic acid biosynthetic process	8	41	19.5121951219512	0.00993280901165272	0.0615024068645522	1	1	0.93252788745099	0.999999999999289	0.57715786444185
down	ABL1; EGFR; PIGR; SOX9; ADAM17; EFEMP1; GRB7; FAM83B; PTK2;	GO:0007173~epidermal growth factor receptor signaling pathway	9	50	18	0.0100276945555253	0.0619750484046852	1	1	0.932575593663855	0.999999999999289	0.581593280807757
down	VPS37C; RAN; NUP54; VPS37D; NUP93; NUP37; NUP35; MVB12A; AAAS;	GO:0075733~intracellular transport of virus	9	50	18	0.0100276945555253	0.0619750484046852	1	1	0.932575593663855	0.999999999999289	0.581593280807757
down	KIF23; RACGAP1; RTKN;	GO:0000915~actomyosin contractile ring assembly	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	HSD17B6; SPP1; SRD5A1;	GO:0006710~androgen catabolic process	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	ALKBH7; FTO; MEST;	GO:0010883~regulation of lipid storage	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	HMGCR; ACAT1; CROT;	GO:0015936~coenzyme A metabolic process	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	MMP16; ACACA; NECAB3;	GO:0019538~protein metabolic process	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	PCCA; PCCB; MCEE;	GO:0019626~short-chain fatty acid catabolic process	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	LTF; FAM3A; RARRES2;	GO:0019732~antifungal humoral response	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	TULP3; SPOCK1; SMO;	GO:0021953~central nervous system neuron differentiation	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	VTA1; LEPROT; TMEM50B;	GO:0032511~late endosome to vacuole transport via multivesicular body sorting pathway	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	PODXL; PLD1; KLF5;	GO:0032534~regulation of microvillus assembly	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	AIFM1; CHCHD4; SAMM50;	GO:0033108~mitochondrial respiratory chain complex assembly	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	OMA1; STOML2; ATP23;	GO:0034982~mitochondrial protein processing	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	UCK2; UCK1; UCKL1;	GO:0044206~UMP salvage	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	TOLLIP; PRDX2; PRDX1;	GO:0045321~leukocyte activation	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	SHMT1; ALDH9A1; TMLHE;	GO:0045329~carnitine biosynthetic process	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	SOX15; BMP4; SIRT2;	GO:0045843~negative regulation of striated muscle tissue development	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	CHEK1; NEK2; KIF11;	GO:0046602~regulation of mitotic centrosome separation	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	CD1A; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	BMP4; FGFR2; MYOCD;	GO:0051150~regulation of smooth muscle cell differentiation	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	NFIB; FGF10; AIMP2;	GO:0060510~type II pneumocyte differentiation	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	DFFA; GLI3; BAK1;	GO:0070242~thymocyte apoptotic process	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	CAV2; EMP2; CAV1;	GO:0070836~caveola assembly	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	TCF21; WNT4; OSR1;	GO:0072162~metanephric mesenchymal cell differentiation	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	ACTA2; ACTG2; FOXF1;	GO:0090131~mesenchyme migration	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	FOXF1; MYOCD; TFAP2B;	GO:0097070~ductus arteriosus closure	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	NOL3; ENO1; TMBIM6;	GO:1903298~negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	GJB5; GJB1; GJB2;	GO:1905867~epididymis development	3	5	60	0.0104982571634066	0.0631881586565039	1	1	0.936399305769417	0.999999999999289	0.592977487670005
down	CHEK1; HUS1; TIPRL; CHEK2; E2F1; RHNO1; INTS7;	GO:0000077~DNA damage checkpoint	7	33	21.2121212121212	0.010658357867189	0.0638068897049194	1	1	0.937935492312636	0.999999999999289	0.598783853774567
down	POLR1C; POLR2E; CCNH; POLR2H; POLR2L; GTF2H3; GTF2H5;	GO:0006361~transcription initiation from RNA polymerase I promoter	7	33	21.2121212121212	0.010658357867189	0.0638068897049194	1	1	0.937935492312636	0.999999999999289	0.598783853774567
down	GTPBP3; THUMPD2; TRMT61A; FTSJ1; TRMT112; TRMT5; METTL1;	GO:0030488~tRNA methylation	7	33	21.2121212121212	0.010658357867189	0.0638068897049194	1	1	0.937935492312636	0.999999999999289	0.598783853774567
down	HSPA1A; HSPA1B; NDUFS1; ATP6V1A; ATP1A2; AK2; BAD;	GO:0046034~ATP metabolic process	7	33	21.2121212121212	0.010658357867189	0.0638068897049194	1	1	0.937935492312636	0.999999999999289	0.598783853774567
down	SAA1; CCL18; CCL14; CCL21; CCL19; CCL11; CCL13;	GO:0048247~lymphocyte chemotaxis	7	33	21.2121212121212	0.010658357867189	0.0638068897049194	1	1	0.937935492312636	0.999999999999289	0.598783853774567
down	FGF10; TCF21; ABL1; NKX3-2; ADAM17; PITX2; BARX1;	GO:0048536~spleen development	7	33	21.2121212121212	0.010658357867189	0.0638068897049194	1	1	0.937935492312636	0.999999999999289	0.598783853774567
down	SDC1; SDC4; GPC1; NAGLU; HYAL2; HPSE2;	GO:0006027~glycosaminoglycan catabolic process	6	25	24	0.0108333088100572	0.0644499876758611	1	1	0.939560147307879	0.999999999999289	0.604818886718124
down	POLR1C; GTF3C1; GTF3C2; GTF3C6; POLR3H; GTF3C5;	GO:0006383~transcription by RNA polymerase III	6	25	24	0.0108333088100572	0.0644499876758611	1	1	0.939560147307879	0.999999999999289	0.604818886718124
down	ARPC2; ACTR3; RAC1; OCLN; BRK1; NCKAP1;	GO:0010592~positive regulation of lamellipodium assembly	6	25	24	0.0108333088100572	0.0644499876758611	1	1	0.939560147307879	0.999999999999289	0.604818886718124
down	CYP1A1; CYP2E1; CBR1; NT5C2; ADAL; CYP4F12;	GO:0017144~drug metabolic process	6	25	24	0.0108333088100572	0.0644499876758611	1	1	0.939560147307879	0.999999999999289	0.604818886718124
down	CRABP2; CYP2C18; CYP27C1; CYP2S1; SCPEP1; ADH1B;	GO:0042573~retinoic acid metabolic process	6	25	24	0.0108333088100572	0.0644499876758611	1	1	0.939560147307879	0.999999999999289	0.604818886718124
down	CYP4B1; NUDT15; CYP2J2; CYP2C18; CYP2S1; CYP2E1;	GO:0042738~exogenous drug catabolic process	6	25	24	0.0108333088100572	0.0644499876758611	1	1	0.939560147307879	0.999999999999289	0.604818886718124
up	TLR4; CD74; TNFRSF4; NCKAP1L; FCRL3; CARD11; TNFSF13B; SASH3; BST1;	GO:0030890~positive regulation of B cell proliferation	9	41	21.9512195121951	0.0110178516384462	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	SH2B2; F2; SERPINA1; IFNA5; SLC4A1; F11; ITGB3; GP1BA; LYN; IRF1; F5; CD36; GATA3; PRTN3; ADORA2A; FCER1G; PRKAR2B; GP5; WAS; HBB; NFE2; P2RX5; P2RX4; P2RX7;	GO:0007596~blood coagulation	24	171	14.0350877192982	0.0111545848763223	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	ITGB2; MME; ITGAM; C5AR1; MARCO;	GO:0097242~amyloid-beta clearance	5	14	35.7142857142857	0.0111570189617338	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
down	POLR1C; POLR2E; CTNNB1; IRAK1; POLR2H; POLR2L; TBK1; DDX41; POLR3H;	GO:0032481~positive regulation of type I interferon production	9	51	17.6470588235294	0.0111650780558721	0.0662215387526205	1	1	0.94180420796722	0.999999999999289	0.621443677329391
down	WASL; STX6; RAB14; SUMO1; SIX1; PLEKHM2; CELSR2; VPS4A; B9D1;	GO:0032880~regulation of protein localization	9	51	17.6470588235294	0.0111650780558721	0.0662215387526205	1	1	0.94180420796722	0.999999999999289	0.621443677329391
down	EGFR; COL4A1; CAPN2; COL16A1; LAMTOR1; RRAGA; SLC38A9; LAMTOR3; LAMTOR2;	GO:0071230~cellular response to amino acid stimulus	9	51	17.6470588235294	0.0111650780558721	0.0662215387526205	1	1	0.94180420796722	0.999999999999289	0.621443677329391
down	ZBTB7A; EIF6; NUP54; NUP93; NUP37; NUP35; JMJD8; AAAS;	GO:0006110~regulation of glycolytic process	8	42	19.047619047619	0.0111981051409871	0.0662662005730156	1	1	0.94180420796722	0.999999999999289	0.621862797851585
down	CTDSPL; RB1; CDK4; WEE1; CDKN2C; FHL1; KANK2; CDC73;	GO:2000134~negative regulation of G1/S transition of mitotic cell cycle	8	42	19.047619047619	0.0111981051409871	0.0662662005730156	1	1	0.94180420796722	0.999999999999289	0.621862797851585
down	GINS2; MCM2; MCM4; CDC45;	GO:0000727~double-strand break repair via break-induced replication	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	NME6; NME1; NME2; NME7;	GO:0006241~CTP biosynthetic process	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	POLRMT; MRPL12; TEFM; TFB2M;	GO:0006390~mitochondrial transcription	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	NMNAT1; PRPSAP1; PRPSAP2; PRPS2;	GO:0009165~nucleotide biosynthetic process	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	P4HB; PRDX4; EGLN3; P4HA2;	GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	MGST3; LTA4H; MGST2; LTC4S;	GO:0019370~leukotriene biosynthetic process	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	GLI3; CTNNB1; CDK5; ADGRG1;	GO:0021819~layer formation in cerebral cortex	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	EPHB3; WNT4; MINK1; CELSR2;	GO:0022407~regulation of cell-cell adhesion	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	B3GNT2; B3GNT6; B3GNT5; B3GNT9;	GO:0030311~poly-N-acetyllactosamine biosynthetic process	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	SREBF1; SDR16C5; JDP2; ING2;	GO:0031065~positive regulation of histone deacetylation	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	ITPKC; IP6K2; IPPK; PPIP5K1;	GO:0032958~inositol phosphate biosynthetic process	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	BUB3; CDK1; AURKB; TTK;	GO:0034501~protein localization to kinetochore	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	TK1; UCK2; UCK1; UCKL1;	GO:0043097~pyrimidine nucleoside salvage	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	CCT3; PDZD11; PLEKHA7; BAD;	GO:0046931~pore complex assembly	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	CAPN2; TSPO; VWA1; LPAR5;	GO:0048266~behavioral response to pain	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	FIGN; TTLL11; LZTS2; KATNB1;	GO:0051013~microtubule severing	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	NOS3; SPR; PTS; MMADHC;	GO:0051186~cofactor metabolic process	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	BCAP31; MICU2; MCUR1; SLC25A23;	GO:0051561~positive regulation of mitochondrial calcium ion concentration	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	ADH5; SIRT2; GLRX2; RNF7;	GO:0051775~response to redox state	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	HDAC1; SIRT2; HDAC2; HDAC3;	GO:0070933~histone H4 deacetylation	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	DSP; ITGB5; CTNNA1; PLEKHA7;	GO:0090136~epithelial cell-cell adhesion	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
down	GSN; RB1; ARF6; STK3;	GO:0097284~hepatocyte apoptotic process	4	11	36.3636363636364	0.0115461725189726	0.0670199640306307	1	1	0.945397737536571	0.999999999999289	0.628936350411074
up	ITGAL; FGL2; APBB1IP;	GO:0002291~T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	3	4	75	0.0116221636241175	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	HLA-DRB1; FGL2; GAPT;	GO:0002381~immunoglobulin production involved in immunoglobulin mediated immune response	3	4	75	0.0116221636241175	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	HLA-DRB1; HLA-DMA; HLA-DMB;	GO:0002503~peptide antigen assembly with MHC class II protein complex	3	4	75	0.0116221636241175	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	CD247; FCER1G; SLC11A1;	GO:0032623~interleukin-2 production	3	4	75	0.0116221636241175	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	AVPR2; ADORA1; SPX;	GO:0035814~negative regulation of renal sodium excretion	3	4	75	0.0116221636241175	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	TLR2; TLR1; SCIMP;	GO:0038123~toll-like receptor TLR1:TLR2 signaling pathway	3	4	75	0.0116221636241175	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	TLR2; CD36; TLR6;	GO:0038124~toll-like receptor TLR6:TLR2 signaling pathway	3	4	75	0.0116221636241175	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	ITGB2; ITGAM; PTAFR;	GO:0043315~positive regulation of neutrophil degranulation	3	4	75	0.0116221636241175	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	TLR2; TLR1; TLR6;	GO:0071221~cellular response to bacterial lipopeptide	3	4	75	0.0116221636241175	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	TLR2; CD36; TLR6;	GO:0071726~cellular response to diacyl bacterial lipopeptide	3	4	75	0.0116221636241175	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	GATA3; CCR6; TBX21;	GO:0072676~lymphocyte migration	3	4	75	0.0116221636241175	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
up	LILRA5; CCL4; CCL5; CCR1; LILRA2; ORAI1; P2RX4;	GO:0051928~positive regulation of calcium ion transport	7	27	25.9259259259259	0.0116273204924577	0.311735509263696	1	1	0.99999999854637	0.99999999854637	1
down	PEX7; PEX10; PEX11A; PEX3; LONP2;	GO:0007031~peroxisome organization	5	18	27.7777777777778	0.0119588838159431	0.0687584361224751	1	1	0.94795979102583	0.999999999999289	0.645250717459023
down	CTSV; NDUFS6; ERCC1; HYAL2; TP63;	GO:0010259~multicellular organism aging	5	18	27.7777777777778	0.0119588838159431	0.0687584361224751	1	1	0.94795979102583	0.999999999999289	0.645250717459023
down	NFIB; BMP7; CTNNB1; SMAD1; WLS;	GO:0030902~hindbrain development	5	18	27.7777777777778	0.0119588838159431	0.0687584361224751	1	1	0.94795979102583	0.999999999999289	0.645250717459023
down	PLA2G2A; LPCAT4; PLA2G4D; SERAC1; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	5	18	27.7777777777778	0.0119588838159431	0.0687584361224751	1	1	0.94795979102583	0.999999999999289	0.645250717459023
down	TUBB; PRDX1; RAET1G; RAET1E; ULBP2;	GO:0042267~natural killer cell mediated cytotoxicity	5	18	27.7777777777778	0.0119588838159431	0.0687584361224751	1	1	0.94795979102583	0.999999999999289	0.645250717459023
down	PDLIM1; ELN; ITGB5; TNFAIP1; FAM171A1;	GO:0043149~stress fiber assembly	5	18	27.7777777777778	0.0119588838159431	0.0687584361224751	1	1	0.94795979102583	0.999999999999289	0.645250717459023
down	ALOX12B; GSTP1; CYP2J2; ELOVL1; ALOX15B;	GO:0043651~linoleic acid metabolic process	5	18	27.7777777777778	0.0119588838159431	0.0687584361224751	1	1	0.94795979102583	0.999999999999289	0.645250717459023
down	CTTN; NPNT; MYOCD; SPHK1; NMU;	GO:0045987~positive regulation of smooth muscle contraction	5	18	27.7777777777778	0.0119588838159431	0.0687584361224751	1	1	0.94795979102583	0.999999999999289	0.645250717459023
down	SULT2B1; SULT1C2; TPST1; BPNT1; SULT1E1;	GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process	5	18	27.7777777777778	0.0119588838159431	0.0687584361224751	1	1	0.94795979102583	0.999999999999289	0.645250717459023
down	ITGB1BP1; APOD; PHLDB2; DLC1; RCC2;	GO:0051895~negative regulation of focal adhesion assembly	5	18	27.7777777777778	0.0119588838159431	0.0687584361224751	1	1	0.94795979102583	0.999999999999289	0.645250717459023
down	LYPD1; TMBIM1; AP2M1; MRAP2; TMEM59;	GO:1903077~negative regulation of protein localization to plasma membrane	5	18	27.7777777777778	0.0119588838159431	0.0687584361224751	1	1	0.94795979102583	0.999999999999289	0.645250717459023
up	SH2D1A; GRAP2; GHRH; LTA; WNT1; ITGB2; CCL4; CCL5; CD33; ADORA2A; ADORA1; CCR1; SSTR3; CD70; CXCL5; PTGIR; CX3CR1; CCR5; CCL7; CRB1; LTB; GRAP; LILRB2; SH3KBP1; FCRL2; TSPAN32; GDF15; IL26; SIRPG; FGFBP2;	GO:0007267~cell-cell signaling	30	230	13.0434782608696	0.0121414231694981	0.323071402983862	1	1	0.99999999854637	0.99999999854637	1
down	POLQ; UNG; FEN1; SMUG1; PRMT6; PARP2; APEX2;	GO:0006284~base-excision repair	7	34	20.5882352941176	0.012181501904647	0.0698580379613273	1	1	0.950157148562462	0.999999999999289	0.655569725793868
down	RAN; NUP54; NUP93; NUP37; NUP35; AAAS; NOL6;	GO:0006409~tRNA export from nucleus	7	34	20.5882352941176	0.012181501904647	0.0698580379613273	1	1	0.950157148562462	0.999999999999289	0.655569725793868
down	DCTN3; TUBB; TUBA1B; GTSE1; TUBG1; VBP1; TUBD1;	GO:0007017~microtubule-based process	7	34	20.5882352941176	0.012181501904647	0.0698580379613273	1	1	0.950157148562462	0.999999999999289	0.655569725793868
down	DLX3; CEACAM1; GJA4; FOXF1; SPHK1; DHCR7; AMHR2; APLNR;	GO:0001568~blood vessel development	8	43	18.6046511627907	0.0125783720962225	0.0720103718722043	1	1	0.953536025090687	0.999999999999289	0.675767901879941
down	PPP2R1A; RGS4; PPP2CA; CAV1; SPRED2; DUSP9;	GO:0000188~inactivation of MAPK activity	6	26	23.0769230769231	0.0126496134621277	0.0721092726454565	1	1	0.953536025090687	0.999999999999289	0.676696017737383
down	ERI2; RECQL5; NME1; RAN; TEFM; ERI1;	GO:0006259~DNA metabolic process	6	26	23.0769230769231	0.0126496134621277	0.0721092726454565	1	1	0.953536025090687	0.999999999999289	0.676696017737383
down	UGDH; DCN; BGN; CSPG4; CHST9; CHPF;	GO:0030206~chondroitin sulfate biosynthetic process	6	26	23.0769230769231	0.0126496134621277	0.0721092726454565	1	1	0.953536025090687	0.999999999999289	0.676696017737383
down	BAG3; HSPA1A; TMBIM6; BAK1; TM7SF3; HSPA1B;	GO:0034620~cellular response to unfolded protein	6	26	23.0769230769231	0.0126496134621277	0.0721092726454565	1	1	0.953536025090687	0.999999999999289	0.676696017737383
down	EFNA3; SIX1; EYA1; CASZ1; NTF3; NTF4;	GO:0045664~regulation of neuron differentiation	6	26	23.0769230769231	0.0126496134621277	0.0721092726454565	1	1	0.953536025090687	0.999999999999289	0.676696017737383
up	LY86; SCIMP; CD180; LY96;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	4	9	44.4444444444444	0.0128931402918508	0.330643648498987	1	1	0.99999999854637	0.99999999854637	1
up	IL2RG; STAT5A; STAT5B; JAK3;	GO:0038113~interleukin-9-mediated signaling pathway	4	9	44.4444444444444	0.0128931402918508	0.330643648498987	1	1	0.99999999854637	0.99999999854637	1
up	LYN; RAC2; STXBP2; ADGRE2;	GO:0043304~regulation of mast cell degranulation	4	9	44.4444444444444	0.0128931402918508	0.330643648498987	1	1	0.99999999854637	0.99999999854637	1
up	CRTAM; CD4; CCL5; SIT1;	GO:0050863~regulation of T cell activation	4	9	44.4444444444444	0.0128931402918508	0.330643648498987	1	1	0.99999999854637	0.99999999854637	1
up	TLR4; CD36; GBP5; TLR6;	GO:1900227~positive regulation of NLRP3 inflammasome complex assembly	4	9	44.4444444444444	0.0128931402918508	0.330643648498987	1	1	0.99999999854637	0.99999999854637	1
up	SASH3; CD3E; HLA-E; GATA3; CD40LG; FCER1G;	GO:0032753~positive regulation of interleukin-4 production	6	21	28.5714285714286	0.013133844279772	0.334393344648297	1	1	0.99999999854637	0.99999999854637	1
up	MPO; GNLY; DEFA3; S100A12; COTL1; CLEC6A; IL17RA;	GO:0050832~defense response to fungus	7	28	25	0.0136176014913183	0.341792139558691	1	1	0.99999999854637	0.99999999854637	1
up	BEST1; CD4; GNAI2; ADORA2A; CXCR4; IL16; ORAI1;	GO:0051924~regulation of calcium ion transport	7	28	25	0.0136176014913183	0.341792139558691	1	1	0.99999999854637	0.99999999854637	1
down	DLL1; CD34; JAG1; MELK; CIAPIN1; NOTCH4; TWSG1; MKNK2; ASH2L;	GO:0030097~hemopoiesis	9	53	16.9811320754717	0.0137256637253214	0.0781100164811516	1	1	0.96150207375477	0.999999999999289	0.733008878873044
down	POLD1; RFC4; RFC2; RFC5; POLD2; USP43; POLH;	GO:0019985~translesion synthesis	7	35	20	0.013855376706889	0.0785804514250638	1	1	0.963249465074633	0.999999999999289	0.737423587848339
down	ERI2; ZC3H12A; PDE12; EXOSC4; EXD2; CNOT7; REXO2;	GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic	7	35	20	0.013855376706889	0.0785804514250638	1	1	0.963249465074633	0.999999999999289	0.737423587848339
down	DLL1; PRCP; NMU; IRX3; OMA1; MRAP2; TRPV4;	GO:0097009~energy homeostasis	7	35	20	0.013855376706889	0.0785804514250638	1	1	0.963249465074633	0.999999999999289	0.737423587848339
down	CNGA1; ATP1A2; TMEM63B; ANO1; SLC30A9; PIEZO2; ANO10;	GO:0098655~cation transmembrane transport	7	35	20	0.013855376706889	0.0785804514250638	1	1	0.963249465074633	0.999999999999289	0.737423587848339
up	LYN; CYBA; PTPN6; CORO1A; PTK2B;	GO:0051279~regulation of release of sequestered calcium ion into cytosol	5	15	33.3333333333333	0.0139766980405347	0.34589884171645	1	1	0.99999999854637	0.99999999854637	1
up	TLR4; TLR2; IFNG; FCER2; CCL2;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	5	15	33.3333333333333	0.0139766980405347	0.34589884171645	1	1	0.99999999854637	0.99999999854637	1
down	LAMA5; KITLG; SMO; OVOL2; SEMA4B; SEMA3F; SEMA3G; SEMA6D;	GO:0001755~neural crest cell migration	8	44	18.1818181818182	0.0140792643258451	0.0793092356362515	1	1	0.965054147913181	0.999999999999289	0.744262727329406
down	KRT14; KRT6A; KRT19; KRT16; KRT10; JUP; DSP; KRT15; CDH3; SFN; DSG3; KRT20; KRT6C; KRT17; TGM3; DSC3; KRT31; KRT80; SPRR4; PKP2; PKP3;	GO:0031424~keratinization	21	181	11.6022099447514	0.0142694889364436	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	GYS1; PGM1; GBE1; NHLRC1; PGM2;	GO:0005978~glycogen biosynthetic process	5	19	26.3157894736842	0.0143509161684326	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	SMARCA4; SMARCB1; SMARCD2; GRWD1; PBRM1;	GO:0006337~nucleosome disassembly	5	19	26.3157894736842	0.0143509161684326	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	VDAC1; TSPO; VDAC2; SLC26A9; LRRC8A;	GO:0006820~anion transport	5	19	26.3157894736842	0.0143509161684326	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	MYO1B; MYO1E; MYH14; MYO6; WASL;	GO:0030048~actin filament-based movement	5	19	26.3157894736842	0.0143509161684326	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	GLI3; POR; SOX9; ZNF219; LOXL2;	GO:0032332~positive regulation of chondrocyte differentiation	5	19	26.3157894736842	0.0143509161684326	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	EGFR; CA2; TFRC; TMEM64; SPP1;	GO:0045780~positive regulation of bone resorption	5	19	26.3157894736842	0.0143509161684326	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	ZMPSTE24; HOXA1; FGF12; UBA5; OPA3;	GO:0050905~neuromuscular process	5	19	26.3157894736842	0.0143509161684326	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	POR; MAP1B; NKX6-1; CAV1; CYP11A1;	GO:0071375~cellular response to peptide hormone stimulus	5	19	26.3157894736842	0.0143509161684326	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	AURKA; DCTN2; STIL; SPAG5; CEP131;	GO:0071539~protein localization to centrosome	5	19	26.3157894736842	0.0143509161684326	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	POLQ; RECQL5; MAGEF1; PARPBP; RMI2;	GO:2000042~negative regulation of double-strand break repair via homologous recombination	5	19	26.3157894736842	0.0143509161684326	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	DAPK3; RAPGEF3; ABL1; PHPT1; F11R;	GO:2000249~regulation of actin cytoskeleton reorganization	5	19	26.3157894736842	0.0143509161684326	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	ABL1; HRAS; NTF3; CDK5; BAIAP2;	GO:2000251~positive regulation of actin cytoskeleton reorganization	5	19	26.3157894736842	0.0143509161684326	0.0793092356362515	1	1	0.966918986846346	0.999999999999289	0.744262727329406
down	SLC25A4; LONP1; MGME1; PIF1;	GO:0000002~mitochondrial genome maintenance	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	SRD5A1; EPHB3; OSR1; OSR2;	GO:0001655~urogenital system development	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	POP7; RPP40; POP4; RPP25;	GO:0001682~tRNA 5'-leader removal	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	PFKM; PFKL; HK1; PFKP;	GO:0006002~fructose 6-phosphate metabolic process	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	ALDH2; ALDH1B1; ALDH3B2; SULT1E1;	GO:0006068~ethanol catabolic process	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	TKT; RPE; PGM2; DERA;	GO:0006098~pentose-phosphate shunt	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	DAPK3; ADRA2A; ATP1A2; CAV1;	GO:0006940~regulation of smooth muscle contraction	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	CCNB2; CDK1; CCNB1; PLK1;	GO:0007077~mitotic nuclear envelope disassembly	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	SNRPB; NCBP2; SNRPF; SNRPG;	GO:0008334~histone mRNA metabolic process	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	SREBF1; ACSS2; OLAH; DOLPP1;	GO:0008610~lipid biosynthetic process	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	FARP2; C3; C1QA; ANKS1A;	GO:0016322~neuron remodeling	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	TTLL5; TTLL7; TTLL11; CFAP20;	GO:0018095~protein polyglutamylation	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	SERPINB4; LTBP4; SERPINB13; NEDD8;	GO:0030162~regulation of proteolysis	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	KRT14; LAMC1; CD151; DST;	GO:0031581~hemidesmosome assembly	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	MUL1; TOLLIP; SAE1; PIAS3;	GO:0033235~positive regulation of protein sumoylation	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	TPO; HFE; CHST9; DUOX1;	GO:0042446~hormone biosynthetic process	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	SLC25A1; ACACA; HSD17B8; PPT2;	GO:0046949~fatty-acyl-CoA biosynthetic process	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	SPINK1; NTF3; PRKCZ; SFRP2;	GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	NCBP2; RITA1; LZTS2; PHAX;	GO:0051168~nuclear export	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	NDUFS6; ABL1; NXN; MYLK;	GO:0072358~cardiovascular system development	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	GIPC1; P4HB; STIP1; HDGF;	GO:0098761~cellular response to interleukin-7	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	NUDT21; NCBP2; CPSF6; CSTF2;	GO:0098789~pre-mRNA cleavage required for polyadenylation	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	CDC73; PHB2; FAM83D; CRNN;	GO:1902808~positive regulation of cell cycle G1/S phase transition	4	12	33.3333333333333	0.0146519593420341	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	FGF10; BMP4; CDH1; SRD5A1; BMPR1A; PITX1;	GO:0021983~pituitary gland development	6	27	22.2222222222222	0.0146690858392544	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	ARL2; MAP1B; RAC1; OCLN; PSRC1; DRG1;	GO:0031116~positive regulation of microtubule polymerization	6	27	22.2222222222222	0.0146690858392544	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	RIDA; THRB; SREBF1; RARG; SREBF2; VDR;	GO:0033993~response to lipid	6	27	22.2222222222222	0.0146690858392544	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	ZMPSTE24; GHR; CDK4; NPPC; GAMT; FTO;	GO:0040014~regulation of multicellular organism growth	6	27	22.2222222222222	0.0146690858392544	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	GJA5; BDKRB1; SCPEP1; APLN; NOS3; RNPEP;	GO:0045776~negative regulation of blood pressure	6	27	22.2222222222222	0.0146690858392544	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	DVL1; MAP1B; CDK5; CYFIP1; NDN; SEMA5B;	GO:0048675~axon extension	6	27	22.2222222222222	0.0146690858392544	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	TFRC; CDK1; NGFR; PLK1; STK11; GTSE1;	GO:1900182~positive regulation of protein localization to nucleus	6	27	22.2222222222222	0.0146690858392544	0.0793092356362515	1	1	0.968847040658602	0.999999999999289	0.744262727329406
down	IL33; IDO1; NOD2;	GO:0002830~positive regulation of type 2 immune response	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	YAP1; WWTR1; PPCS;	GO:0003015~heart process	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	BMP4; HEY2; FZD1;	GO:0003150~muscular septum morphogenesis	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	BMP7; BMPR1A; ROBO2;	GO:0003272~endocardial cushion formation	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	PRPS2; PRPSAP2; PRPSAP1;	GO:0006015~5-phosphoribose 1-diphosphate biosynthetic process	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	ALDH2; ALDH3B2; DHRS4;	GO:0006066~alcohol metabolic process	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	ERCC1; MSH3; RAD51;	GO:0006312~mitotic recombination	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	GART; SHMT1; SHMT2;	GO:0006544~glycine metabolic process	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	PMPCA; UQCRC2; MIPEP;	GO:0006627~protein processing involved in protein targeting to mitochondrion	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	SPTLC2; SGMS2; PEMT;	GO:0006686~sphingomyelin biosynthetic process	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	MOCS2; MOCS1; NFS1;	GO:0006777~Mo-molybdopterin cofactor biosynthetic process	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	CDC23; CDC16; ANAPC7;	GO:0007091~metaphase/anaphase transition of mitotic cell cycle	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	BCL10; BAK1; ATG5;	GO:0009620~response to fungus	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	RBX1; CAND1; FBXL7;	GO:0010265~SCF complex assembly	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	PRDX2; RAC1; NOXA1;	GO:0010310~regulation of hydrogen peroxide metabolic process	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	HGS; SNX3; FCHO2;	GO:0010324~membrane invagination	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	F12; CLEC3B; ENO1;	GO:0010756~positive regulation of plasminogen activation	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	TICRR; CDT1; WDR18;	GO:0030174~regulation of DNA-dependent DNA replication initiation	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	HACD2; TECR; HACD1;	GO:0030497~fatty acid elongation	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	MOCS2; MOCS1; NFS1;	GO:0032324~molybdopterin cofactor biosynthetic process	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	SLC9A3R1; SLC51B; STARD10;	GO:0032782~bile acid secretion	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	CORO1B; PICK1; GMFB;	GO:0034316~negative regulation of Arp2/3 complex-mediated actin nucleation	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	CH25H; GAS6; HSD3B7;	GO:0035754~B cell chemotaxis	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	EIF6; C1QBP; NSUN4;	GO:0042256~mature ribosome assembly	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	PKM; HOGA1; SRR;	GO:0042866~pyruvate biosynthetic process	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	EFNA1; EPHA2; PRCP;	GO:0043535~regulation of blood vessel endothelial cell migration	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	FGF1; POR; SREBF1;	GO:0045542~positive regulation of cholesterol biosynthetic process	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	RECQL5; TTK; NCAPD2;	GO:0051304~chromosome separation	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	ALOX12B; P2RY2; ATG5;	GO:0070257~positive regulation of mucus secretion	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	EXOSC10; EXOSC8; EXOSC3;	GO:0071035~nuclear polyadenylation-dependent rRNA catabolic process	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	EXOSC8; EXOSC3; EXOSC10;	GO:0071038~nuclear polyadenylation-dependent tRNA catabolic process	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	ASNA1; SGTA; UBL4A;	GO:0071816~tail-anchored membrane protein insertion into ER membrane	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	NFIA; FOXF1; SOX17;	GO:0072189~ureter development	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	JUP; DSP; PKP2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	MYO1C; CCBE1; SMOC2;	GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	NRP2; FN1; SEMA3F;	GO:1901166~neural crest cell migration involved in autonomic nervous system development	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	CDH5; TJP1; F11R;	GO:1902396~protein localization to bicellular tight junction	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	RNF40; SKP2; FBXO4;	GO:1902916~positive regulation of protein polyubiquitination	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	CLDN5; CDH5; F11R;	GO:1903142~positive regulation of establishment of endothelial barrier	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	SLC7A1; SLC7A2; SLC25A29;	GO:1903401~L-lysine transmembrane transport	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	ATXN3; RNF185; TMEM259;	GO:1904294~positive regulation of ERAD pathway	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	ITSN1; CYFIP1; BAIAP2;	GO:1905274~regulation of modification of postsynaptic actin cytoskeleton	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	GREM1; HFE; NCAPG2;	GO:2000273~positive regulation of signaling receptor activity	3	6	50	0.0150285125453516	0.0793092356362515	1	1	0.972906101315983	0.999999999999289	0.744262727329406
down	IMPA2; BPNT1; IMPA1; INPP1; PIP5KL1; PIP4K2C; IP6K2; PIK3C2G; PI4K2B;	GO:0046854~phosphatidylinositol phosphorylation	9	54	16.6666666666667	0.0151575933948794	0.0799272939788394	1	1	0.972906101315983	0.999999999999289	0.750062780551617
up	ACOD1; IRF1; CDC34; AIM2; PYHIN1; MNDA;	GO:0035458~cellular response to interferon-beta	6	22	27.2727272727273	0.015681875734826	0.378774476011247	1	1	0.99999999854637	0.99999999854637	1
down	WDR62; SPOCK1; NAV2; LEMD2; RITA1; TRAK1; BTBD1; BTBD2;	GO:0022008~neurogenesis	8	45	17.7777777777778	0.0157063439799953	0.0826160064721779	1	1	0.97726036638481	0.999999999999289	0.775294501387697
down	MYL9; EIF6; WDR5; HDAC1; PRMT6; PRMT1; DPY30; ASH2L;	GO:0045652~regulation of megakaryocyte differentiation	8	45	17.7777777777778	0.0157063439799953	0.0826160064721779	1	1	0.97726036638481	0.999999999999289	0.775294501387697
down	MYO1B; EZR; SHROOM2; DPYSL3; SHROOM1; CORO1B; BAIAP2; ESPNL;	GO:0051017~actin filament bundle assembly	8	45	17.7777777777778	0.0157063439799953	0.0826160064721779	1	1	0.97726036638481	0.999999999999289	0.775294501387697
up	TLR4; PGLYRP1; HLA-DRB1; IL10; GATA3; LILRB1; PGLYRP2;	GO:0032689~negative regulation of interferon-gamma production	7	29	24.1379310344828	0.0158402436986902	0.378774476011247	1	1	0.99999999854637	0.99999999854637	1
up	TLR4; TNF; IL10; PTPN6; NCKAP1L; SLAMF1; KLF2;	GO:0032715~negative regulation of interleukin-6 production	7	29	24.1379310344828	0.0158402436986902	0.378774476011247	1	1	0.99999999854637	0.99999999854637	1
up	ITGB3; ITGB2; CD2; CD1D; ITGAX; ITGB7; LILRB2;	GO:0034113~heterotypic cell-cell adhesion	7	29	24.1379310344828	0.0158402436986902	0.378774476011247	1	1	0.99999999854637	0.99999999854637	1
down	ATP13A5; ANO1; PIEZO2; ANO10; ATP10D; TRPC6;	GO:0006812~cation transport	6	28	21.4285714285714	0.0169019195991029	0.0885660586992993	1	1	0.986993429479834	0.999999999999289	0.831131656578808
down	MID1; MAP1B; FGF13; KATNB1; HDAC6; TPX2;	GO:0007026~negative regulation of microtubule depolymerization	6	28	21.4285714285714	0.0169019195991029	0.0885660586992993	1	1	0.986993429479834	0.999999999999289	0.831131656578808
down	CLIC1; NDUFS1; PRDX3; BAK1; MUL1; PPA2;	GO:0051881~regulation of mitochondrial membrane potential	6	28	21.4285714285714	0.0169019195991029	0.0885660586992993	1	1	0.986993429479834	0.999999999999289	0.831131656578808
down	RB1; GNAI3; CTNNB1; TMBIM6; WNT4; MEIS3;	GO:2001234~negative regulation of apoptotic signaling pathway	6	28	21.4285714285714	0.0169019195991029	0.0885660586992993	1	1	0.986993429479834	0.999999999999289	0.831131656578808
up	PTPN6; NFAM1; FCRL3; CARD11;	GO:0045577~regulation of B cell differentiation	4	10	40	0.0169986192334601	0.393549065565229	1	1	0.99999999854637	0.99999999854637	1
down	MTX2; SLC25A10; SLC25A13; TMEM14C; TMEM14A;	GO:0006839~mitochondrial transport	5	20	25	0.0170437383961011	0.0888908791759182	1	1	0.988536826973862	0.999999999999289	0.834179873748995
down	LAMC1; BMP4; HDAC1; PELO; EPB41L5;	GO:0007492~endoderm development	5	20	25	0.0170437383961011	0.0888908791759182	1	1	0.988536826973862	0.999999999999289	0.834179873748995
down	ERCC1; CCND1; BRCC3; RAD51; ERCC8;	GO:0010165~response to X-ray	5	20	25	0.0170437383961011	0.0888908791759182	1	1	0.988536826973862	0.999999999999289	0.834179873748995
down	NGFR; NTF4; AKT1S1; NDN; DDIT4;	GO:0048011~neurotrophin TRK receptor signaling pathway	5	20	25	0.0170437383961011	0.0888908791759182	1	1	0.988536826973862	0.999999999999289	0.834179873748995
down	EFNA1; EPHB3; MARK2; UST; RUFY3;	GO:0050770~regulation of axonogenesis	5	20	25	0.0170437383961011	0.0888908791759182	1	1	0.988536826973862	0.999999999999289	0.834179873748995
down	TP73; NUDT21; SHMT2; CPSF6; TP63;	GO:0051262~protein tetramerization	5	20	25	0.0170437383961011	0.0888908791759182	1	1	0.988536826973862	0.999999999999289	0.834179873748995
down	DLL1; PLXNA2; BMPR1A; FOXF1; ABI1; POFUT1; DLL3; MESP2;	GO:0001756~somitogenesis	8	46	17.3913043478261	0.0174650566174863	0.0908754231007991	1	1	0.992455862849491	0.999999999999289	0.852803456011359
down	TULP1; BMP7; CRK; HDAC2; IGSF9; BAIAP2; EGFLAM; MAP1B;	GO:0016358~dendrite development	8	46	17.3913043478261	0.0174650566174863	0.0908754231007991	1	1	0.992455862849491	0.999999999999289	0.852803456011359
up	LTA; TNF; FCER2;	GO:0002925~positive regulation of humoral immune response mediated by circulating immunoglobulin	3	5	60	0.0175701476008212	0.393549065565229	1	1	0.99999999854637	0.99999999854637	1
up	STAT5A; STAT5B; BAAT;	GO:0019530~taurine metabolic process	3	5	60	0.0175701476008212	0.393549065565229	1	1	0.99999999854637	0.99999999854637	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0175701476008212	0.393549065565229	1	1	0.99999999854637	0.99999999854637	1
up	ACOD1; LYN; TLR6;	GO:0034136~negative regulation of toll-like receptor 2 signaling pathway	3	5	60	0.0175701476008212	0.393549065565229	1	1	0.99999999854637	0.99999999854637	1
up	SCIMP; PIK3AP1; TLR7;	GO:0034154~toll-like receptor 7 signaling pathway	3	5	60	0.0175701476008212	0.393549065565229	1	1	0.99999999854637	0.99999999854637	1
up	PECAM1; CCR2; JAML;	GO:0035696~monocyte extravasation	3	5	60	0.0175701476008212	0.393549065565229	1	1	0.99999999854637	0.99999999854637	1
up	OXT; SLC4A1; AVPR2;	GO:0035811~negative regulation of urine volume	3	5	60	0.0175701476008212	0.393549065565229	1	1	0.99999999854637	0.99999999854637	1
up	IRF1; CTLA4; LAG3;	GO:0045590~negative regulation of regulatory T cell differentiation	3	5	60	0.0175701476008212	0.393549065565229	1	1	0.99999999854637	0.99999999854637	1
down	CCL21; CTNNB1; SOX18; HES1; HES5; CCL19; LHX6;	GO:0048469~cell maturation	7	37	18.9189189189189	0.0176848304649935	0.0918758571824428	1	1	0.992455862849491	0.999999999999289	0.862191843027625
down	DNM1L; CANX; ARF6; CDK5; ITSN1; OPHN1; FCHO2;	GO:0048488~synaptic vesicle endocytosis	7	37	18.9189189189189	0.0176848304649935	0.0918758571824428	1	1	0.992455862849491	0.999999999999289	0.862191843027625
down	PES1; WDR12; RPF2; ZNHIT3;	GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	ZPR1; GINS1; NCAPG2; PELO;	GO:0001833~inner cell mass cell proliferation	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	BMP4; ENG; HEYL; HEY2;	GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	DNPH1; NT5C2; NT5C; NUDT15;	GO:0006195~purine nucleotide catabolic process	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	AKR1B15; HSD17B12; DHRS11; HSD17B8;	GO:0006703~estrogen biosynthetic process	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	DDAH2; NOS3; SPR; SLC7A2;	GO:0006809~nitric oxide biosynthetic process	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	"NADSYN1; NMNAT1; NAPRT; AFMID;"	GO:0009435~NAD biosynthetic process	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	ERCC1; FEN1; MFAP4; SCARA3;	GO:0009650~UV protection	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	SLC7A5; SLC1A5; SLC38A9; SLC7A8;	GO:0015804~neutral amino acid transport	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	WASL; CAV2; CAV1; SAR1A;	GO:0016050~vesicle organization	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	INTS5; INTS1; INTS7; INTS10;	GO:0016180~snRNA processing	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	CDK1; CCNA2; CDK2; CDK5;	GO:0016572~histone phosphorylation	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	AQP1; TNS2; MUC17; FBXO4;	GO:0019725~cellular homeostasis	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	EML2; STMN1; CDH5; FKBP4;	GO:0031115~negative regulation of microtubule polymerization	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	CCL21; CDC42EP1; CDC42EP5; CDC42EP4;	GO:0031274~positive regulation of pseudopodium assembly	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	VPS37C; LAPTM4B; VPS37D; CHMP1A;	GO:0032509~endosome transport via multivesicular body sorting pathway	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	CAPN1; CDK5; SH3GLB1; MVB12A;	GO:0032801~receptor catabolic process	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	SCP2; HSD17B4; ACOX1; ELOVL1;	GO:0036109~alpha-linolenic acid metabolic process	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	APOD; UFM1; CABP1; RAB23;	GO:0042308~negative regulation of protein import into nucleus	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	ZMPSTE24; SCAP; FAM135A; LTA4H;	GO:0044255~cellular lipid metabolic process	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	RDX; SHROOM2; DLG5; CELSR1;	GO:0045176~apical protein localization	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	HGS; LEPROT; NF2; CAV1;	GO:0046426~negative regulation of receptor signaling pathway via JAK-STAT	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	PLPP3; PLPP2; PLPP4; PLPPR4;	GO:0046839~phospholipid dephosphorylation	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	CENPA; CENPW; CENPN; CENPH;	GO:0051382~kinetochore assembly	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	BMP2; ADAM15; HEYL; HEY2;	GO:0060317~cardiac epithelial to mesenchymal transition	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	EPHA2; CCL11; DDR1; BTRC;	GO:0060444~branching involved in mammary gland duct morphogenesis	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	MICALL1; SNX33; EHD2; PACSIN3;	GO:0097320~plasma membrane tubulation	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
down	NOL3; HSPB1; MAPK7; NFE2L2;	GO:1902176~negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	4	13	30.7692307692308	0.0182379077995172	0.0927301841769971	1	1	0.997787603391372	0.999999999999289	0.870209115340202
up	PSTPIP1; PLXNC1; LPXN; CD4; ITGB3; ITGB2; GP1BA; HCK; ITGAM; CCL4; CCL2; SELL; CD36; CD22; ITGAL; ITGAX; CD72; IL32; FPR2; ITGB7; CCR1; GP5; CX3CR1; CXCR3; CCR3; CCR8; BMX; SLAMF1; SCARF1; SELPLG; ADGRE1; NEDD9; MYBPC3; COL19A1; THEMIS2; OLFM4; MUC16; CSF3R; OMD; LY9; SLAMF7; CASS4; SIRPG; CD300A; ADGRE2; NINJ2; ICAM2; SIGLEC14; SIGLEC9; CD33; NINJ1;	GO:0007155~cell adhesion	51	454	11.2334801762115	0.0183245907465521	0.400340863496167	1	1	0.99999999854637	0.99999999854637	1
down	TULP1; DLL1; IMPDH2; SOX9; CLCN2; LAMB2; TTLL5; VAX2; NR2E3;	GO:0060041~retina development in camera-type eye	9	56	16.0714285714286	0.0183461562464545	0.0932096348916826	1	1	0.997787603391372	0.999999999999289	0.8747084311345
up	CD8A; PSAP; RAB3B; CTSS; RAB32; RAB33A;	GO:0019882~antigen processing and presentation	6	23	26.0869565217391	0.0185521055703225	0.400340863496167	1	1	0.99999999854637	0.99999999854637	1
up	IL2RA; IL12RB1; STAT5B; TMIGD2; PYCARD; HHLA2;	GO:0042104~positive regulation of activated T cell proliferation	6	23	26.0869565217391	0.0185521055703225	0.400340863496167	1	1	0.99999999854637	0.99999999854637	1
up	CPNE6; CXCR4; RNF157; SYT4; CPNE5; RIMS2;	GO:1903861~positive regulation of dendrite extension	6	23	26.0869565217391	0.0185521055703225	0.400340863496167	1	1	0.99999999854637	0.99999999854637	1
down	TLR3; IL33; CXCL10; RNASE1; IFI27; HYAL2; G3BP1; SKP2; ZC3H12A; PDE12; IFNLR1; ELMOD2; DDX1; EXOSC4; EXOC1; DDIT4; APOBEC3B; TBK1; CNOT7; CD207; DDX41; POLR3H;	GO:0051607~defense response to virus	22	198	11.1111111111111	0.0186286048030658	0.0945009177595162	1	1	0.999999999999289	0.999999999999289	0.886826234329267
down	AHCYL1; NUTF2; RAN; EIF5A; CSE1L; CCHCR1;	GO:0006611~protein export from nucleus	6	29	20.6896551724138	0.0193577559862637	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	CHST1; B4GALT2; LUM; PRELP; FMOD; B3GNT2;	GO:0018146~keratan sulfate biosynthetic process	6	29	20.6896551724138	0.0193577559862637	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	DVL1; PLXNA2; EPHA2; STIL; HES5; GRHL2;	GO:0021915~neural tube development	6	29	20.6896551724138	0.0193577559862637	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	WASL; ARPC2; GSN; RAC1; CTTN; WASF1;	GO:0030041~actin filament polymerization	6	29	20.6896551724138	0.0193577559862637	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	RAB13; ARF6; CDK5; EHD2; LLGL2; NCKAP1;	GO:0030866~cortical actin cytoskeleton organization	6	29	20.6896551724138	0.0193577559862637	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	UQCRQ; FGFR2; HES1; SMAD1; WLS; DLG5;	GO:0030901~midbrain development	6	29	20.6896551724138	0.0193577559862637	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	IL33; SCGB1A1; C1QBP; GAS6; IL20RB; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	6	29	20.6896551724138	0.0193577559862637	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	TP73; CHEK2; TP63; DDIT4; PHLDA3; TMEM109;	GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	6	29	20.6896551724138	0.0193577559862637	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	SLC9A3R1; ABL1; EGFR; GAS1; MAD2L1; TRIM35;	GO:0045930~negative regulation of mitotic cell cycle	6	29	20.6896551724138	0.0193577559862637	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	CXCL11; ABL1; CXCL10; APLNR; BDKRB1; CEMIP;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	6	29	20.6896551724138	0.0193577559862637	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	CYP1A1; AOC1; AQP1; BACE1; NFE2L2; MT1X;	GO:0071280~cellular response to copper ion	6	29	20.6896551724138	0.0193577559862637	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	MEIS2; B4GALT2; HMGCR; ATP1A2; CDK5; TANC1; NDRG4; NPTN;	GO:0008542~visual learning	8	47	17.0212765957447	0.0193607075748515	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	RBP1; ACACA; ABHD4; PNPLA4; ACOX3; ACOX1; VDR;	GO:0055088~lipid homeostasis	7	38	18.4210526315789	0.0198545393413617	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	JUP; DSP; GJA5; YWHAE; CAV1; TRPM4; PKP2;	GO:0086091~regulation of heart rate by cardiac conduction	7	38	18.4210526315789	0.0198545393413617	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	ABL1; C1QA; CAPN2; ELK1; AIMP2; BAD; DDIT4;	GO:1901216~positive regulation of neuron death	7	38	18.4210526315789	0.0198545393413617	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	PLPP3; PLPP2; PPP2R1A; PPP2CA; ORMDL2;	GO:0006672~ceramide metabolic process	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	FGF10; FGFR2; GAS1; IFT81; WDR11;	GO:0008589~regulation of smoothened signaling pathway	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	TCN1; PRSS3; MMAB; AMN; MMADHC;	GO:0009235~cobalamin metabolic process	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	NFE2L2; MYOCD; SFRP2; SIRT5; HEY2;	GO:0010667~negative regulation of cardiac muscle cell apoptotic process	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	NFU1; NFS1; CIAPIN1; NUBPL; NUBP2;	GO:0016226~iron-sulfur cluster assembly	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	BCL10; CYP1A1; SREBF1; SLC16A1; HSD11B2;	GO:0032094~response to food	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	OBSL1; RAB6A; ARL1; COG7; BICD2;	GO:0034067~protein localization to Golgi apparatus	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	RFC4; RFC2; RFC5; POLE2; POLH;	GO:0042276~error-prone translesion synthesis	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	NF2; CXADR; TJP1; OCLN; MARVELD2;	GO:0045216~cell-cell junction organization	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	BAG3; ALDOA; PFKM; LARGE2; CFL2;	GO:0046716~muscle cell cellular homeostasis	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	PTBP1; HNRNPK; C1QBP; SRSF9; RBM42;	GO:0048025~negative regulation of mRNA splicing, via spliceosome	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	LRP4; NGFR; PTK2; EFNB3; RUFY3;	GO:0050771~negative regulation of axonogenesis	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	KLK8; TUBB; SPARC; DAG1; IGSF9;	GO:0050807~regulation of synapse organization	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	PLK1; UBE2N; UBE2L3; STUB1; DCUN1D5;	GO:0051443~positive regulation of ubiquitin-protein transferase activity	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	TRIAP1; NOL3; PSMD10; LMNA; HIGD1A;	GO:0090201~negative regulation of release of cytochrome c from mitochondria	5	21	23.8095238095238	0.020051111713395	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	GSN; EZR; NPR3; GPR143; NCS1; EXOC1; INPP5F; PLCD1; PIK3C2G;	GO:0048015~phosphatidylinositol-mediated signaling	9	57	15.7894736842105	0.020111141031242	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	EGFR; HMGCR; BMP4; FGFR2; IRAK1; SKP2; CALCRL; HES5; NOTCH3;	GO:0048661~positive regulation of smooth muscle cell proliferation	9	57	15.7894736842105	0.020111141031242	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	CCL21; CCL19; NOD2;	GO:0002606~positive regulation of dendritic cell antigen processing and presentation	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	ENG; DLL4; CCM2L;	GO:0003209~cardiac atrium morphogenesis	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	FPGT; B3GLCT; POFUT1;	GO:0006004~fucose metabolic process	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	PPIP5K1; IMPA2; IMPA1;	GO:0006020~inositol metabolic process	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	GTF3C5; GTF3C1; POLR3H;	GO:0006384~transcription initiation from RNA polymerase III promoter	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	ETF1; OGFOD1; GLE1;	GO:0006449~regulation of translational termination	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	MDH2; NAA10; EHHADH;	GO:0006475~internal protein amino acid acetylation	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	DDAH2; FAH; NOS3;	GO:0006527~arginine catabolic process	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	SHMT2; PSPH; SRR;	GO:0006564~L-serine biosynthetic process	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	CKB; CKMT1A; GAMT;	GO:0006600~creatine metabolic process	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	MDH2; MDH1; MDH1B;	GO:0006734~NADH metabolic process	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	TCN1; SLC11A2; SLC30A5;	GO:0006824~cobalt ion transport	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	COASY; MMADHC; PPCS;	GO:0009108~coenzyme biosynthetic process	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	NPR1; NPPC; ADORA2B;	GO:0010753~positive regulation of cGMP-mediated signaling	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	"NAA30; NAA35; NAA20;"	GO:0017196~N-terminal peptidyl-methionine acetylation	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	HYAL2; GAS6; NECTIN2;	GO:0019064~fusion of virus membrane with host plasma membrane	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	GPD2; TPI1; TKFC;	GO:0019563~glycerol catabolic process	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	NFASC; CD9; UGT8;	GO:0030913~paranodal junction assembly	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	FGF10; FGFR2; SOX9;	GO:0030916~otic vesicle formation	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	CCNB1; NCBP2; CDC73;	GO:0031442~positive regulation of mRNA 3'-end processing	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	RBBP4; CHAF1A; NOC2L;	GO:0031497~chromatin assembly	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	GSTP1; FOXM1; PBK;	GO:0032873~negative regulation of stress-activated MAPK cascade	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	IDO1; ADCYAP1R1; LRP11;	GO:0033555~multicellular organismal response to stress	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	GSTP1; CEACAM1; FBXO4;	GO:0035726~common myeloid progenitor cell proliferation	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	AHCYL1; CA2; AGTR1;	GO:0038166~angiotensin-activated signaling pathway	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	BMP2; BMP4; APCDD1;	GO:0042487~regulation of odontogenesis of dentin-containing tooth	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	NDUFS2; NDUFB6; NDUFV1;	GO:0042775~mitochondrial ATP synthesis coupled electron transport	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	HOXA7; GRHL2; TP63;	GO:0045617~negative regulation of keratinocyte differentiation	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	CTNNB1; SMOC2; NPTN;	GO:0045743~positive regulation of fibroblast growth factor receptor signaling pathway	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	DVL1; ABL1; HDAC6;	GO:0048668~collateral sprouting	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	GSN; DSTN; FLII;	GO:0051014~actin filament severing	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	NTF3; CYFIP1; WASF1;	GO:0051388~positive regulation of neurotrophin TRK receptor signaling pathway	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	TCF21; CTSV; SOX9;	GO:0060008~Sertoli cell differentiation	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	JCHAIN; IGHA1; IGHA2;	GO:0060267~positive regulation of respiratory burst	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	FGFR2; FOXF1; GRHL2;	GO:0060463~lung lobe morphogenesis	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	SPDEF; NKX3-2; KLF5;	GO:0060576~intestinal epithelial cell development	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	CTSD; EPB41L5; HDAC6;	GO:0070201~regulation of establishment of protein localization	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	EXOSC4; EXOSC10; EXOSC3;	GO:0071051~polyadenylation-dependent snoRNA 3'-end processing	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	ATXN3; HDAC6; STUB1;	GO:0071218~cellular response to misfolded protein	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	TSPO; MYLK; TRPV4;	GO:0071476~cellular hypotonic response	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	C9orf116; IMPACT; POLH;	GO:0071494~cellular response to UV-C	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	SREBF2; MAPK7; NFE2L2;	GO:0071499~cellular response to laminar fluid shear stress	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	SCGB1A1; ELK1; TNC;	GO:0071774~response to fibroblast growth factor	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	RAB5A; RAB11A; RAB11B;	GO:0150093~amyloid-beta clearance by transcytosis	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	DNM1L; DNM1; SH3GL1;	GO:1900244~positive regulation of synaptic vesicle endocytosis	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	RAN; RRS1; RPF2;	GO:1902570~protein localization to nucleolus	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	CAV1; LIN7B; PDZD11;	GO:1903361~protein localization to basolateral plasma membrane	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	AGR2; TMEM33; BAK1;	GO:1903896~positive regulation of IRE1-mediated unfolded protein response	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
down	NUDT21; PWP1; TACSTD2;	GO:2000738~positive regulation of stem cell differentiation	3	7	42.8571428571429	0.0204926153613827	0.0952966290843588	1	1	0.999999999999289	0.999999999999289	0.894293438823715
up	TNF; IFNG; C5AR1; FPR2; ADORA2A;	GO:0048143~astrocyte activation	5	17	29.4117647058824	0.0209656485707983	0.444295989772786	1	1	0.99999999854637	0.99999999854637	1
down	BMP2; BMP4; ENG; BMP7; TTK; BMPR1A; HFE; TWSG1;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	8	48	16.6666666666667	0.0213984391336766	0.096271361516561	1	1	0.999999999999289	0.999999999999289	0.903440633505234
down	SPARC; SCGB1A1; FOSL1; OXTR; DDOST; TMEM102; OSMR; TIMP3;	GO:0034097~response to cytokine	8	48	16.6666666666667	0.0213984391336766	0.096271361516561	1	1	0.999999999999289	0.999999999999289	0.903440633505234
up	ADORA2A; OPRL1; TRPV2; PNOC;	GO:0007600~sensory perception	4	11	36.3636363636364	0.0218333693913428	0.449234269046292	1	1	0.99999999854637	0.99999999854637	1
up	CD74; CD3E; CCR7; ZAP70;	GO:0045060~negative thymic T cell selection	4	11	36.3636363636364	0.0218333693913428	0.449234269046292	1	1	0.99999999854637	0.99999999854637	1
up	CD4; HLA-DRB1; CD74; DCSTAMP;	GO:0045657~positive regulation of monocyte differentiation	4	11	36.3636363636364	0.0218333693913428	0.449234269046292	1	1	0.99999999854637	0.99999999854637	1
up	LYN; CD19; BLK; PAX5;	GO:0050855~regulation of B cell receptor signaling pathway	4	11	36.3636363636364	0.0218333693913428	0.449234269046292	1	1	0.99999999854637	0.99999999854637	1
up	TLR4; CYBA; CD36; TLR6;	GO:1903428~positive regulation of reactive oxygen species biosynthetic process	4	11	36.3636363636364	0.0218333693913428	0.449234269046292	1	1	0.99999999854637	0.99999999854637	1
down	EIF4A3; NCBP2; SRSF3; SRSF9; THOC7; ALYREF; MAGOHB; POLDIP3; RBM8A;	GO:0006405~RNA export from nucleus	9	58	15.5172413793103	0.0219953381877559	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	OVOL1; TBX6; TIE1; PPP2CA; IRX3; MEST;	GO:0007498~mesoderm development	6	30	20	0.0220456237377439	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	VPS37C; VPS37D; CHMP4C; MVB12A; VTA1; VPS4A;	GO:0019058~viral life cycle	6	30	20	0.0220456237377439	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	TXN; NME1; TRIM28; HES1; SIRT2; MYOCD;	GO:0043388~positive regulation of DNA binding	6	30	20	0.0220456237377439	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	NEK2; SUMO3; SUMO1; E2F1; HDAC2; SMO;	GO:0043392~negative regulation of DNA binding	6	30	20	0.0220456237377439	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	MATN2; APOD; CDK1; RANGAP1; DPYSL3; TXN2;	GO:0048678~response to axon injury	6	30	20	0.0220456237377439	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	SPTLC2; CDK4; ACAT1; OXCT1; AACS; FTO;	GO:0060612~adipose tissue development	6	30	20	0.0220456237377439	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	DFFA; SGTA; HSPB1; FKBP4; TRAP1; UNC45A;	GO:0061077~chaperone-mediated protein folding	6	30	20	0.0220456237377439	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	DHCR24; EGFLAM; LAMA5; LAMC1; LAMB2; ATRNL1; BARX1;	GO:0009888~tissue development	7	39	17.9487179487179	0.022203164901931	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	HMGCR; GSTP1; BMP4; BMP7; HYAL2; CBLC; SPRY2;	GO:0043407~negative regulation of MAP kinase activity	7	39	17.9487179487179	0.022203164901931	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	HSD17B4; ACOX1; CYP4F12; SLC27A6;	GO:0000038~very long-chain fatty acid metabolic process	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	RAMP3; NSF; VAMP3; INPP5F;	GO:0001921~positive regulation of receptor recycling	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	VDR; FGFR2; SFN; KDF1;	GO:0010839~negative regulation of keratinocyte proliferation	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	ABL1; NKX6-1; CTTN; TTL;	GO:0030516~regulation of axon extension	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	PRKRA; TARBP2; MRPL44; DROSHA;	GO:0031054~pre-miRNA processing	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	KANK2; CNOT9; PHB2; TP63;	GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	PRDX2; MAP3K6; PRDX1; PRDX4;	GO:0033554~cellular response to stress	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	NPR1; NPR3; HYAL2; TFAP2B;	GO:0035810~positive regulation of urine volume	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	JAG1; SIX1; TFAP2B; EYA1;	GO:0035909~aorta morphogenesis	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	SIRT2; PPP1R14C; PPP1R14B; BARD1;	GO:0042325~regulation of phosphorylation	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	GHR; ALDH9A1; FOXA1; WNT4;	GO:0042445~hormone metabolic process	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	CYP27C1; RDH10; SDR16C5; RDH13;	GO:0042574~retinal metabolic process	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	PDE2A; APLNR; PDE3A; LPAR1;	GO:0043951~negative regulation of cAMP-mediated signaling	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	GNAI3; RAN; AK3; RAB23;	GO:0046039~GTP metabolic process	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	AGR2; EGFR; EPHB3; SFRP2;	GO:0048546~digestive tract morphogenesis	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	GCNT3; ADRA2A; VDR; F11R;	GO:0050892~intestinal absorption	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	ADRA2A; NOS3; STC1; PACSIN3;	GO:0051926~negative regulation of calcium ion transport	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	SCNN1A; SCNN1G; TFAP2B; CYP4F12;	GO:0055078~sodium ion homeostasis	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	TRIM16; SRD5A1; NME2; RBBP4;	GO:0060416~response to growth hormone	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	E2F8; SOX15; GJB5; NR2F2;	GO:0060707~trophoblast giant cell differentiation	4	14	28.5714285714286	0.0223227967518851	0.098441323497917	1	1	0.999999999999289	0.999999999999289	0.923804236930343
down	FOXE1; FGF10; HOXA5; SIX1; THRB;	GO:0030878~thyroid gland development	5	22	22.7272727272727	0.0233853490510716	0.102518055780977	1	1	0.999999999999289	0.999999999999289	0.962061570559156
down	HOXB9; HOXD9; SOX9; CAV1; NOTCH4;	GO:0030879~mammary gland development	5	22	22.7272727272727	0.0233853490510716	0.102518055780977	1	1	0.999999999999289	0.999999999999289	0.962061570559156
down	SNAPIN; GPR143; SHROOM2; BLOC1S2; RAB38;	GO:0032438~melanosome organization	5	22	22.7272727272727	0.0233853490510716	0.102518055780977	1	1	0.999999999999289	0.999999999999289	0.962061570559156
down	STMN1; TNFAIP1; RASIP1; DLC1; KCTD10;	GO:0035024~negative regulation of Rho protein signal transduction	5	22	22.7272727272727	0.0233853490510716	0.102518055780977	1	1	0.999999999999289	0.999999999999289	0.962061570559156
down	FGF10; APOD; GSN; CCNB1; ADAM15;	GO:0042246~tissue regeneration	5	22	22.7272727272727	0.0233853490510716	0.102518055780977	1	1	0.999999999999289	0.999999999999289	0.962061570559156
down	SERPINE2; IDE; SERPINB3; CDK5; HDAC6;	GO:0045861~negative regulation of proteolysis	5	22	22.7272727272727	0.0233853490510716	0.102518055780977	1	1	0.999999999999289	0.999999999999289	0.962061570559156
down	CCL21; C3; HNRNPK; HFE; CCL19;	GO:0048260~positive regulation of receptor-mediated endocytosis	5	22	22.7272727272727	0.0233853490510716	0.102518055780977	1	1	0.999999999999289	0.999999999999289	0.962061570559156
down	CAV2; NDRG4; TSNARE1; STX12; STX6;	GO:0048278~vesicle docking	5	22	22.7272727272727	0.0233853490510716	0.102518055780977	1	1	0.999999999999289	0.999999999999289	0.962061570559156
down	DVL1; KLK8; LRP4; NFASC; C1QA; CTNNB1; PCDHGC3; PPFIBP1;	GO:0050808~synapse organization	8	49	16.3265306122449	0.0235832086106081	0.103317650313097	1	1	0.999999999999289	0.999999999999289	0.969565216287916
down	GRM8; PDE2A; GPR37; ADCY6; GNAI3; ADRA2A; NPR3; GNAI1; LPAR1;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	9	59	15.2542372881356	0.0240026651952028	0.105017554793156	1	1	0.999999999999289	0.999999999999289	0.985517652777546
up	SRGN; GZMH; GZMB;	GO:0008626~granzyme-mediated apoptotic signaling pathway	3	6	50	0.0249081767131483	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	HCLS1; EVI2B; LEF1;	GO:0030854~positive regulation of granulocyte differentiation	3	6	50	0.0249081767131483	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	CD3E; CCL5; SKAP1;	GO:0033634~positive regulation of cell-cell adhesion mediated by integrin	3	6	50	0.0249081767131483	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	HLA-B; HLA-E; HLA-G;	GO:0042270~protection from natural killer cell mediated cytotoxicity	3	6	50	0.0249081767131483	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	PF4; SPI1; IL10;	GO:0045347~negative regulation of MHC class II biosynthetic process	3	6	50	0.0249081767131483	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	CD19; SH2B2; LAX1;	GO:0050851~antigen receptor-mediated signaling pathway	3	6	50	0.0249081767131483	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	IFNG; FCER2; PRF1;	GO:0051712~positive regulation of killing of cells of other organism	3	6	50	0.0249081767131483	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	IRF4; SLAMF6; LY9;	GO:0072540~T-helper 17 cell lineage commitment	3	6	50	0.0249081767131483	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	IFNG; CCL2; CCR2;	GO:1904783~positive regulation of NMDA glutamate receptor activity	3	6	50	0.0249081767131483	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	CCL4; CCL5; CCL7;	GO:2000503~positive regulation of natural killer cell chemotaxis	3	6	50	0.0249081767131483	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	HLA-G; LILRB1; TMEM176A;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.0249081767131483	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
down	MID1; HOXB1; SIX1; GRHL3; EYA1; RFNG;	GO:0007389~pattern specification process	6	31	19.3548387096774	0.0249738857764046	0.108626647703229	1	1	0.999999999999289	0.999999999999289	1
down	KIF4A; SNAPIN; BLOC1S2; AP3S1; ARL8B; TRAK1;	GO:0008089~anterograde axonal transport	6	31	19.3548387096774	0.0249738857764046	0.108626647703229	1	1	0.999999999999289	0.999999999999289	1
down	JCHAIN; IGHA1; IGHA2; LTF; CTSG; DEFB1;	GO:0019731~antibacterial humoral response	6	31	19.3548387096774	0.0249738857764046	0.108626647703229	1	1	0.999999999999289	0.999999999999289	1
down	ABL1; EGFR; KDR; PTK2; DDR1; YES1;	GO:0038083~peptidyl-tyrosine autophosphorylation	6	31	19.3548387096774	0.0249738857764046	0.108626647703229	1	1	0.999999999999289	0.999999999999289	1
down	NRG2; EGFR; ERBB2; ERBB3; GRB7; STUB1;	GO:0038128~ERBB2 signaling pathway	6	31	19.3548387096774	0.0249738857764046	0.108626647703229	1	1	0.999999999999289	0.999999999999289	1
down	CCL21; FGFR3; PTK2; CCL19; NOD2; VAV3;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	6	31	19.3548387096774	0.0249738857764046	0.108626647703229	1	1	0.999999999999289	0.999999999999289	1
down	EGFR; SRD5A1; GJB2; AQP1; EIF4EBP1; DDIT4;	GO:0071549~cellular response to dexamethasone stimulus	6	31	19.3548387096774	0.0249738857764046	0.108626647703229	1	1	0.999999999999289	0.999999999999289	1
down	PRMT5; AURKA; EGFR; GLI3; CCND1; HFE;	GO:0097421~liver regeneration	6	31	19.3548387096774	0.0249738857764046	0.108626647703229	1	1	0.999999999999289	0.999999999999289	1
down	LEPROT; UBE2L3; SREBF2; UBE2J2; SAE1; SH3GLB1;	GO:1903955~positive regulation of protein targeting to mitochondrion	6	31	19.3548387096774	0.0249738857764046	0.108626647703229	1	1	0.999999999999289	0.999999999999289	1
up	CCDC88B; TNF; SLC11A1; NFAM1; TMIGD2; HHLA2;	GO:0001819~positive regulation of cytokine production	6	25	24	0.0253244668197595	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	TLR4; TLR2; SASH3; CD40LG; FCER1G; TIGIT;	GO:0032733~positive regulation of interleukin-10 production	6	25	24	0.0253244668197595	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	CCL5; CD1D; FPR2; ADAM8; GBP5; TLR8;	GO:0045089~positive regulation of innate immune response	6	25	24	0.0253244668197595	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	MT1F; GLRA1; MT1H; MT1L; HVCN1; P2RX4;	GO:0071294~cellular response to zinc ion	6	25	24	0.0253244668197595	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
down	RAN; NMD3; RRS1;	GO:0000055~ribosomal large subunit export from nucleus	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	RECQL4; SMARCA1; ZRANB3;	GO:0000733~DNA strand renaturation	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	POLR2I; CPSF2; CPSF3;	GO:0006379~mRNA cleavage	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	APEH; ETF1; TRMT112;	GO:0006415~translational termination	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	PLPP3; PLPP2; SPHK1;	GO:0006670~sphingosine metabolic process	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	CHEK1; CHEK2; ABL1;	GO:0006975~DNA damage induced protein phosphorylation	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	SPARC; PKM; FOSL1;	GO:0009629~response to gravity	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	CTNNB1; BMPR1A; VAX2;	GO:0009950~dorsal/ventral axis specification	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	GALNT1; GALNT3; GALNT11;	GO:0018243~protein O-linked glycosylation via threonine	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	"NAV2; LPAR1; TMEM126A;"	GO:0021554~optic nerve development	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	EGFR; FGF13; PEX13;	GO:0021795~cerebral cortex cell migration	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	SLC9A3R1; EZR; FGFR2;	GO:0022612~gland morphogenesis	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	PDLIM1; DST; DLG5;	GO:0030011~maintenance of cell polarity	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	GPC1; MTMR2; PMP22;	GO:0032288~myelin assembly	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	CCND1; EPHA2; BTRC;	GO:0033598~mammary gland epithelial cell proliferation	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	PLPP3; CEACAM5; XG;	GO:0034109~homotypic cell-cell adhesion	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	UGDH; LETM1; LRRC8A;	GO:0034214~protein hexamerization	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	EXOSC4; EXOSC8; EXOSC3;	GO:0034475~U4 snRNA 3'-end processing	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	HOXD9; BMPR1A; TFAP2B;	GO:0035137~hindlimb morphogenesis	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	CTNND1; CDH1; CTNNB1;	GO:0035635~entry of bacterium into host cell	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	PLEKHG5; RAB13; CORO1B;	GO:0035767~endothelial cell chemotaxis	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	NGFR; BEX3; TP63;	GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	IGFBP2; IGFBP4; IGFBP6;	GO:0043567~regulation of insulin-like growth factor receptor signaling pathway	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	SLC27A2; ACSL3; SLC27A4;	GO:0044539~long-chain fatty acid import into cell	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	RAB11A; RAB35; COMMD1;	GO:0048227~plasma membrane to endosome transport	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	YAP1; EPB41L5; DLL3;	GO:0048339~paraxial mesoderm development	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	HOXB1; FOXA1; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	NRP2; SLIT3; SEMA3F;	GO:0048846~axon extension involved in axon guidance	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	CYP1A1; MAOB; DUOX1;	GO:0050665~hydrogen peroxide biosynthetic process	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	PCDH17; BCHE; GNAI1;	GO:0050805~negative regulation of synaptic transmission	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	TSPO; IDH2; HES1;	GO:0060253~negative regulation of glial cell proliferation	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	CD34; KDR; NDNF;	GO:0061042~vascular wound healing	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	BMP4; BMPR1A; HES1;	GO:0061626~pharyngeal arch artery morphogenesis	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	SLC25A12; SLC38A7; SLC25A13;	GO:0070778~L-aspartate transmembrane transport	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	CCNH; GTF2H3; GTF2H5;	GO:0070816~phosphorylation of RNA polymerase II C-terminal domain	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	UBE2S; BARD1; UBE2T;	GO:0085020~protein K6-linked ubiquitination	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	SMIM22; SQLE; TMEM159;	GO:0140042~lipid droplet formation	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	DVL1; DVL3; FZD4;	GO:0150012~positive regulation of neuron projection arborization	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	PTPRF; ADAM15; HFE;	GO:1900121~negative regulation of receptor binding	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	LMNA; NF2; SUMO3;	GO:1900180~regulation of protein localization to nucleus	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	HMGCR; CYP51A1; MYOCD;	GO:1900222~negative regulation of amyloid-beta clearance	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	RNF40; NELFE; ZC3H14;	GO:1900364~negative regulation of mRNA polyadenylation	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	CDK10; TCHP; TBC1D7;	GO:1902018~negative regulation of cilium assembly	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	EZR; RDX; MTMR2;	GO:2000643~positive regulation of early endosome to late endosome transport	3	8	37.5	0.026899990333844	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	SCO1; SLC11A2; FKBP4; HEPH;	GO:0006825~copper ion transport	4	15	26.6666666666667	0.0269212987907903	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	SLC25A12; SLC1A3; SLC38A7; SLC25A13;	GO:0015813~L-glutamate transmembrane transport	4	15	26.6666666666667	0.0269212987907903	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	RHOV; RHOJ; RTKN; RAC1;	GO:0030865~cortical cytoskeleton organization	4	15	26.6666666666667	0.0269212987907903	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	PSMC5; KANK2; DNAJA3; TM7SF3;	GO:0043069~negative regulation of programmed cell death	4	15	26.6666666666667	0.0269212987907903	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	IDH1; CA2; SPP1; RBBP7;	GO:0048545~response to steroid hormone	4	15	26.6666666666667	0.0269212987907903	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	PTTG1; CDCA8; CENPW; PELO;	GO:0051276~chromosome organization	4	15	26.6666666666667	0.0269212987907903	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	ZPR1; DDR1; MARK2; PLP1;	GO:0061564~axon development	4	15	26.6666666666667	0.0269212987907903	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	ITGB1BP1; MEOX2; MMRN2; DLL4;	GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis	4	15	26.6666666666667	0.0269212987907903	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	EZR; PRDX1; AKIP1; LIME1;	GO:1901222~regulation of NIK/NF-kappaB signaling	4	15	26.6666666666667	0.0269212987907903	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	NIPAL1; ZDHHC13; MAGT1; NIPAL2;	GO:1903830~magnesium ion transmembrane transport	4	15	26.6666666666667	0.0269212987907903	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	CCL21; CXCL10; CXCL12; TMEM102;	GO:2000406~positive regulation of T cell migration	4	15	26.6666666666667	0.0269212987907903	0.113049149730528	1	1	0.999999999999289	0.999999999999289	1
down	BACE1; ADAM17; DAG1; SPPL3; APH1A;	GO:0006509~membrane protein ectodomain proteolysis	5	23	21.7391304347826	0.0270572461026002	0.113051570488725	1	1	0.999999999999289	0.999999999999289	1
down	ARL3; COMMD1; EXOC5; EXOC6B; EXOC1;	GO:0006893~Golgi to plasma membrane transport	5	23	21.7391304347826	0.0270572461026002	0.113051570488725	1	1	0.999999999999289	0.999999999999289	1
down	PROM1; TFAP2A; FJX1; RDH13; TFAP2B;	GO:0010842~retina layer formation	5	23	21.7391304347826	0.0270572461026002	0.113051570488725	1	1	0.999999999999289	0.999999999999289	1
down	VDAC1; VDAC2; LRRC8E; LRRC8A; VDAC3;	GO:0015698~inorganic anion transport	5	23	21.7391304347826	0.0270572461026002	0.113051570488725	1	1	0.999999999999289	0.999999999999289	1
down	RAB4A; RAB6A; RAB35; HFE; RAB34;	GO:0019882~antigen processing and presentation	5	23	21.7391304347826	0.0270572461026002	0.113051570488725	1	1	0.999999999999289	0.999999999999289	1
down	SNAPIN; CRK; PLK1; PCBD1; BTBD1;	GO:0043393~regulation of protein binding	5	23	21.7391304347826	0.0270572461026002	0.113051570488725	1	1	0.999999999999289	0.999999999999289	1
down	ENG; GJA5; HOXA1; HES1; NOTCH3;	GO:0048844~artery morphogenesis	5	23	21.7391304347826	0.0270572461026002	0.113051570488725	1	1	0.999999999999289	0.999999999999289	1
down	NGFR; CTSC; TPD52L1; TRAF7; MAGED1;	GO:2001235~positive regulation of apoptotic signaling pathway	5	23	21.7391304347826	0.0270572461026002	0.113051570488725	1	1	0.999999999999289	0.999999999999289	1
up	PRF1; CD6; CORO1A; EPHB1;	GO:0001771~immunological synapse formation	4	12	33.3333333333333	0.0274252561865249	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	PIK3CD; HNF1A; STAT5B; ID2;	GO:0001779~natural killer cell differentiation	4	12	33.3333333333333	0.0274252561865249	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	IL18RAP; CCL5; CXCR2; PREX1;	GO:0042119~neutrophil activation	4	12	33.3333333333333	0.0274252561865249	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	JAK3; TIGIT; LAX1; TNFAIP8L2;	GO:0050868~negative regulation of T cell activation	4	12	33.3333333333333	0.0274252561865249	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
down	SLC3A2; SLC7A1; SLC7A2; SLC1A5; SFXN4; SLC25A29; SLC7A8;	GO:0006865~amino acid transport	7	41	17.0731707317073	0.0274618998914965	0.114598971377319	1	1	0.999999999999289	0.999999999999289	1
down	CDK1; ARL2; PLK1; SLC16A1; SDCCAG8; SSX2IP; PARD6G;	GO:0007098~centrosome cycle	7	41	17.0731707317073	0.0274618998914965	0.114598971377319	1	1	0.999999999999289	0.999999999999289	1
down	TP73; ABL1; MSH3; POLD1; POLD2; PMS1;	GO:0006298~mismatch repair	6	32	18.75	0.028150192788901	0.117178466057724	1	1	0.999999999999289	0.999999999999289	1
down	FARP2; TFRC; EPHA2; CTNNB1; GLO1; EFNA4;	GO:0030316~osteoclast differentiation	6	32	18.75	0.028150192788901	0.117178466057724	1	1	0.999999999999289	0.999999999999289	1
down	GSTP1; ALAD; GSS; BAD; PEMT; GLRB;	GO:0043200~response to amino acid	6	32	18.75	0.028150192788901	0.117178466057724	1	1	0.999999999999289	0.999999999999289	1
down	KCNK3; CCNA2; HOXA1; MCM2; HES1; HEY2;	GO:0090102~cochlea development	6	32	18.75	0.028150192788901	0.117178466057724	1	1	0.999999999999289	0.999999999999289	1
down	DLL1; RAMP2; NPR1; NPR3; PTGS1; CD34; NOS3; ATP1A2; ACTA2;	GO:0008217~regulation of blood pressure	9	61	14.7540983606557	0.0284017201383453	0.117903639136751	1	1	0.999999999999289	0.999999999999289	1
down	TIPRL; ELFN2; PPP1R26; PPP1R14C; SH3RF2; PPP1R14B; PPME1; STYXL1;	GO:0032515~negative regulation of phosphoprotein phosphatase activity	8	51	15.6862745098039	0.0284126416719308	0.117903639136751	1	1	0.999999999999289	0.999999999999289	1
down	SPRY2; LTF; MAP2K2; PPP2CA; STK3; MLST8; HIGD1A; TELO2;	GO:0071902~positive regulation of protein serine/threonine kinase activity	8	51	15.6862745098039	0.0284126416719308	0.117903639136751	1	1	0.999999999999289	0.999999999999289	1
down	CD34; PPP5C; CDK5; TMEM259; VPS35; BTBD10; PARP2; NENF;	GO:1901215~negative regulation of neuron death	8	51	15.6862745098039	0.0284126416719308	0.117903639136751	1	1	0.999999999999289	0.999999999999289	1
down	HSBP1L1; PRMT5; HOXC6; YAP1; RBBP8; NIF3L1; TLE6; RUVBL2;	GO:1903507~negative regulation of nucleic acid-templated transcription	8	51	15.6862745098039	0.0284126416719308	0.117903639136751	1	1	0.999999999999289	0.999999999999289	1
up	TLR4; TNF; CD4; HLA-DRB1; CD74; GNAI2; CD36; C5AR1; FPR2; CCR1; CCR7; SLAMF1; PTK2B; SCIMP; NECAB2; GPBAR1; GLIPR2; IL26; C5AR2; MARCO; PYCARD; GPR55; CCL7; CCL4; CCL5; CCL2;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	26	209	12.4401913875598	0.0294855793895229	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	TLR4; FFAR2; TLR2; TNF; TLR7;	GO:0032722~positive regulation of chemokine production	5	19	26.3157894736842	0.02990320064277	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	IL2RA; CD74; GATA3; CD27; ZAP70;	GO:0045582~positive regulation of T cell differentiation	5	19	26.3157894736842	0.02990320064277	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
up	CD160; CCL2; HLA-G; CD40LG; RGCC;	GO:2000353~positive regulation of endothelial cell apoptotic process	5	19	26.3157894736842	0.02990320064277	0.470034513841633	1	1	0.99999999854637	0.99999999854637	1
down	HUS1; POLD1; UBE2A; ERCC8; ZRANB3; DDB2; SERPINB13;	GO:0009411~response to UV	7	42	16.6666666666667	0.0303834150380439	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	CA2; CA4; AQP1; CYB5R2; SLC26A9; SLC4A11; CYB5R1;	GO:0015701~bicarbonate transport	7	42	16.6666666666667	0.0303834150380439	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	TRIM16; WDR5; TAF9; JADE3; POLE3; MBIP; TAF6L;	GO:0043966~histone H3 acetylation	7	42	16.6666666666667	0.0303834150380439	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
up	MS4A1; IL10; CD40LG; CD70; CARD11; LEF1; IFNA5;	GO:0042100~B cell proliferation	7	34	20.5882352941176	0.0308687401843057	0.477050093939991	1	1	0.99999999854637	0.99999999854637	1
down	AIFM1; TFAP2A; MYBL2; CTNNB1; BACE1; UBE2M; CDK5; TFAP2B;	GO:0043525~positive regulation of neuron apoptotic process	8	52	15.3846153846154	0.0310661129974688	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	POLD1; RFC4; RFC2; RFC5; POLD2;	GO:0006297~nucleotide-excision repair, DNA gap filling	5	24	20.8333333333333	0.0310760322842261	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	RAD51C; CCNA1; TRIP13; ING2; SLC2A8;	GO:0007141~male meiosis I	5	24	20.8333333333333	0.0310760322842261	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	NUDT21; CAV1; PUM1; EPB41L5; FBXO4;	GO:0010608~posttranscriptional regulation of gene expression	5	24	20.8333333333333	0.0310760322842261	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	PDE2A; NPR1; NPPC; AQP1; PDE3A;	GO:0019934~cGMP-mediated signaling	5	24	20.8333333333333	0.0310760322842261	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	RYR1; KEL; CAV2; SMO; SIX1;	GO:0048741~skeletal muscle fiber development	5	24	20.8333333333333	0.0310760322842261	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	CCNB1; NME1; NME2; SREBF1; E2F1;	GO:0071398~cellular response to fatty acid	5	24	20.8333333333333	0.0310760322842261	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	ERBB2; ERBB3; C1QBP; PREX2; SIRT2; PIK3C2G;	GO:0014065~phosphatidylinositol 3-kinase signaling	6	33	18.1818181818182	0.0315814436978873	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	ABL1; AP2S1; SPHK1; PACSIN3; RAB4A; OPHN1;	GO:0030100~regulation of endocytosis	6	33	18.1818181818182	0.0315814436978873	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	PTGS1; PTGES3; PTGIS; MGST1;	GO:0001516~prostaglandin biosynthetic process	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	EIF3D; EIF3B; EIF3I; EIF3K;	GO:0001732~formation of cytoplasmic translation initiation complex	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	PGM1; PHKA1; PHKB; PGM2;	GO:0005980~glycogen catabolic process	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	PLXNB2; ID4; ARTN; RACGAP1;	GO:0007405~neuroblast proliferation	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	PRKRA; RAN; TARBP2; DROSHA;	GO:0010586~miRNA metabolic process	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	TACSTD2; MCC; PFN2; STRAP;	GO:0010633~negative regulation of epithelial cell migration	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	CCL21; S100A7; ADAM17; TMEM102;	GO:0010820~positive regulation of T cell chemotaxis	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	ERN2; DROSHA; EXOSC4; EXOSC8;	GO:0016075~rRNA catabolic process	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	ADRA2A; BDKRB2; AGTR1; ATP1A2;	GO:0019229~regulation of vasoconstriction	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	HYAL3; HMMR; HYAL2; CEMIP;	GO:0030214~hyaluronan catabolic process	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	KEL; BDKRB2; CAV1; TRPM4;	GO:0042310~vasoconstriction	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	DLL1; FOXA1; SIX1; EYA1;	GO:0048665~neuron fate specification	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	NELFE; CTNNB1; WDR5; WDR61;	GO:0051571~positive regulation of histone H3-K4 methylation	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	HOXA5; CCND1; DDR1; PHB2;	GO:0060749~mammary gland alveolus development	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	ROBO4; CNTN4; NPTN; IGSF9;	GO:0070593~dendrite self-avoidance	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	ERBB3; PTBP1; SPPL3; LMCD1;	GO:0070886~positive regulation of calcineurin-NFAT signaling cascade	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	RNF40; PSMC2; PSMC4; ECSCR;	GO:1901800~positive regulation of proteasomal protein catabolic process	4	16	25	0.0320440638746209	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	TNFRSF21; SCGB1A1; IDO1; SDC4; IL20RB; DLG5; PLA2G2A;	GO:0042130~negative regulation of T cell proliferation	7	43	16.2790697674419	0.0335066050212096	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
up	CD3E; CD36; CCR7; PTK2B; SKAP1; NINJ1;	GO:0001954~positive regulation of cell-matrix adhesion	6	27	22.2222222222222	0.0335666002436573	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	CD4; LCK; HCK; CD8B; CD247; AP1S2;	GO:0050690~regulation of defense response to virus by virus	6	27	22.2222222222222	0.0335666002436573	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	CD74; CCR7; SLC11A1;	GO:0002606~positive regulation of dendritic cell antigen processing and presentation	3	7	42.8571428571429	0.0336377751855836	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	SKAP1; PYCARD; SASH3;	GO:0002821~positive regulation of adaptive immune response	3	7	42.8571428571429	0.0336377751855836	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	ADORA2A; P2RX7; SYT4;	GO:0014049~positive regulation of glutamate secretion	3	7	42.8571428571429	0.0336377751855836	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	VNN1; VNN2; VNN3;	GO:0015939~pantothenate metabolic process	3	7	42.8571428571429	0.0336377751855836	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	CD4; CCR5; CXCR4;	GO:0019064~fusion of virus membrane with host plasma membrane	3	7	42.8571428571429	0.0336377751855836	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	OXT; P2RX4; P2RX7;	GO:0032308~positive regulation of prostaglandin secretion	3	7	42.8571428571429	0.0336377751855836	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	STAT5B; NCKAP1L; LEF1;	GO:0045588~positive regulation of gamma-delta T cell differentiation	3	7	42.8571428571429	0.0336377751855836	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	APOA2; SCT; ADORA1;	GO:0050996~positive regulation of lipid catabolic process	3	7	42.8571428571429	0.0336377751855836	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	SLC4A1; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.0336377751855836	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	TMOD1; LMOD3; LMOD2;	GO:0051694~pointed-end actin filament capping	3	7	42.8571428571429	0.0336377751855836	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	CRYBA1; IL10; SLC11A1; BTK;	GO:0001818~negative regulation of cytokine production	4	13	30.7692307692308	0.0337933402413076	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
up	VNN1; APOA2; TREM1; HPR;	GO:0002526~acute inflammatory response	4	13	30.7692307692308	0.0337933402413076	0.490141930795032	1	1	0.99999999854637	0.99999999854637	1
down	MAPK13; TLR3; IL33; ADORA2B; IL17D; TSLP; RAB7B; NOD2;	GO:0032755~positive regulation of interleukin-6 production	8	53	15.0943396226415	0.033884202009026	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	CCL21; SDC4; VLDLR; CDK5; PTK2; DAG1; GAS6; CCL19;	GO:0045860~positive regulation of protein kinase activity	8	53	15.0943396226415	0.033884202009026	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	CASQ2; AHCYL1; NPR1; RYR1; NPPC; ATP1A2; ATP1B3; FXYD3;	GO:1903779~regulation of cardiac conduction	8	53	15.0943396226415	0.033884202009026	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	TAF9; RUVBL2; ZNHIT3;	GO:0000492~box C/D snoRNP assembly	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	SLC1A3; SLC6A9; ATP1A2;	GO:0001504~neurotransmitter uptake	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	DENR; EIF2D; MCTS1;	GO:0001731~formation of translation preinitiation complex	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	LYPLA2; ABHD17C; LYPLA1;	GO:0002084~protein depalmitoylation	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	BCR; BMP4; RRM2B;	GO:0003014~renal system process	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	YAP1; HES1; SOX17;	GO:0003143~embryonic heart tube morphogenesis	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	BMP4; ERBB3; FOXF1;	GO:0003197~endocardial cushion development	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	SFN; KDF1; EXPH5;	GO:0003334~keratinocyte development	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	DCTD; NME2; NME1;	GO:0006220~pyrimidine nucleotide metabolic process	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	UBE2N; UBE2V2; POLH;	GO:0006282~regulation of DNA repair	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	"NAA10; NAA50; NAA35;"	GO:0006474~N-terminal protein amino acid acetylation	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	CYP2J2; PTGIS; CYP2S1;	GO:0006690~icosanoid metabolic process	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	DCXR; IDH1; IDH2;	GO:0006739~NADP metabolic process	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	NME2; CMPK1; SUCLG1;	GO:0009142~nucleoside triphosphate biosynthetic process	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	YES1; SLC2A1; OCLN;	GO:0010827~regulation of glucose transmembrane transport	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	DNM1L; PEX11A; MFF;	GO:0016559~peroxisome fission	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	NRP2; HOXB1; SEMA3F;	GO:0021612~facial nerve structural organization	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	SURF4; TMED9; PREB;	GO:0032527~protein exit from endoplasmic reticulum	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	TCF21; WWTR1; HEYL;	GO:0032835~glomerulus development	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	RNF40; RNF8; CDC73;	GO:0033523~histone H2B ubiquitination	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	EXOSC3; EXOSC8; EXOSC4;	GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	UQCC3; BCS1L; UQCR10;	GO:0034551~mitochondrial respiratory chain complex III assembly	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	VGLL4; DLG5; AJUBA;	GO:0035331~negative regulation of hippo signaling	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	ALOX15B; PTGIS; STARD10;	GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	PRMT5; CXCL10; BMPER;	GO:0042118~endothelial cell activation	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	PRKRA; HOXA1; EYA1;	GO:0042473~outer ear morphogenesis	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	TPM2; VMA21; TMEM64;	GO:0043462~regulation of ATPase activity	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	DNM1L; VPS35; MFF;	GO:0043653~mitochondrial fragmentation involved in apoptotic process	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	AKR7A2; AKR1B10; AKR1A1;	GO:0044597~daunorubicin metabolic process	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	AKR7A2; AKR1B10; AKR1A1;	GO:0044598~doxorubicin metabolic process	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	LRSAM1; MVB12A; VTA1;	GO:0046755~viral budding	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	CYTH3; STX6; ARL1;	GO:0048193~Golgi vesicle transport	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	ELN; NPPC; CTNNB1;	GO:0048660~regulation of smooth muscle cell proliferation	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	DHH; TSPO; IGFBP7;	GO:0050810~regulation of steroid biosynthetic process	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	ITGB1BP1; SIX1; SMO;	GO:0051451~myoblast migration	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	PUM1; AURKB; KIF2C;	GO:0051983~regulation of chromosome segregation	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	KCNK1; KCNK5; KCNK6;	GO:0060075~regulation of resting membrane potential	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	HOXA5; FGFR2; CTNNB1;	GO:0060484~lung-associated mesenchyme development	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	SLC11A2; HYAL2; HFE;	GO:0060586~multicellular organismal iron ion homeostasis	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	ZMPSTE24; GCNT3; WWTR1;	GO:0060993~kidney morphogenesis	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	NRP2; CTNNB1; SEMA3F;	GO:0061549~sympathetic ganglion development	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	RAMP2; PXDN; LAMB2;	GO:0070831~basement membrane assembly	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	EXOSC10; EXOSC4; EXOSC8;	GO:0071028~nuclear mRNA surveillance	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	RAB18; LNPK; TMEM33;	GO:0071786~endoplasmic reticulum tubular network organization	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	NPC1; RAB11A; RAB11B;	GO:0090150~establishment of protein localization to membrane	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	CTNNB1; PLPP4; WNK3;	GO:0090279~regulation of calcium ion import	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	HRAS; PRKCZ; DAG1;	GO:0098696~regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
down	GPR37; TXN; NFE2L2;	GO:1903206~negative regulation of hydrogen peroxide-induced cell death	3	9	33.3333333333333	0.0342465014070967	0.12537034295935	1	1	0.999999999999289	0.999999999999289	1
up	ITGB3; ITGA2B; PLEK; PTPN6; HBB; FERMT3; TSPAN32; GP1BA;	GO:0070527~platelet aggregation	8	43	18.6046511627907	0.0344821178736937	0.498090674102049	1	1	0.99999999854637	0.99999999854637	1
down	KCNK3; GIPC1; CNP; CHRNA5; CTNNB1; SLC1A3; GLRB; ATXN3; USP14; PLP1; FGF12; CDK5; PMP22; SYPL1; MINK1; PCDHB10; PCDHB4; PCDHB3; PCDHB14; PCDHB13; PCDHB11; GABRA4; GABRE; CACNB3; GABRA3;	GO:0007268~chemical synaptic transmission	25	249	10.0401606425703	0.0347567748832869	0.127168681815575	1	1	0.999999999999289	0.999999999999289	1
up	NCKAP1L; PARVG; RHOG; CYFIP2; RAC2;	GO:0030031~cell projection assembly	5	20	25	0.035146135046628	0.50357154627537	1	1	0.99999999854637	0.99999999854637	1
down	ADCY6; AQP1; RAB11A; TFAP2B; AQP3; CYP4F12;	GO:0003091~renal water homeostasis	6	34	17.6470588235294	0.0352737529619815	0.128989569534208	1	1	0.999999999999289	0.999999999999289	1
down	SNRPG; SNRPD1; SNRPD2; USP39; DDX1;	GO:0000245~spliceosomal complex assembly	5	25	20	0.0354493402402497	0.129277861432919	1	1	0.999999999999289	0.999999999999289	1
down	PITPNB; CEP55; CHMP4C; CHMP1A; VPS4A;	GO:0006997~nucleus organization	5	25	20	0.0354493402402497	0.129277861432919	1	1	0.999999999999289	0.999999999999289	1
down	GLUD1; GOT2; OAT; GOT1; ALDH18A1;	GO:0008652~cellular amino acid biosynthetic process	5	25	20	0.0354493402402497	0.129277861432919	1	1	0.999999999999289	0.999999999999289	1
down	BMP4; ENG; WNT4; HDAC2; LARP6;	GO:0032967~positive regulation of collagen biosynthetic process	5	25	20	0.0354493402402497	0.129277861432919	1	1	0.999999999999289	0.999999999999289	1
down	BCL10; LTBR; CAV1; HYAL2; TNFRSF12A;	GO:2001238~positive regulation of extrinsic apoptotic signaling pathway	5	25	20	0.0354493402402497	0.129277861432919	1	1	0.999999999999289	0.999999999999289	1
up	TLR4; AIM2; TLR2; IL18RAP; TNF; ITGB2; PRKCB; CD36; CD40LG; CTH; CX3CR1; ADAM8; S100A12; BTK; CARD16; RHEBL1; CARD11; NLRC4; PYCARD; TLR6;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	20	154	12.987012987013	0.0365375336761191	0.521396498708813	1	1	0.99999999854637	0.99999999854637	1
up	PGLYRP1; GNLY; PRTN3; SLC11A1; CAMP; DEFA3; LYZ; RNASE6; PGLYRP2;	GO:0019730~antimicrobial humoral response	9	52	17.3076923076923	0.036704584320485	0.521676802852194	1	1	0.99999999854637	0.99999999854637	1
down	RECQL4; POLD1; POLD2; PTGES3; RAD50; PIF1; HUS1;	GO:0000723~telomere maintenance	7	44	15.9090909090909	0.0368360966231072	0.134042462711862	1	1	0.999999999999289	0.999999999999289	1
down	LGALS3; CCL14; CCL18; CCL21; CCL19; CCL13; CCL11;	GO:0002548~monocyte chemotaxis	7	44	15.9090909090909	0.0368360966231072	0.134042462711862	1	1	0.999999999999289	0.999999999999289	1
down	SULT2B1; CYP1A1; CYP2E1; TSPO; SULT1E1; DHRS4; DHCR24;	GO:0008202~steroid metabolic process	7	44	15.9090909090909	0.0368360966231072	0.134042462711862	1	1	0.999999999999289	0.999999999999289	1
down	TLR3; IL33; IFI27; BAD; TNFRSF12A; NDUFA13; PARP2;	GO:0097191~extrinsic apoptotic signaling pathway	7	44	15.9090909090909	0.0368360966231072	0.134042462711862	1	1	0.999999999999289	0.999999999999289	1
down	VIT; SCARA3; MATN2; VWA1;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	LTA4H; GGT5; PTGR1; LTC4S;	GO:0006691~leukotriene metabolic process	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	TLR3; IRAK1; COPS8; CARD14;	GO:0007250~activation of NF-kappaB-inducing kinase activity	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	ZMPSTE24; IDE; TFCP2L1; COQ7;	GO:0008340~determination of adult lifespan	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	ETFA; ETFB; NDUFA5; SDHB;	GO:0022904~respiratory electron transport chain	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	TMBIM6; BAK1; CCDC47; TMCO1;	GO:0032469~endoplasmic reticulum calcium ion homeostasis	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	RNF8; ERCC1; UNG; EXOSC3;	GO:0045190~isotype switching	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	SLC9A3R1; OPHN1; EZR; FOXF1;	GO:0045198~establishment of epithelial cell apical/basal polarity	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	CTSV; CTSK; AQP3; SERPINB13;	GO:0045616~regulation of keratinocyte differentiation	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	SDC4; HES1; HES5; MKS1;	GO:0060122~inner ear receptor cell stereocilium organization	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	GNAI1; GPSM2; PSRC1; TPX2;	GO:0060236~regulation of mitotic spindle organization	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	BMP2; BMP4; SOX9; SMAD1;	GO:0061036~positive regulation of cartilage development	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	TLR3; CAV1; COLEC12; MUL1;	GO:0071360~cellular response to exogenous dsRNA	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	APOD; IL1R2; ZC3H12A; CHID1;	GO:1900016~negative regulation of cytokine production involved in inflammatory response	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
down	CEACAM5; CAV1; TLE1; PTK2;	GO:2000811~negative regulation of anoikis	4	17	23.5294117647059	0.0376978517560194	0.135993168240802	1	1	0.999999999999289	0.999999999999289	1
up	CALCA; CCL2; CCL5; CCR2; CCL7; S100A12; PTPRO; CCL4;	GO:0002548~monocyte chemotaxis	8	44	18.1818181818182	0.0381781093870144	0.537420665757203	1	1	0.99999999854637	0.99999999854637	1
up	TLR4; AIM2; NLRC4; PYCARD; PYHIN1; MNDA;	GO:0002218~activation of innate immune response	6	28	21.4285714285714	0.0382678744760709	0.537420665757203	1	1	0.99999999854637	0.99999999854637	1
up	ITGB2; CCL5; PECAM1; ITGAL; CD40LG; FERMT3;	GO:0007159~leukocyte cell-cell adhesion	6	28	21.4285714285714	0.0382678744760709	0.537420665757203	1	1	0.99999999854637	0.99999999854637	1
up	PIK3CD; TNF; LCK; OSM; HCLS1; RAC2; CD19; GATA3; CCR7; CD80; CD86; CX3CR1; ADAM8; RHOG; TRAT1; PIK3AP1; PIK3R5; P2RX4; GDF15; IL26; ICOS;	GO:0051897~positive regulation of protein kinase B signaling	21	165	12.7272727272727	0.0387250444716228	0.541691432352068	1	1	0.99999999854637	0.99999999854637	1
down	BHLHE40; HDAC3; CDK1; TOP2A; PPP1CA; DDB1; TIMELESS; BTRC; MAGED1;	GO:0042752~regulation of circadian rhythm	9	65	13.8461538461538	0.0388338291576138	0.139940028372178	1	1	0.999999999999289	0.999999999999289	1
down	TLR3; DAPK3; CAV1; FASTK; BAK1; PTGIS; NDUFA13; IFI27; IFI27L2;	GO:0097190~apoptotic signaling pathway	9	65	13.8461538461538	0.0388338291576138	0.139940028372178	1	1	0.999999999999289	0.999999999999289	1
down	COPZ1; COG5; NSF; COPZ2; RAB6A; TRAPPC3;	GO:0006891~intra-Golgi vesicle-mediated transport	6	35	17.1428571428571	0.039232424571743	0.141072028290536	1	1	0.999999999999289	0.999999999999289	1
down	FGF10; SOX9; RAB11A; DOCK1; EPB41L5; HDAC6;	GO:0010634~positive regulation of epithelial cell migration	6	35	17.1428571428571	0.039232424571743	0.141072028290536	1	1	0.999999999999289	0.999999999999289	1
down	LTF; GAPDH; ROMO1; PGLYRP4; PGLYRP3; CCL13;	GO:0031640~killing of cells of other organism	6	35	17.1428571428571	0.039232424571743	0.141072028290536	1	1	0.999999999999289	0.999999999999289	1
down	HGS; SPRY2; STAM2; EGFR; STAM; CBLC;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	6	35	17.1428571428571	0.039232424571743	0.141072028290536	1	1	0.999999999999289	0.999999999999289	1
down	TGFB1I1; SPRY2; BMP2; FGFR2; GAS1; HEY2; SOX13; WNT4;	GO:0045165~cell fate commitment	8	55	14.5454545454545	0.0400289152133574	0.143858624282109	1	1	0.999999999999289	0.999999999999289	1
down	RRS1; MRTO4; MRPL11; RPF2; RPL3L;	GO:0000027~ribosomal large subunit assembly	5	26	19.2307692307692	0.0401831924383403	0.143871333698045	1	1	0.999999999999289	0.999999999999289	1
down	RAD51C; PLK1; PHB2; ESCO2; STAG3L4;	GO:0007062~sister chromatid cohesion	5	26	19.2307692307692	0.0401831924383403	0.143871333698045	1	1	0.999999999999289	0.999999999999289	1
down	BCL10; EGFR; PTGES3; BTBD10; APLN;	GO:0042327~positive regulation of phosphorylation	5	26	19.2307692307692	0.0401831924383403	0.143871333698045	1	1	0.999999999999289	0.999999999999289	1
down	ABL1; CTNNA1; CTNNB1; TARBP2; BOC;	GO:0051149~positive regulation of muscle cell differentiation	5	26	19.2307692307692	0.0401831924383403	0.143871333698045	1	1	0.999999999999289	0.999999999999289	1
down	DNM1L; CCL21; RAC1; C1QBP; CCL19;	GO:0090023~positive regulation of neutrophil chemotaxis	5	26	19.2307692307692	0.0401831924383403	0.143871333698045	1	1	0.999999999999289	0.999999999999289	1
down	BMP2; ZC3H12A; MINK1; PRMT1; SPHK1;	GO:1900745~positive regulation of p38MAPK cascade	5	26	19.2307692307692	0.0401831924383403	0.143871333698045	1	1	0.999999999999289	0.999999999999289	1
down	DVL1; RGS4; CACNB3; PRKCZ; BAIAP2;	GO:2000463~positive regulation of excitatory postsynaptic potential	5	26	19.2307692307692	0.0401831924383403	0.143871333698045	1	1	0.999999999999289	0.999999999999289	1
down	SAP30; RB1; LEMD2; ANKRD2; HEYL; HMG20B; GTF3C5;	GO:0035914~skeletal muscle cell differentiation	7	45	15.5555555555556	0.0403760483137464	0.144329790681723	1	1	0.999999999999289	0.999999999999289	1
down	MAPKBP1; ABL1; GSTP1; TLE1; HDAC1; ZC3H12A; NLRX1;	GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling	7	45	15.5555555555556	0.0403760483137464	0.144329790681723	1	1	0.999999999999289	0.999999999999289	1
down	EXOC5; TMEM17; POC1A; BBS10; MKS1; TMEM80; TTC8;	GO:1905515~non-motile cilium assembly	7	45	15.5555555555556	0.0403760483137464	0.144329790681723	1	1	0.999999999999289	0.999999999999289	1
up	LYN; NCKAP1L; PKN1; TNFSF13B; GAPT;	GO:0001782~B cell homeostasis	5	21	23.8095238095238	0.0409213914665584	0.559520403952479	1	1	0.99999999854637	0.99999999854637	1
up	TNF; IL10; GPM6A; IL10RA; PTPRO;	GO:0050807~regulation of synapse organization	5	21	23.8095238095238	0.0409213914665584	0.559520403952479	1	1	0.99999999854637	0.99999999854637	1
up	CHST7; CHST2; MGAT3; RENBP;	GO:0006044~N-acetylglucosamine metabolic process	4	14	28.5714285714286	0.0409482296195796	0.559520403952479	1	1	0.99999999854637	0.99999999854637	1
up	APOA2; MPO; CETP; PLA2G7;	GO:0034374~low-density lipoprotein particle remodeling	4	14	28.5714285714286	0.0409482296195796	0.559520403952479	1	1	0.99999999854637	0.99999999854637	1
up	LYN; STAT5A; STAT5B; JAK3;	GO:0060397~growth hormone receptor signaling pathway via JAK-STAT	4	14	28.5714285714286	0.0409482296195796	0.559520403952479	1	1	0.99999999854637	0.99999999854637	1
up	CYBB; SPI1; GLRA1; CCL7;	GO:0071361~cellular response to ethanol	4	14	28.5714285714286	0.0409482296195796	0.559520403952479	1	1	0.99999999854637	0.99999999854637	1
down	RAD51C; RAD51; RAD50;	GO:0000722~telomere maintenance via recombination	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	FGF10; FGF1; SIX1;	GO:0001759~organ induction	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	AGPAT2; GAS6; TSLP;	GO:0001961~positive regulation of cytokine-mediated signaling pathway	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	BMP4; FGFR2; FZD1;	GO:0003149~membranous septum morphogenesis	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	MGMT; ALKBH2; FTO;	GO:0006307~DNA dealkylation involved in DNA repair	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	RBBP4; CHAF1A; ASF1B;	GO:0006335~DNA replication-dependent nucleosome assembly	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	HSD17B6; SRD5A1; SRD5A3;	GO:0006702~androgen biosynthetic process	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	SLC30A9; SLC30A5; SLC39A2;	GO:0006829~zinc ion transport	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	WASL; AP2M1; VPS4A;	GO:0006900~vesicle budding from membrane	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	JUP; EZR; DAG1;	GO:0007016~cytoskeletal anchoring at plasma membrane	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	ADAM17; GALNT11; APH1A;	GO:0007220~Notch receptor processing	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	EGFR; FOXF1; SMO;	GO:0007494~midgut development	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	UQCRQ; B4GALT2; NAGLU;	GO:0021680~cerebellar Purkinje cell layer development	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	BMP4; FOXA1; SMO;	GO:0021904~dorsal/ventral neural tube patterning	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	SERPINE2; PCSK6; USE1;	GO:0032940~secretion by cell	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	CTNNB1; HMG20B; PIAS3;	GO:0033234~negative regulation of protein sumoylation	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	ETFA; ETFB; ACADVL;	GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	CYC1; CCNA2; SREBF1;	GO:0033762~response to glucagon	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	WASL; SNAPIN; EZR;	GO:0034629~cellular protein-containing complex localization	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	MMP12; ADAM17; AJUBA;	GO:0035313~wound healing, spreading of epidermal cells	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	FGFR3; MMP16; STC1;	GO:0035988~chondrocyte proliferation	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	MICU2; MCUR1; SLC25A23;	GO:0036444~calcium import into the mitochondrion	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	CEACAM1; RHBDF1; MVB12A;	GO:0042058~regulation of epidermal growth factor receptor signaling pathway	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	BACE1; DHCR24; APH1A;	GO:0042987~amyloid precursor protein catabolic process	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	DDR1; SHROOM2; RDH10;	GO:0043583~ear development	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	CNP; BAK1; BAD;	GO:0046902~regulation of mitochondrial membrane permeability	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	DCN; TSPO; KDR;	GO:0051901~positive regulation of mitochondrial depolarization	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	SDC1; SOX9; HSD17B4;	GO:0060009~Sertoli cell development	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	GPR4; DAG1; PRCP;	GO:0060055~angiogenesis involved in wound healing	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	GLRX3; MAGEF1; NFU1;	GO:0097428~protein maturation by iron-sulfur cluster transfer	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	RDX; CAV1; RCC2;	GO:1900027~regulation of ruffle assembly	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	KEL; RGS4; CAV1;	GO:1901380~negative regulation of potassium ion transmembrane transport	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	DDB1; CHMP4C; VPS4A;	GO:1902188~positive regulation of viral release from host cell	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	NCK1; RNF183; BOK;	GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	HSPA1A; HSPA1B; ADAM17;	GO:1903265~positive regulation of tumor necrosis factor-mediated signaling pathway	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	CHMP1A; VTA1; VPS4A;	GO:1904903~ESCRT III complex disassembly	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	CTNNB1; RAB11B; HFE;	GO:2000008~regulation of protein localization to cell surface	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
down	LRSAM1; PIP4K2C; SH3GLB1;	GO:2000786~positive regulation of autophagosome assembly	3	10	30	0.0425166394997734	0.148953156003139	1	1	0.999999999999289	0.999999999999289	1
up	HLA-B; HLA-H; HLA-C; HLA-E; HLA-G; HLA-F;	GO:0002474~antigen processing and presentation of peptide antigen via MHC class I	6	29	20.6896551724138	0.0433679309556489	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
up	F2; TNF; CCL5; IL10; IL10RA; IL26;	GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT	6	29	20.6896551724138	0.0433679309556489	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
down	NRP2; SLIT3; SEMA4B; SEMA3G; SEMA3F; SEMA6D;	GO:0050919~negative chemotaxis	6	36	16.6666666666667	0.0434619325492447	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
up	ADORA2A; ADORA1; GNAI2;	GO:0001973~G protein-coupled adenosine receptor signaling pathway	3	8	37.5	0.0437343510846118	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
up	MS4A1; ORAI1; ORAI2;	GO:0002115~store-operated calcium entry	3	8	37.5	0.0437343510846118	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
up	FOLR3; SLC19A1; SLC25A32;	GO:0015884~folic acid transport	3	8	37.5	0.0437343510846118	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
up	P2RX5; P2RX4; P2RX7;	GO:0035590~purinergic nucleotide receptor signaling pathway	3	8	37.5	0.0437343510846118	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
up	TLR4; IRF1; LTB;	GO:0045084~positive regulation of interleukin-12 biosynthetic process	3	8	37.5	0.0437343510846118	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
up	TLR4; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.0437343510846118	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
up	PTAFR; SNCA; CD244;	GO:0060732~positive regulation of inositol phosphate biosynthetic process	3	8	37.5	0.0437343510846118	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
up	AQP9; SLC14A1; AQP10;	GO:0071918~urea transmembrane transport	3	8	37.5	0.0437343510846118	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
up	CD160; CD2; CD244;	GO:1902715~positive regulation of interferon-gamma secretion	3	8	37.5	0.0437343510846118	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
down	MFN2; ACTL6A; TM4SF1; SF3B6;	GO:0001825~blastocyst formation	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	CES2; PTGR1; ACOX1; CYP2S1;	GO:0006693~prostaglandin metabolic process	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	WDR62; CDK2; CETN2; CNTROB;	GO:0007099~centriole replication	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	DLGAP5; NOTCH4; HEYL; NOTCH3;	GO:0007221~positive regulation of transcription of Notch receptor target	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	HUS1; GMNN; S100A11; CDC6;	GO:0008156~negative regulation of DNA replication	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	DHH; F12; CTSE; PCSK2;	GO:0016540~protein autoprocessing	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	DAG1; SIRT2; LGI4; PARD3;	GO:0022011~myelination in peripheral nervous system	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	ZMPSTE24; FAM83D; TELO2; DDIT4;	GO:0032006~regulation of TOR signaling	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	STK25; MID1; HMGCR; NOD2;	GO:0032874~positive regulation of stress-activated MAPK cascade	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	SOX15; PKM; DAG1; TARBP2;	GO:0043403~skeletal muscle tissue regeneration	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	DSP; DES; KRT20; KRT17;	GO:0045109~intermediate filament organization	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	HMGCR; RB1; DTYMK; JAG1;	GO:0045445~myoblast differentiation	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	DLL1; MEIS2; CDC73; WDR61;	GO:0045638~negative regulation of myeloid cell differentiation	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	CLTA; AP2S1; FCHO2; CLTB;	GO:0048268~clathrin coat assembly	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	MFN2; GLI3; COL8A1; SHROOM2;	GO:0048593~camera-type eye morphogenesis	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	PLXNA2; BMP7; SIX1; EYA1;	GO:0060037~pharyngeal system development	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	WASL; DVL1; EPHB3; HDAC6;	GO:0060997~dendritic spine morphogenesis	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	SLC30A5; SLC39A2; SLC30A4; SLC39A11;	GO:0071577~zinc ion transmembrane transport	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	GJA5; SNTA1; GPD1L; PKP2;	GO:0086005~ventricular cardiac muscle cell action potential	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	PRCP; EIF6; FOXM1; COQ7;	GO:2000377~regulation of reactive oxygen species metabolic process	4	18	22.2222222222222	0.0438857028228246	0.152074886182205	1	1	0.999999999999289	0.999999999999289	1
down	SLC9A3R1; EPHA2; HYAL2; DAG1; LEMD2; MUL1; PHLDA3;	GO:0051898~negative regulation of protein kinase B signaling	7	46	15.2173913043478	0.0441301337558014	0.152842624998709	1	1	0.999999999999289	0.999999999999289	1
down	ITGB1BP1; GCLC; GCLM; HYAL2; DLL4;	GO:0044344~cellular response to fibroblast growth factor stimulus	5	27	18.5185185185185	0.0452820033599625	0.155341748963822	1	1	0.999999999999289	0.999999999999289	1
down	TULP3; RB1; SERPINE2; GLI3; BTRC;	GO:0045879~negative regulation of smoothened signaling pathway	5	27	18.5185185185185	0.0452820033599625	0.155341748963822	1	1	0.999999999999289	0.999999999999289	1
down	AP2S1; RAC1; AP1B1; AP2M1; AP1M2;	GO:0050690~regulation of defense response to virus by virus	5	27	18.5185185185185	0.0452820033599625	0.155341748963822	1	1	0.999999999999289	0.999999999999289	1
down	TSPO; AGTR1; ROMO1; NFE2L2; ZC3H12A;	GO:2000379~positive regulation of reactive oxygen species metabolic process	5	27	18.5185185185185	0.0452820033599625	0.155341748963822	1	1	0.999999999999289	0.999999999999289	1
up	LYN; HCLS1; SPI1; ALAS2; GATA3; KLF1; JAK3; AHSP;	GO:0030218~erythrocyte differentiation	8	46	17.3913043478261	0.0463431382710614	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
down	RTCA; RNGTT; DUSP11; HNRNPF; HNRNPK; LARP6; DROSHA; MRPL44;	GO:0006396~RNA processing	8	57	14.0350877192982	0.0468731536905188	0.155341748963822	1	1	0.999999999999289	0.999999999999289	1
up	IFNG; CD4; HLA-DRB1; MMP9; SPI1;	GO:0030225~macrophage differentiation	5	22	22.7272727272727	0.047236743099815	0.562355133880998	1	1	0.99999999854637	0.99999999854637	1
down	CLDN7; STXBP1; PRKCZ; EIF4EBP1; IMPACT; HDAC6;	GO:0031333~negative regulation of protein-containing complex assembly	6	37	16.2162162162162	0.0479659077144128	0.155341748963822	1	1	0.999999999999289	0.999999999999289	1
down	TRIM16; ACTL6A; KAT5; NAA50; RUVBL2; MORF4L2;	GO:0043967~histone H4 acetylation	6	37	16.2162162162162	0.0479659077144128	0.155341748963822	1	1	0.999999999999289	0.999999999999289	1
down	TACSTD2; SCNN1A; SCNN1G; IRX5; TGFBI; MYO3A; BBS10; OPA3; CABP1;	GO:0050896~response to stimulus	9	68	13.2352941176471	0.0481818736448819	0.155341748963822	1	1	0.999999999999289	0.999999999999289	1
up	TYROBP; DKK1; IFNG; ITGB2; ITGAM; ADORA1; SNCA;	GO:1901216~positive regulation of neuron death	7	38	18.4210526315789	0.048196632496576	0.562930304968259	1	1	0.99999999854637	0.99999999854637	1
up	AIM2; PYCARD; MNDA; PYHIN1;	GO:0032731~positive regulation of interleukin-1 beta production	4	15	26.6666666666667	0.0488925524616732	0.563618055901829	1	1	0.99999999854637	0.99999999854637	1
up	IFNG; IL2RA; CTLA4; CR1;	GO:0045589~regulation of regulatory T cell differentiation	4	15	26.6666666666667	0.0488925524616732	0.563618055901829	1	1	0.99999999854637	0.99999999854637	1
up	SRGN; NLRP12; RGCC; TNFRSF4;	GO:0050710~negative regulation of cytokine secretion	4	15	26.6666666666667	0.0488925524616732	0.563618055901829	1	1	0.99999999854637	0.99999999854637	1
up	CCL5; SPN; AIF1; PYCARD;	GO:2000406~positive regulation of T cell migration	4	15	26.6666666666667	0.0488925524616732	0.563618055901829	1	1	0.99999999854637	0.99999999854637	1
